"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties"
"CHEMBL1289";"HALOPROGIN";"4";"361.39";"0";"4.42";"HALOPROGIN";"Clc1cc(Cl)c(OCC#CI)cc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL427216";"GLICLAZIDE";"4";"323.42";"0";"1.63";"GLICLAZIDE";"Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL222863";"OUABAIN";"4";"584.66";"3";"-1.51";"OUABAIN";"C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL502896";"CETRAXATE HYDROCHLORIDE";"0";"341.84";"0";"2.37";"CETRAXATE";"Cl.NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL110691";"CHLORMADINONE ACETATE";"4";"404.93";"0";"4.75";"CHLORMADINONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3545252";"DOCETAXEL";"4";"861.94";"2";"3.26";"DOCETAXEL";"CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C.O.O.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL228998";"";"0";"317.39";"0";"2.36";"BDBM50213097";"COc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1";"IC50";"'='";"3.16";"nM";"8.50";"";"365706";"UO_0000065";"26.78";"0.50";"6.14";"10.37";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL270299";"BAY-11-7085";"0";"249.34";"0";"2.80";"BAY-117085";"CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3943564";"";"0";"801.94";"4";"5.33";"BDBM221908";"COc1cc(NC(=O)OCCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(C#N)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12";"IC50";"'='";"4.5";"nM";"8.35";"";"388368";"UO_0000065";"10.41";"0.20";"3.02";"4.04";"False";"CHEMBL3888303";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 μg/well for beta1 and 5 μg/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 μl, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 μM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886646";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL302893";"";"0";"624.64";"1";"4.89";"7f";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(OC(F)(F)F)cc3)n2)cc1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"9.28";"0.18";"0.91";"4.42";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL941";"IMATINIB";"4";"493.62";"0";"4.59";"IMATINIB";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL160";"CYCLOSPORINE";"4";"1202.63";"None";"None";"CYCLOSPORIN A";"C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL115";"INDINAVIR";"4";"613.80";"1";"2.87";"INDINAVIR";"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL63963";"";"0";"572.67";"1";"4.06";"12a";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3cccc(F)c3)n2)cc1";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"11.21";"0.21";"2.36";"5.26";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL2112075";"";"0";"445.39";"0";"4.72";"38, (NPS 2143,SB-262470A)";"CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1cccc(Cl)c1C#N.Cl";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"13.12";"0.25";"0.65";"8.22";"False";"CHEMBL952690";"Binding affinity to beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137011";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL382741";"";"0";"374.48";"0";"4.06";"5";"CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1ccccc1C#N";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"False";"CHEMBL1052906";"Inhibition of beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154613";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL135";"ESTRADIOL";"4";"272.39";"0";"3.61";"BETA-ESTRADIOL";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1089735";"";"0";"430.55";"0";"3.80";"47";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1N1CCCC1";"IC50";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"12.25";"0.23";"1.48";"6.81";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1078575";"";"0";"477.57";"0";"4.74";"55";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1nc2ccccc2[nH]1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1078495";"";"0";"467.57";"0";"4.78";"56";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1COc1ccccc1";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"11.39";"0.21";"0.55";"6.38";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1078496";"";"0";"454.57";"0";"4.24";"57";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(CCn2cccc2)c1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"13.69";"0.25";"1.98";"7.86";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1094715";"";"0";"365.44";"0";"1.78";"33";"O=C(Cn1cccn1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1091479";"";"0";"407.52";"0";"2.96";"40";"Cc1cc(C)n(C(C)C(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL509";"MECLOFENAMIC ACID";"4";"296.15";"0";"4.74";"MECLOFENAMIC ACID";"Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL6437";"MIANSERIN";"4";"264.37";"0";"3.08";"MIANSERIN";"CN1CCN2c3ccccc3Cc3ccccc3C2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL294042";"L-749372";"0";"553.42";"1";"3.06";"8";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(I)cc1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"12.57";"0.31";"3.90";"6.92";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL4095361";"";"0";"552.68";"1";"3.79";"19b";"Cc1nnc(-c2cccc(CN3CCN(C(=O)c4ccc(C[C@@H]5CC[C@H]([C@H](O)c6ccccc6)N5)cc4)CC3)n2)o1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4004025";"Activity at human beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4074920";"";"0";"552.68";"1";"3.79";"19c";"Cc1noc(-c2cccc(CN3CCN(C(=O)c4ccc(C[C@@H]5CC[C@H]([C@H](O)c6ccccc6)N5)cc4)CC3)n2)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4004025";"Activity at human beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL513389";"ICI-118551";"0";"277.41";"0";"2.61";"ICI-118551";"Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"31.01";"0.59";"5.99";"20.73";"False";"CHEMBL1663576";"Inhibition of human alpha2 adrenoceptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649335";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2010";"None";""
"CHEMBL21731";"MAPROTILINE";"4";"277.41";"0";"4.21";"MAPROTILINE";"CNCCCC12CCC(c3ccccc31)c1ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL458019";"PARAQUAT DICHLORIDE";"0";"257.16";"0";"1.00";"PARAQUAT DICHLORIDE";"C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL13341";"NIMETAZEPAM";"0";"295.30";"0";"2.41";"NIMETAZEPAM";"CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909071";"";"0";"None";"None";"None";"NOVARTIS P-38 INHIBITOR";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL56564";"TROPISETRON";"4";"284.36";"0";"2.95";"TROPISETRON";"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)c1c[nH]c3ccccc13)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL990";"BUTENAFINE";"4";"317.48";"1";"5.77";"BUTENAFINE";"CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1371125";"BENZO[E]PYRENE";"0";"252.32";"1";"5.74";"BENZO[E]PYRENE";"c1ccc2c(c1)c1cccc3ccc4cccc2c4c31";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL452861";"(-)-PROPANOLOL ";"2";"259.35";"0";"2.58";"S-(-)-PROPRANOLOL";"CC(C)NC[C@H](O)COc1cccc2ccccc12";"IC50";"'='";"0.355";"nM";"9.45";"";"";"UO_0000065";"36.44";"0.68";"6.87";"22.78";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL24944";"TRIBROMSALAN";"4";"449.92";"0";"4.93";"TRIBROMSALAN";"O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL104127";"";"0";"335.43";"0";"1.32";"5a";"CS(=O)(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"14.91";"0.30";"3.68";"5.48";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL488025";"EXISULIND";"3";"372.42";"0";"4.03";"SULINDAC SULFONE";"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL154111";"SALSALATE";"4";"258.23";"0";"2.31";"SALSALATE";"O=C(Oc1ccccc1C(=O)O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL588119";"SULOCTIDIL";"0";"337.57";"1";"5.56";"SULOCTIDIL";"CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1643";"RIBAVIRIN";"4";"244.21";"0";"-3.01";"RIBAVIRIN";"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1447";"LINCOMYCIN";"4";"406.55";"0";"-0.86";"LINCOMYCIN";"CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL163";"RITONAVIR";"4";"720.96";"2";"5.91";"RITONAVIR";"CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL479";"THIORIDAZINE";"4";"370.59";"1";"5.89";"THIORIDAZINE";"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL493";"BROMOCRIPTINE";"4";"654.61";"1";"3.19";"BROMOCRIPTINE";"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL311350";"PIROMIDIC ACID";"0";"288.31";"0";"1.11";"PIROMIDIC ACID";"CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL727";"THIOGUANINE";"4";"167.20";"0";"0.60";"THIOGUANINE";"Nc1nc2[nH]cnc2c(=S)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL190";"THEOPHYLLINE";"4";"180.17";"0";"-1.04";"THEOPHYLLINE";"Cn1c(=O)c2nc[nH]c2n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1515611";"BROMISOVALUM";"0";"223.07";"0";"0.60";"BROMISOVALUM";"CC(C)C(Br)C(=O)NC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1321154";"ROXARSONE";"0";"263.04";"None";"None";"ROXARSONE";"O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL526";"PROPOFOL";"4";"178.27";"0";"3.64";"PROPOFOL";"CC(C)c1cccc(C(C)C)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL712";"ANISINDIONE";"4";"252.27";"0";"2.86";"ANISINDIONE";"COc1ccc(C2C(=O)c3ccccc3C2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3215298";"ABAMECTIN";"3";"1732.15";"None";"None";"ABAMECTIN";"CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200391";"TROMETHAMINE";"4";"121.14";"0";"-2.34";"TROMETHAMINE";"NC(CO)(CO)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL637";"VENLAFAXINE";"4";"277.41";"0";"3.04";"VENLAFAXINE";"COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL415324";"TRANILAST";"3";"327.34";"0";"3.05";"TRANILAST";"COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1054";"TRICHLORMETHIAZIDE";"4";"380.66";"0";"0.82";"TRICHLORMETHIAZIDE";"NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL70586";"SPIRADOLINE";"0";"425.40";"0";"4.56";"SPIRADOLINE";"CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1386";"TRANSPLATIN";"3";"300.05";"None";"None";"TRANS-PLATINUM(II)DIAMMINE DICHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL310555";"OXYQUINOLINE";"0";"145.16";"0";"1.94";"OXYQUINOLINE";"Oc1cccc2cccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL748";"PRALIDOXIME CHLORIDE";"4";"172.61";"0";"0.32";"PRALIDOXIME CHLORIDE";"C[n+]1ccccc1/C=N/O.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL716";"QUETIAPINE";"4";"383.52";"0";"2.86";"QUETIAPINE";"OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909064";"LIPOPOLYSACCHARIDE E. COLI O55:B5";"0";"None";"None";"None";"LIPOPOLYSACCHARIDE E. COLI O55:B5";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909068";"";"0";"None";"None";"None";"MC 258717";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1196";"PROPARACAINE";"4";"294.39";"0";"2.56";"PROPARACAINE";"CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL511";"PYRILAMINE";"4";"285.39";"0";"2.66";"PYRILAMINE";"COc1ccc(CN(CCN(C)C)c2ccccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1428";"NIMODIPINE";"4";"418.45";"0";"2.97";"NIMODIPINE";"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1065";"METHYSERGIDE";"0";"353.47";"0";"1.94";"METHYSERGIDE";"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL564";"PROMAZINE";"4";"284.43";"0";"4.24";"PROMAZINE";"CN(C)CCCN1c2ccccc2Sc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL649";"NADOLOL";"4";"309.41";"0";"0.63";"NADOLOL";"CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL119385";"NEFLAMAPIMOD";"2";"436.27";"1";"5.49";"VX-745";"O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL79";"LIDOCAINE";"4";"234.34";"0";"2.58";"LIDOCAINE";"CCN(CC)CC(=O)Nc1c(C)cccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3183075";"NIZATIDINE";"4";"331.47";"0";"1.32";"NIZATIDINE";"CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1306";"TERCONAZOLE";"4";"532.47";"1";"4.46";"TERCONAZOLE";"CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL165";"RESVERATROL";"3";"228.25";"0";"2.97";"RESVERATROL";"Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1208572";"SALINOMYCIN";"0";"751.01";"2";"6.19";"SALINOMYCIN";"CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1172";"DESLORATADINE";"4";"310.83";"0";"4.02";"DESLORATADINE";"Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL52440";"DEXTROMETHORPHAN";"4";"271.40";"0";"3.38";"DEXTROMETHORPHAN";"COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1148";"TORSEMIDE";"4";"348.43";"0";"2.53";"TORSEMIDE";"Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1566956";"TROXIPIDE";"0";"294.35";"0";"1.19";"TROXIPIDE";"COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL714";"ALBUTEROL";"4";"239.31";"0";"1.31";"(rac)-4";"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1";"IC50";"'='";"980.0";"nM";"6.01";"";"";"UO_0000065";"25.11";"0.48";"4.70";"8.26";"False";"CHEMBL1010734";"Displacement of [3H]CGP1217 from human recombinant adrenergic beta2 receptor transfected in insect Sf9 cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152790";"1";"Scientific Literature";"J. Med. Chem.";"2009";"CHEMBL3308860";""
"CHEMBL509336";"RACTOPAMINE";"0";"301.39";"0";"2.74";"(rac)-3";"CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)cc1";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"21.51";"0.40";"3.74";"8.91";"False";"CHEMBL1010734";"Displacement of [3H]CGP1217 from human recombinant adrenergic beta2 receptor transfected in insect Sf9 cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152790";"1";"Scientific Literature";"J. Med. Chem.";"2009";"CHEMBL3308860";""
"CHEMBL17157";"TERFENADINE";"4";"471.69";"1";"6.45";"TERFENADINE";"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1697694";"AFLATOXIN";"0";"312.28";"0";"2.28";"AFLATOXIN B1";"COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1455";"ALTRETAMINE";"4";"210.28";"0";"0.07";"ALTRETAMINE";"CN(C)c1nc(N(C)C)nc(N(C)C)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL130";"CHLORAMPHENICOL";"4";"323.13";"0";"0.91";"CHLORAMPHENICOL";"O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL167911";"DICHLORVOS";"0";"220.98";"0";"2.68";"DICHLORVOS";"COP(=O)(OC)OC=C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL580";"LORAZEPAM";"4";"321.16";"0";"3.10";"LORAZEPAM";"O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1504";"TRIAMCINOLONE ACETONIDE";"4";"434.50";"0";"2.42";"TRIAMCINOLONE ACETONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4";"OFLOXACIN";"4";"361.37";"0";"1.54";"OFLOXACIN";"CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL583";"GREPAFLOXACIN";"4";"359.40";"0";"2.28";"GREPAFLOXACIN";"Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL788";"IDOXURIDINE";"4";"354.10";"0";"-1.22";"IDOXURIDINE";"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL817";"TOLAZAMIDE";"4";"311.41";"0";"1.77";"TOLAZAMIDE";"Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909055";"COBALTOUS CHLORIDE";"4";"129.84";"None";"None";"COBALT (II) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL529";"AZITHROMYCIN";"4";"749.00";"2";"1.90";"AZM";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201203";"BENZTROPINE";"4";"307.44";"0";"4.42";"BENZTROPINE";"CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909048";"";"0";"313.83";"0";"4.43";"1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"O=C(c1ccccc1Cl)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1371";"CHLORZOXAZONE";"4";"169.57";"0";"1.77";"CHLORZOXAZONE";"O=c1[nH]c2cc(Cl)ccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL2079587";"STANOZOLOL";"4";"328.50";"0";"4.12";"STANOZOLOL";"C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1243";"SULFABENZAMIDE";"4";"276.32";"0";"1.39";"SULFABENZAMIDE";"Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1940686";"";"0";"446.54";"1";"1.34";"5e";"OCc1cc(C(O)CN[C@H]2CC[C@H](NCC(O)c3ccc(O)c(CO)c3)CC2)ccc1O";"IC50";"'='";"5011.87";"nM";"5.30";"";"";"UO_0000065";"11.87";"0.23";"3.96";"3.64";"False";"CHEMBL1943767";"Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938358";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1940810";"";"0";"468.55";"1";"1.73";"5h";"OCc1cc(C(O)CNCc2cccc(CNCC(O)c3ccc(O)c(CO)c3)c2)ccc1O";"IC50";"'='";"19952.62";"nM";"4.70";"";"";"UO_0000065";"10.03";"0.19";"2.97";"3.23";"False";"CHEMBL1943767";"Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938358";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1940812";"";"0";"468.55";"1";"2.09";"5j";"OCc1cc(C(O)CNCCc2ccc(NCC(O)c3ccc(O)c(CO)c3)cc2)ccc1O";"IC50";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"14.09";"0.27";"4.51";"4.54";"False";"CHEMBL1943767";"Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938358";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945291";"";"0";"493.63";"0";"3.80";"39";"COc1ccccc1CN(C)Cc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"15.40";"0.30";"3.80";"7.77";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL229401";"";"0";"337.42";"0";"3.51";"BDBM50213115";"C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1";"IC50";"'='";"1.57";"nM";"8.80";"";"365708";"UO_0000065";"26.09";"0.48";"5.29";"12.11";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL437002";"";"0";"297.37";"0";"3.92";"1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"O=C(c1ccccc1F)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1944692";"";"0";"481.59";"0";"3.63";"19";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4F)cc3)c2s1";"IC50";"'='";"1.995";"nM";"8.70";"";"";"UO_0000065";"18.07";"0.35";"5.07";"8.93";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945039";"";"0";"479.60";"0";"3.46";"31";"COc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1";"IC50";"'='";"6.31";"nM";"8.20";"";"";"UO_0000065";"17.10";"0.33";"4.74";"7.69";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945040";"";"0";"479.60";"0";"3.46";"32";"COc1ccccc1CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1";"IC50";"'='";"125.89";"nM";"6.90";"";"";"UO_0000065";"14.39";"0.28";"3.44";"6.47";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945294";"";"0";"413.54";"0";"2.76";"42";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CN4CCCC4)c3)c2s1";"IC50";"'='";"3.981";"nM";"8.40";"";"";"UO_0000065";"20.31";"0.40";"5.64";"9.48";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945298";"";"0";"497.59";"0";"3.47";"46";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOc3cccc(CNCCc4ccccc4F)c3)c2s1";"IC50";"'='";"7.943";"nM";"8.10";"";"";"UO_0000065";"16.28";"0.32";"4.63";"7.60";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL93645";"ACECLOFENAC";"4";"354.19";"0";"3.91";"ACECLOFENAC";"O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909073";"PIPERILATE ETHOBROMIDE";"0";"448.40";"0";"3.49";"PIPERILATE ETHOBROMIDE";"CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1517";"OXYTETRACYCLINE";"4";"460.44";"1";"-1.24";"OXYTETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200709";"CROTAMITON";"4";"203.28";"0";"2.92";"CROTAMITON";"C/C=C/C(=O)N(CC)c1ccccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL47244";"PICROTOXININ";"0";"292.29";"0";"-0.06";"COCCULIN";"C=C(C)[C@H]1[C@@H]2C(=O)O[C@H]1[C@H]1OC(=O)[C@@]34O[C@@H]3C[C@]2(O)[C@@]14C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL500";"PINDOLOL";"4";"248.33";"0";"1.91";"PINDOLOL";"CC(C)NCC(O)COc1cccc2[nH]ccc12";"IC50";"'='";"0.549";"nM";"9.26";"";"";"UO_0000065";"37.29";"0.70";"7.35";"16.17";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL506";"PRIMAQUINE";"4";"259.35";"0";"2.78";"PRIMAQUINE";"COc1cc(NC(C)CCCN)c2ncccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3747487";"";"0";"450.58";"0";"3.50";"24b";"CCOC(=O)C1CCN(C(=O)c2ccc(C[C@@H]3CC[C@H]([C@H](O)c4ccccc4)N3)cc2)CC1";"IC50";"'='";"10900.0";"nM";"4.96";"";"";"UO_0000065";"11.01";"0.21";"1.46";"6.29";"False";"CHEMBL3750559";"Displacement of [125I]CYP from human beta-2 adrenergic receptor expressed in CHO cell membrane after 1 hr by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745665";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2016";"CHEMBL3308072";""
"CHEMBL3747710";"";"0";"470.64";"0";"3.12";"24e";"CCS(=O)(=O)C1CCN(C(=O)c2ccc(C[C@@H]3CC[C@H]([C@H](O)c4ccccc4)N3)cc2)CC1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3750559";"Displacement of [125I]CYP from human beta-2 adrenergic receptor expressed in CHO cell membrane after 1 hr by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745665";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2016";"CHEMBL3308072";""
"CHEMBL1144";"PRAVASTATIN";"4";"424.53";"0";"2.44";"PRAVASTATIN";"CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1006";"AMIFOSTINE";"4";"214.23";"0";"-0.25";"AMIFOSTINE";"NCCCNCCSP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1475";"TRIOXSALEN";"4";"228.25";"0";"3.46";"TRIOXSALEN";"Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1451";"TRIAMCINOLONE";"4";"394.44";"0";"0.62";"TRIAMCINOLONE";"C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL156455";"1,1-DICHLOROETHENE";"0";"96.94";"0";"1.94";"1,1-DICHLOROETHENE";"C=C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3704833";"";"0";"303.36";"0";"0.53";"BDBM175238";"N#CC1CCCN1C(=O)CNCC(O)COc1ccccc1";"IC50";"'='";"32000.0";"nM";"4.50";"";"321186";"UO_0000065";"14.82";"0.28";"3.96";"5.25";"False";"CHEMBL3705663";"Inhibition Assay: Human recombinant adrenergic β2 receptors expressed in CHO cells are used in modified Tris-HCl buffer pH 7.4. A 50 aliquot is incubated with 0.2 nM [3H]CGP-12177 for 60 minutes at 25° C. Non-specific binding is estimated in the presence of 10 μM ICI-118551. Receptors are filtered and washed, the filters are then counted to determine [3H]CGP-12177 specifically bound. Compounds are screened at 10 μM.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639212";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";""
"CHEMBL34259";"METHOTREXATE";"4";"454.45";"0";"0.27";"METHOTREXATE";"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL7568";"QUINACRINE";"2";"399.97";"1";"5.97";"QUINACRINE";"CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1042";"CHOLECALCIFEROL";"4";"384.65";"1";"7.62";"CHOLECALCIFEROL";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL104";"CLOTRIMAZOLE";"4";"344.85";"1";"5.38";"CLOTRIMAZOLE";"Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL683";"CLOFIBRIC ACID";"0";"214.65";"0";"2.58";"CLOFIBRIC ACID";"CC(C)(Oc1ccc(Cl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL572";"NITROFURANTOIN";"4";"238.16";"0";"0.07";"NITROFURANTOIN";"O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL481";"IRINOTECAN";"4";"586.69";"1";"4.09";"IRINOTECAN";"CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL267744";"TICRYNAFEN";"4";"331.18";"0";"3.75";"TICRYNAFEN";"O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL88";"CYCLOPHOSPHAMIDE";"4";"261.09";"0";"1.88";"CYCLOPHOSPHAMIDE";"O=P1(N(CCCl)CCCl)NCCCO1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL452";"CLONAZEPAM";"4";"315.72";"0";"3.04";"CLONAZEPAM";"O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL625";"THIABENDAZOLE";"4";"201.25";"0";"2.69";"THIABENDAZOLE";"c1ccc2[nH]c(-c3cscn3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL24441";"BETAHISTINE";"4";"136.20";"0";"0.84";"BETAHISTINE";"CNCCc1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1479";"DANAZOL";"4";"337.46";"0";"4.22";"DANAZOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL898";"DIFLUNISAL";"4";"250.20";"0";"3.04";"DIFLUNISAL";"O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL508338";"THIMEROSAL";"4";"404.82";"None";"None";"THIMEROSAL";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL2105617";"AJMALINE";"3";"326.44";"0";"1.55";"AJMALINE";"CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL441687";"GLYCYRRHIZIN";"2";"822.94";"3";"2.25";"GLYCYRRHIZIN";"CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL640";"PROCAINAMIDE";"4";"235.33";"0";"1.34";"PROCAINAMIDE";"CCN(CC)CCNC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL30";"CIMETIDINE";"4";"252.35";"0";"0.60";"CIMETIDINE";"CN/C(=N/CCSCc1nc[nH]c1C)NC#N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL45245";"";"0";"195.22";"0";"2.68";"6(5H)-PHENANTHRIDINONE";"O=c1[nH]c2ccccc2c2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1016";"CANDESARTAN";"3";"440.46";"0";"4.03";"CANDESARTAN";"CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL457299";"MACROGOL";"4";"62.07";"0";"-1.03";"ETHYLENE GLYCOL";"OCCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1105";"6-METHOXY-2-NAPHTHYLACETIC ACID";"0";"216.24";"0";"2.48";"6-METHOXY-2-NAPHTHYLACETIC ACID";"COc1ccc2cc(CC(=O)O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL445206";"ISOEUGENOL";"0";"164.20";"0";"2.43";"ISOEUGENOL";"C/C=C\c1ccc(O)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL245416";"L-MIMOSINE";"0";"198.18";"0";"-1.03";"L-MIMOSINE";"N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL561";"LOMEFLOXACIN";"4";"351.35";"0";"1.80";"LOMEFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL290916";"EDARAVONE";"4";"174.20";"0";"1.80";"EDARAVONE";"CC1=NN(c2ccccc2)C(=O)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL98350";"LY-294002";"0";"307.35";"0";"3.30";"LY-294002";"O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201010";"FLUDROCORTISONE ACETATE";"4";"422.49";"0";"2.44";"FLUDROCORTISONE ACETATE";"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL888";"GEMCITABINE";"4";"263.20";"0";"-1.29";"GEMCITABINE";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL914";"FEXOFENADINE";"4";"501.67";"2";"5.51";"FEXOFENADINE";"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1727";"CEPHALEXIN";"4";"347.40";"0";"0.44";"CEPHALEXIN";"CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL565";"CLOFIBRATE";"4";"242.70";"0";"3.06";"CLOFIBRATE";"CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1149";"LEVOCARNITINE";"4";"161.20";"0";"-1.81";"LEVOCARNITINE";"C[N+](C)(C)C[C@H](O)CC(=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL14060";"PHENOL";"4";"94.11";"0";"1.39";"PHENOL";"Oc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1601669";"ALFACALCIDOL";"4";"400.65";"1";"6.59";"ALFACALCIDOL";"C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL19019";"NALTREXONE";"4";"341.41";"0";"1.53";"NTX";"O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL469";"KETOROLAC";"4";"255.27";"0";"2.29";"ketorolac";"O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL58";"MITOXANTRONE";"4";"444.49";"1";"-0.14";"MITOXANTRONE";"O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL164290";"N-NITROSODIETHYLAMINE";"0";"102.14";"0";"1.01";"N-NITROSODIETHYLAMINE";"CCN(CC)N=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909072";"PIPAMAZINE";"4";"401.96";"0";"4.53";"PIPAMAZINE";"NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1162";"NORETHINDRONE";"4";"298.43";"0";"3.49";"NORETHINDRONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL105";"MITOMYCIN";"4";"334.33";"0";"-1.65";"MITOMYCIN C";"CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1712923";"IRSOGLADINE MALEATE";"1";"372.17";"0";"2.01";"IRSOGLADINE MALEATE";"Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909070";"NAFENOPIN";"0";"310.39";"0";"4.40";"NAFENOPIN";"CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL2107687";"VALETHAMATE BROMIDE";"0";"386.37";"0";"3.85";"VALETHAMATE BROMIDE";"CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3915401";"";"0";"774.96";"3";"5.31";"BDBM200745";"CN(CCN(C)[C@H]1CC[C@H](OC(C(=O)O)(c2cccs2)c2cccs2)CC1)C(=O)COc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1";"IC50";"'='";"34.0";"nM";"7.47";"";"356813";"UO_0000065";"9.64";"0.19";"2.16";"4.54";"False";"CHEMBL3887836";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 ug/well for beta1 and 5 ug/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 ul, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 uM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886468";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL3908788";"";"0";"774.99";"3";"5.67";"BDBM200749";"CN(CCCn1c(=O)sc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1";"IC50";"'='";"4.2";"nM";"8.38";"";"356817";"UO_0000065";"10.81";"0.22";"2.71";"5.33";"False";"CHEMBL3887836";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 ug/well for beta1 and 5 ug/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 ul, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 uM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886468";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL852";"MELPHALAN";"4";"305.21";"0";"1.93";"MELPHALAN";"N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1411979";"METHAPYRILENE";"4";"261.39";"0";"2.71";"METHAPYRILENE";"CN(C)CCN(Cc1cccs1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1020";"TOLMETIN";"4";"257.29";"0";"2.19";"TOLMETIN";"Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL37161";"FENBENDAZOLE";"0";"299.36";"0";"3.89";"FENBENDAZOLE";"COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL549";"CITALOPRAM";"4";"324.40";"0";"3.81";"CITALOPRAM";"CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL44657";"ETOPOSIDE";"4";"588.56";"2";"1.34";"ETOPOSIDE";"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL902";"FAMOTIDINE";"4";"337.46";"0";"-0.77";"FAMOTIDINE";"NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1771";"CLOPIDOGREL";"4";"321.83";"0";"3.67";"CLOPIDOGREL";"COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL414804";"OXALIPLATIN";"4";"395.27";"None";"None";"OXALIPLATIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL189171";"ACEMETACIN";"4";"415.83";"0";"3.47";"ACEMETACIN";"COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL276257";"";"0";"568.43";"1";"3.37";"40";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(I)cc1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"12.18";"0.30";"3.55";"6.41";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL1087";"MEPIVACAINE";"4";"246.35";"0";"2.73";"MEPIVACAINE";"Cc1cccc(C)c1NC(=O)C1CCCCN1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1221";"SULCONAZOLE";"4";"397.76";"1";"6.52";"SULCONAZOLE";"Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1946765";"";"0";"459.62";"0";"4.32";"6";"O=c1[nH]c2c(O)ccc(CCNCCc3cccc(CN[C@H]4C[C@@H]4c4ccccc4)c3)c2s1";"IC50";"'='";"12.59";"nM";"7.90";"";"";"UO_0000065";"17.19";"0.33";"3.58";"10.24";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1946761";"";"0";"516.49";"2";"5.31";"2";"O=c1[nH]c2c(O)ccc(CCNCCc3ccc(CNCCc4c(Cl)cccc4Cl)cc3)c2s1";"IC50";"'='";"501.19";"nM";"6.30";"";"";"UO_0000065";"12.20";"0.25";"0.99";"8.17";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1940815";"";"0";"422.53";"1";"2.90";"8";"OCc1cc(C(O)CNCCc2ccc(NCC(O)c3ccccc3)cc2)ccc1O";"IC50";"'='";"39.81";"nM";"7.40";"";"";"UO_0000065";"17.51";"0.33";"4.50";"7.05";"False";"CHEMBL1943767";"Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938358";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1947156";"";"0";"525.67";"2";"5.12";"Table 2, R9C7";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(-c4cccc(CNCc5ccccc5)c4)c3)c2s1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"15.22";"0.29";"2.88";"8.22";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1944689";"";"0";"532.49";"1";"4.80";"16";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4c(Cl)cccc4Cl)cc3)c2s1";"IC50";"'='";"3.981";"nM";"8.40";"";"";"UO_0000065";"15.77";"0.33";"3.60";"8.63";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945037";"";"0";"477.63";"0";"3.88";"29";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccc4)c3)c2s1";"IC50";"'='";"0.7943";"nM";"9.10";"";"";"UO_0000065";"19.05";"0.37";"5.22";"9.34";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945042";"";"0";"467.57";"0";"3.59";"34";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4F)c3)c2s1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"19.25";"0.37";"5.41";"9.24";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945503";"";"0";"458.56";"0";"2.83";"49";"O=c1ccc2c([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)ccc(O)c2[nH]1";"IC50";"'='";"63.1";"nM";"7.20";"";"";"UO_0000065";"15.70";"0.29";"4.37";"6.53";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1940685";"";"0";"542.72";"2";"3.54";"5d";"OCc1cc(C(O)CNC2CCC(CC3CCC(NCC(O)c4ccc(O)c(CO)c4)CC3)CC2)ccc1O";"IC50";"'='";"19952.62";"nM";"4.70";"";"";"UO_0000065";"8.66";"0.16";"1.16";"3.23";"False";"CHEMBL1943767";"Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938358";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1399";"ANASTROZOLE";"4";"293.37";"0";"2.93";"ANASTROZOLE";"CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL63842";"";"0";"521.44";"1";"2.80";"25";"Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(Br)cc3)cc2)cn1";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"12.31";"0.27";"3.62";"5.07";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL268289";"";"0";"569.72";"1";"4.67";"11";"CCCCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"11.65";"0.23";"1.97";"4.85";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL13106";"";"0";"543.64";"1";"3.72";"16";"CC(C)OC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"12.28";"0.24";"2.96";"4.57";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL1630578";"TIRILAZAD";"3";"624.87";"2";"5.46";"TIRILAZAD";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1";"IC50";"'='";"22659.0";"nM";"4.64";"";"";"UO_0000065";"7.43";"0.14";"-0.82";"6.37";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL513389";"ICI-118551";"0";"277.41";"0";"2.61";"ICI-118551";"Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"31.14";"0.59";"6.03";"20.82";"False";"CHEMBL884282";"Percent inhibition against Beta-2 adrenergic receptor at 1 uM";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140374";"1";"Scientific Literature";"J. Med. Chem.";"2005";"None";""
"CHEMBL274807";"";"0";"448.59";"0";"3.04";"27";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C1CCCCC1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"12.31";"0.24";"2.48";"5.12";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL27";"PROPRANOLOL";"4";"259.35";"0";"2.58";"1";"CC(C)NCC(O)COc1cccc2ccccc12";"IC50";"'='";"50.12";"nM";"7.30";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3738004";"Antagonist activity at human beta2 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3734721";"1";"Scientific Literature";"J. Med. Chem.";"2015";"CHEMBL3307512";""
"CHEMBL229477";"";"0";"303.36";"0";"2.06";"BDBM50213103";"C[C@H](Cc1ccc(O)cc1)NC[C@@H](O)c1cc(O)cc(O)c1";"IC50";"'='";"6.74";"nM";"8.17";"";"365702";"UO_0000065";"26.94";"0.51";"6.11";"8.79";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL165513";"";"0";"579.77";"1";"4.96";"1e";"CCCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"10.35";"0.20";"1.04";"5.22";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL228992";"";"0";"317.39";"0";"2.36";"BDBM50213099";"COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1";"IC50";"'='";"0.17";"nM";"9.77";"";"365704";"UO_0000065";"30.78";"0.58";"7.41";"11.92";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL1385840";"ERGOCORNINE";"0";"561.68";"1";"2.04";"ERGOCORNINE";"CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL13432";"";"0";"582.72";"2";"4.22";"27";"O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1)NC1CCCCC1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"9.10";"0.18";"1.08";"3.56";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL12686";"";"0";"472.56";"0";"2.77";"35";"COc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"14.22";"0.28";"3.95";"5.74";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL111201";"";"0";"624.71";"2";"6.56";"3; MK-0634";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1";"IC50";"'='";"670.0";"nM";"6.17";"";"";"UO_0000065";"9.88";"0.20";"-0.39";"5.92";"False";"CHEMBL3767773";"Displacement of [125]I-cyanopindolol from human recombinant beta2 adrenergic receptor after 1 hr by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763146";"1";"Scientific Literature";"J. Med. Chem.";"2016";"None";""
"CHEMBL82296";"";"0";"565.74";"1";"4.57";"4a";"CCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"9.97";"0.19";"1.07";"4.91";"False";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL175";"DEXIBUPROFEN";"4";"206.28";"0";"3.07";"DEXIBUPROFEN";"CC(C)Cc1ccc([C@H](C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL56449";"";"0";"435.59";"1";"5.70";"12b";"CCCCCCc1ccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)nc1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"15.20";"0.29";"0.92";"10.63";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL1201146";"NORETHINDRONE ACETATE";"4";"340.46";"0";"4.06";"NORETHINDRONE ACETATE";"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL46";"ONDANSETRON";"4";"293.37";"0";"3.13";"ONDANSETRON";"Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL19299";"LOXOPROFEN";"3";"246.31";"0";"2.79";"LOXOPROFEN";"CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL741";"LAMOTRIGINE";"4";"256.10";"0";"2.01";"LAMOTRIGINE";"Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL276659";"";"0";"406.48";"0";"3.22";"18";"O=C(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"16.33";"0.30";"3.42";"7.31";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL975";"MESNA";"4";"164.18";"0";"-0.20";"MESNA";"O=S(=O)([O-])CCS.[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL57430";"";"0";"429.59";"0";"4.92";"5c";"CCCCCCCCNC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21";"IC50";"'='";"630.0";"nM";"6.20";"";"";"UO_0000065";"14.43";"0.28";"1.28";"7.90";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL124668";"";"0";"418.48";"0";"3.26";"3d";"N#CN/C(=N\c1cccc(F)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"16.01";"0.30";"3.44";"6.36";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL308126";"";"0";"568.70";"2";"4.87";"12";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(OCC3NCCc4cc(O)c(O)cc43)cc2)cc1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"11.47";"0.22";"1.65";"4.38";"False";"CHEMBL647877";"Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132774";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL287567";"";"0";"655.66";"2";"5.28";"6f";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(OC(F)(F)F)cc3)n2)cc1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"8.09";"0.16";"0.02";"3.56";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL3948979";"";"0";"765.35";"4";"5.88";"BDBM221901";"CN(CCC(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1Cl)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1";"IC50";"'='";"6.7";"nM";"8.17";"";"388361";"UO_0000065";"10.68";"0.21";"2.29";"4.98";"False";"CHEMBL3888303";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 μg/well for beta1 and 5 μg/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 μl, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 μM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886646";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL3963417";"";"0";"766.89";"4";"5.51";"BDBM221906";"CN(CCC(=O)Nc1cc(F)c(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1F)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1";"IC50";"'='";"13.0";"nM";"7.89";"";"388366";"UO_0000065";"10.28";"0.20";"2.38";"4.80";"False";"CHEMBL3888303";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 μg/well for beta1 and 5 μg/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 μl, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 μM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886646";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL325372";"METHYLPARABEN";"0";"152.15";"0";"1.18";"METHYLPARABEN";"COC(=O)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL80";"NALOXONE";"4";"327.38";"0";"1.30";"NALOXONE";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL274143";"";"0";"598.77";"1";"4.49";"29";"CCCCCCNC(=O)N(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"10.92";"0.21";"2.05";"4.66";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL13003";"";"0";"484.62";"0";"3.34";"30";"O=S(=O)(CCCc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"14.21";"0.28";"3.55";"6.38";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL410702";"";"0";"469.55";"0";"4.70";"7f";"O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1ccc2ccccc2c1";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"11.65";"0.21";"0.77";"4.87";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL1393";"SPIRONOLACTONE";"4";"416.58";"0";"4.85";"SPIRONOLACTONE";"CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL84";"TOPOTECAN";"4";"421.45";"0";"1.85";"TOPOTECAN";"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL289250";"";"0";"612.71";"1";"4.35";"5o";"CC(=O)Nc1ccc(Cc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"8.65";"0.16";"0.95";"3.33";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL421";"SULFASALAZINE";"4";"398.40";"0";"3.70";"SULFASALAZINE";"O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL714";"ALBUTEROL";"4";"239.31";"0";"1.31";"SALBUTAMOL";"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1";"IC50";"'='";"810.2";"nM";"6.09";"";"";"UO_0000065";"25.45";"0.49";"4.78";"8.38";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL415";"CLOMIPRAMINE";"4";"314.86";"0";"4.53";"CLOMIPRAMINE";"CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL44814";"CARBON TETRACHLORIDE";"0";"153.82";"0";"2.55";"CARBON TETRACHLORIDE";"ClC(Cl)(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL467";"HYDROXYUREA";"4";"76.05";"0";"-0.96";"HYDROXYUREA";"NC(=O)NO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL42442";"OXFENDAZOLE";"2";"315.35";"0";"2.91";"OXFENDAZOLE";"COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3916700";"";"0";"811.38";"4";"6.11";"BDBM221902";"COc1cc(NC(=O)OCCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12";"IC50";"'='";"1.6";"nM";"8.80";"";"388362";"UO_0000065";"10.84";"0.22";"2.69";"4.81";"False";"CHEMBL3888303";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 μg/well for beta1 and 5 μg/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 μl, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 μM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886646";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL63825";"";"0";"654.67";"1";"4.81";"15c";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(COc3ccc(OC(F)(F)F)cc3)n2)cc1";"IC50";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"9.48";"0.18";"1.40";"4.42";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL3940214";"";"0";"809.41";"4";"5.94";"BDBM221907";"COc1cc(NC(=O)CCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12";"IC50";"'='";"5.3";"nM";"8.28";"";"388367";"UO_0000065";"10.22";"0.21";"2.34";"4.77";"False";"CHEMBL3888303";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 μg/well for beta1 and 5 μg/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 μl, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 μM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886646";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL32418";"";"0";"639.70";"3";"5.21";"6h";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(C4N=NN=N4)cc3)n2)cc1";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"7.97";"0.15";"-0.11";"2.70";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL83753";"";"0";"591.78";"2";"5.06";"5b";"CCCCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"10.95";"0.21";"1.42";"5.48";"True";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL309673";"";"0";"579.72";"1";"4.10";"9a";"CCCCCCN1CC(=O)N(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL4290197";"";"0";"311.38";"0";"2.78";"3";"COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@]3(C)NCC2";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"24.73";"0.46";"4.92";"15.18";"False";"CHEMBL4258826";"Displacement of [3H]-CGP-12177 from human beta2-adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257493";"1";"Scientific Literature";"MedChemComm";"2018";"None";""
"CHEMBL33384";"";"0";"607.64";"1";"4.66";"9d";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(COc3ccc(F)c(F)c3)no2)cc1";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"8.98";"0.17";"0.80";"3.91";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL1684577";"";"0";"649.76";"2";"7.69";"31, 3:1 diastereomeric mixture";"O=S(=O)(Nc1ccc(CC2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1";"IC50";"'='";"2180.0";"nM";"5.66";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1687005";"Agonist activity at human beta2 adrenergic receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681775";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2011";"None";""
"CHEMBL1684583";"";"0";"649.76";"2";"7.69";"35, cis";"O=S(=O)(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1";"IC50";"'='";"2509.0";"nM";"5.60";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1687005";"Agonist activity at human beta2 adrenergic receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681775";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2011";"None";""
"CHEMBL3934681";"";"0";"778.92";"4";"5.38";"BDBM221905";"COc1cc(NC(=O)CCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(F)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12";"IC50";"'='";"4.8";"nM";"8.32";"";"388365";"UO_0000065";"10.68";"0.21";"2.94";"4.80";"False";"CHEMBL3888303";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 μg/well for beta1 and 5 μg/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 μl, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 μM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886646";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL4279962";"";"0";"297.35";"0";"2.60";"(-)-Nornuciferidine";"COc1cc2c3c(c1OC)-c1ccccc1[C@H](O)[C@H]3NCC2";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"19.49";"0.36";"3.20";"11.43";"False";"CHEMBL4258826";"Displacement of [3H]-CGP-12177 from human beta2-adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257493";"1";"Scientific Literature";"MedChemComm";"2018";"None";""
"CHEMBL296419";"ASTEMIZOLE";"4";"458.58";"1";"5.35";"ASTEMIZOLE";"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL267894";"AMOBARBITAL";"4";"226.28";"0";"1.39";"AMOBARBITAL";"CCC1(CCC(C)C)C(=O)N=C(O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL273348";"TOSUFLOXACIN";"0";"404.35";"0";"2.04";"TOSUFLOXACIN";"NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL63560";"(R)-BICALUTAMIDE";"0";"430.38";"0";"2.88";"(R)-BICALUTAMIDE";"C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL567597";"ARTEMISININ";"4";"282.34";"0";"2.39";"ARTEMISININ";"C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1230333";"";"0";"170.23";"0";"2.16";"4-(2-THIENYL)BUTYRIC ACID";"O=C(O)CCCc1cccs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4584173";"";"0";"628.86";"2";"3.13";"4e";"CC(C)NC[C@H](O)COc1ccccc1CCCC(=O)NCCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"6.457";"nM";"8.19";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4472564";"";"0";"642.88";"2";"3.52";"4f";"CC(C)NC[C@H](O)COc1ccccc1CCCC(=O)NCCCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"11.22";"nM";"7.95";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4442559";"";"0";"621.79";"2";"1.73";"5b";"CC(C)NC[C@H](O)COc1ccccc1Cn1cc(CNCc2cn(Cc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1";"IC50";"'='";"64.57";"nM";"7.19";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL266195";"ALPRENOLOL";"0";"249.35";"0";"2.15";"rac-ALP";"C=CCc1ccccc1OCC(O)CNC(C)C";"IC50";"'='";"1.148";"nM";"8.94";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4514723";"";"0";"677.90";"2";"2.90";"5d";"CC(C)NC[C@H](O)COc1ccccc1CCCn1cc(CNCc2cn(CCCc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1";"IC50";"'='";"1.202";"nM";"8.92";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL405245";"";"0";"645.72";"1";"3.96";"5g";"CNC(=O)NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"9.02";"0.17";"1.86";"3.40";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL308868";"";"0";"628.79";"3";"6.70";"6";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)c2)cc1";"IC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"9.78";"0.19";"-0.55";"4.40";"False";"CHEMBL647877";"Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132774";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL104551";"";"0";"425.55";"0";"2.93";"5c";"O=S(=O)(CCc1ccccc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"11.98";"0.23";"2.17";"5.58";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL34291";"";"0";"323.82";"0";"2.14";"12a";"COc1cc(N)c(Cl)cc1C(=O)NC[C@@H]1CCN2CCC[C@@H]12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL858809";"Binding affinity to adrenergic beta-2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149398";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL383577";"";"0";"299.37";"0";"2.21";"13h";"Cn1nc(C(=O)OC[C@@H]2CCN3CCC[C@@H]23)c2ccccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL858809";"Binding affinity to adrenergic beta-2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149398";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL201878";"";"0";"285.35";"0";"2.20";"13g";"O=C(OC[C@@H]1CCN2CCC[C@@H]12)c1[nH]nc2ccccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL858809";"Binding affinity to adrenergic beta-2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149398";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL2448165";"";"0";"321.81";"0";"1.61";"6";"COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1C2CC3CN(C2)CC31";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL858809";"Binding affinity to adrenergic beta-2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149398";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL399203";"";"0";"426.41";"0";"3.68";"9aa";"O=[N+]([O-])c1cc(O)c2c(c1)S(=O)(=O)N=C(Nc1ccccc1Oc1ccccc1)N2";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL896537";"Inhibition of adrenergic beta2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149534";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2007";"None";""
"CHEMBL8";"CIPROFLOXACIN";"4";"331.35";"0";"1.58";"CIPROFLOXACIN";"O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200559";"LACTIC ACID";"4";"90.08";"0";"-0.55";"LACTIC ACID";"CC(O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1679";"LEUCOVORIN";"4";"473.45";"1";"-0.73";"LEUCOVORIN";"Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL165015";"";"0";"551.71";"1";"4.18";"1c";"CCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"9.61";"0.19";"1.12";"4.61";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL83754";"";"0";"641.66";"1";"4.97";"1n";"O=C1N(CCCC(F)(F)C(F)(F)F)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"7.86";"0.16";"0.08";"4.39";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL1089395";"";"0";"437.54";"0";"4.87";"44";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1ccccc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1085442";"";"0";"427.51";"0";"3.59";"49";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1ncc[nH]1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1078876";"";"0";"444.58";"0";"4.11";"62";"Cc1ccc(C(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c(N2CCCC2)c1";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"10.79";"0.20";"0.69";"6.19";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL124929";"";"0";"636.87";"2";"7.17";"5a";"CCCCCCCCc1csc(N2CCc3ccc(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)cc32)n1";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"11.27";"0.21";"0.01";"5.91";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL832";"SULFINPYRAZONE";"4";"404.49";"0";"3.80";"SULFINPYRAZONE";"O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL124929";"";"0";"636.87";"2";"7.17";"5a";"CCCCCCCCc1csc(N2CCc3ccc(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)cc32)n1";"IC50";"";"";"nM";"";"";"Not Determined";"";"";"";"";"";"False";"CHEMBL647112";"Binding affinity towards human Beta-2 adrenergic receptor; ND= not determined";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"None";""
"CHEMBL13398";"";"0";"514.60";"2";"2.52";"19";"CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"12.43";"0.24";"3.88";"4.29";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL1200862";"METYROSINE";"4";"195.22";"0";"0.74";"METYROSINE";"C[C@](N)(Cc1ccc(O)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL12945";"";"0";"511.43";"1";"4.07";"36";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Cl)c(Cl)c1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"10.80";"0.23";"1.45";"5.12";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL4065251";"";"0";"489.62";"0";"2.05";"19f";"CCn1nnc(CN2CCN(C(=O)c3ccc(C[C@@H]4CC[C@H]([C@H](O)c5ccccc5)N4)cc3)CC2)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4004025";"Activity at human beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4092912";"";"0";"515.66";"1";"2.44";"19g";"O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1CCN(Cc2nnn(CC3CC3)n2)CC1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4004025";"Activity at human beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL34139";"GENACONAZOLE";"0";"331.34";"0";"0.88";"GENACONAZOLE (RR(+) ISOMER)";"C[C@H]([C@](O)(Cn1cncn1)c1ccc(F)cc1F)S(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1754";"DOXAPRAM";"4";"378.52";"0";"3.17";"DOXAPRAM";"CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL989";"FLUOCINOLONE ACETONIDE";"4";"452.49";"0";"2.37";"FLUOCINOLONE ACETONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL72";"DESIPRAMINE";"4";"266.39";"0";"3.53";"DESIPRAMINE";"CNCCCN1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1413";"CICLOPIROX";"4";"207.27";"0";"2.44";"CICLOPIROX";"Cc1cc(C2CCCCC2)n(O)c(=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL11359";"CISPLATIN";"4";"300.05";"None";"None";"CISPLATIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL622";"ETODOLAC";"4";"287.36";"0";"3.38";"ETODOLAC";"CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1626";"CLEMASTINE";"4";"343.90";"1";"5.10";"CLEMASTINE";"CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4527821";"";"0";"528.78";"2";"5.29";"1b";"CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"2.344";"nM";"8.63";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL1351";"CARBOPLATIN";"4";"371.25";"None";"None";"CARBOPLATIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4280606";"";"0";"301.39";"0";"2.57";"6";"COc1ccc(CCNC[C@H](O)c2ccccc2)cc1OC";"IC50";"'='";"8400.0";"nM";"5.08";"";"";"UO_0000065";"16.84";"0.32";"2.51";"10.01";"False";"CHEMBL4258826";"Displacement of [3H]-CGP-12177 from human beta2-adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257493";"1";"Scientific Literature";"MedChemComm";"2018";"None";""
"CHEMBL282618";"";"0";"678.87";"2";"7.35";"1";"NCCCCCOC[C@H]1O[C@@H](OCCc2c[nH]c3ccccc23)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"8.14";"0.15";"-1.83";"5.68";"False";"CHEMBL647109";"Binding affinity towards cloned human Beta-2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129787";"1";"Scientific Literature";"J. Med. Chem.";"1996";"None";""
"CHEMBL266195";"ALPRENOLOL";"0";"249.35";"0";"2.15";"rac-ALP";"C=CCc1ccccc1OCC(O)CNC(C)C";"IC50";"'='";"5.495";"nM";"8.26";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4441975";"";"0";"584.89";"2";"6.85";"1d";"CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"6.918";"nM";"8.16";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL41189";"";"0";"520.67";"1";"2.64";"2a";"CC(C)NC[C@H](O)COc1ccccc1OCCOCCOc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"46.77";"nM";"7.33";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4473518";"";"0";"500.72";"1";"4.51";"1a";"CC(C)NC[C@H](O)COc1ccccc1CCCCCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"3.802";"nM";"8.42";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL1501";"FLUOCINONIDE";"4";"494.53";"0";"2.94";"FLUOCINONIDE";"CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL643";"PROMETHAZINE";"4";"284.43";"0";"4.24";"PROMETHAZINE";"CC(CN1c2ccccc2Sc2ccccc21)N(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1370561";"AMINOPHYLLINE";"4";"420.43";"0";"-1.04";"AMINOPHYLLINE";"Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL14192";"BENZYLIMIDAZOLE";"0";"158.20";"0";"1.93";"1-BENZYLIMIDAZOLE";"c1ccc(Cn2ccnc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1333512";"N,N'-DIPHENYL-P-PHENYLENEDIAMINE";"0";"260.34";"1";"5.17";"N,N'-DIPHENYL-P-PHENYLENEDIAMINE";"c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL12674";"";"0";"470.59";"0";"2.95";"29";"O=S(=O)(CCc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"14.71";"0.29";"3.97";"6.41";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL301231";"";"0";"633.88";"2";"6.80";"1";"CCCCCCCCc1csc(N2CCc3cc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)ccc32)n1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"9.29";"0.18";"-0.91";"5.48";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL1160723";"LEVISOPRENALINE";"0";"211.26";"0";"1.13";"BDBM50407517";"CC(C)NC[C@H](O)c1ccc(O)c(O)c1";"IC50";"'='";"0.05";"nM";"10.30";"";"365699";"UO_0000065";"48.76";"0.94";"9.17";"14.17";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL228417";"";"0";"317.39";"0";"2.36";"BDBM50213102";"COc1ccc(C[C@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1";"IC50";"'='";"337.2";"nM";"6.47";"";"365707";"UO_0000065";"20.39";"0.38";"4.11";"7.90";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL229401";"";"0";"337.42";"0";"3.51";"BDBM50213115";"C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1";"IC50";"'='";"229.1";"nM";"6.64";"";"365711";"UO_0000065";"19.68";"0.36";"3.13";"9.13";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL323113";"";"0";"567.76";"2";"5.23";"5n";"CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"11.25";"0.22";"1.16";"4.82";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL351596";"";"0";"593.79";"2";"5.21";"1g";"CCCCC(C)(C)CN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"8.93";"0.17";"0.09";"4.61";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL66908";"";"0";"558.64";"1";"4.13";"7a";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3cccc(F)c3)n2)cc1";"IC50";"'='";"8800.0";"nM";"5.06";"";"";"UO_0000065";"9.05";"0.17";"0.93";"4.14";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL1946762";"";"0";"465.59";"0";"4.14";"3";"O=c1[nH]c2c(O)ccc(CCNCCc3ccc(CNCCc4ccccc4F)cc3)c2s1";"IC50";"'='";"1258.93";"nM";"5.90";"";"";"UO_0000065";"12.67";"0.24";"1.76";"7.65";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1946763";"";"0";"448.59";"0";"3.40";"4";"O=c1[nH]c2c(O)ccc(CCNCCc3ccc(CNCCc4ccccn4)cc3)c2s1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.60";"0.30";"3.60";"7.77";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1947150";"";"0";"521.69";"2";"5.85";"12";"O=c1[nH]c2c(O)ccc(CCNCCc3ccc(-c4cccc(CN5Cc6ccccc6C5)c4)cc3)c2s1";"IC50";"'='";"15.85";"nM";"7.80";"";"";"UO_0000065";"14.95";"0.28";"1.95";"11.41";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1947152";"";"0";"509.68";"2";"5.63";"14";"O=c1[nH]c2c(O)ccc(CCNCCc3cccc(-c4cccc(CNCc5ccccc5)c4)c3)c2s1";"IC50";"'='";"31.62";"nM";"7.50";"";"";"UO_0000065";"14.72";"0.28";"1.87";"9.72";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945044";"";"0";"479.60";"0";"3.46";"36";"COc1cccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)c1";"IC50";"'='";"6.31";"nM";"8.20";"";"";"UO_0000065";"17.10";"0.33";"4.74";"7.69";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL12911";"";"0";"529.62";"1";"3.33";"14";"CCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"12.08";"0.24";"3.07";"4.38";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL166013";"";"0";"537.69";"1";"3.79";"1b";"CCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O";"IC50";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"9.81";"0.19";"1.49";"4.59";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL1568";"FLUDARABINE";"0";"285.24";"0";"-1.84";"FLUDARABINE";"Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL33013";"";"0";"507.62";"1";"3.75";"6";"CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"8500.0";"nM";"5.07";"";"";"UO_0000065";"9.99";"0.19";"1.32";"3.89";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL1672973";"ENCALERET";"2";"514.04";"2";"6.20";"15, JTT-305";"Cc1cc(-c2ccccc2[C@@H](C)OC[C@H](O)CNC(C)(C)Cc2ccc(Cl)c(F)c2)ccc1C(=O)O";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"11.22";"0.22";"-0.43";"7.32";"False";"CHEMBL1681074";"Inhibition of beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1671846";"1";"Scientific Literature";"ACS Med. Chem. Lett.";"2011";"None";""
"CHEMBL267306";"";"0";"476.98";"0";"3.42";"31";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1Cl";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.68";"0.30";"3.58";"6.49";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL417250";"";"0";"561.66";"1";"4.02";"12";"O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1)c1ccccc1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"12.39";"0.24";"2.94";"5.08";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL4565954";"";"0";"850.95";"4";"6.48";"GS-5759";"COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)Nc5ccc(C#CCCCNC[C@H](O)c6ccc(O)c7[nH]c(=O)ccc67)cc5)c4)cc23)c1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"9.35";"0.18";"1.48";"3.52";"False";"CHEMBL4406938";"Inhibition of beta2 adrenoceptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406790";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL104981";"";"0";"439.58";"0";"3.87";"5g";"CC(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"11.88";"0.23";"1.35";"5.72";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL18701";"RO-201724";"0";"278.35";"0";"2.10";"Ro-201724";"CCCCOc1cc(CC2CNC(=O)N2)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL12762";"";"0";"331.41";"0";"2.36";"11";"COc1ccc(CCCNC[C@H](O)COc2ccc(O)cc2)cc1";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"21.73";"0.41";"4.84";"10.15";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL1237044";"TRAMADOL";"4";"263.38";"0";"2.63";"TRAMADOL";"COc1cccc(C2(O)CCCCC2CN(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL293994";"";"0";"592.69";"2";"5.82";"2a";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"9.73";"0.19";"-0.05";"5.54";"False";"CHEMBL647872";"Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-2 adrenergic receptor in the presence of [125I]- iodocyanopindolol.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133690";"1";"Scientific Literature";"J. Med. Chem.";"2000";"CHEMBL3308072";""
"CHEMBL1909078";"SODIUM ARSENITE";"0";"129.91";"None";"None";"SODIUM ARSENITE";"O=[As][O-].[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3128199";"";"0";"466.58";"0";"3.93";"15";"Nc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccc(F)c3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL1077199";"";"0";"375.47";"0";"3.51";"5";"Cc1ccccc1C(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1085898";"";"0";"375.47";"0";"3.13";"7";"O=C(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1085444";"";"0";"458.56";"0";"2.90";"23";"O=C(CN1CC(c2ccccc2)CC1=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"6700.0";"nM";"5.17";"";"";"UO_0000065";"11.28";"0.21";"2.27";"5.47";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1395";"METHYLTESTOSTERONE";"4";"302.46";"0";"4.27";"17-METHYLTESTOSTERONE";"C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL599";"MELOXICAM";"4";"351.41";"0";"1.95";"MELOXICAM";"Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL459";"METHYLDOPA";"4";"211.22";"0";"0.44";"METHYLDOPA";"C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL972";"SELEGILINE";"4";"187.29";"0";"2.18";"SELEGILINE";"C#CCN(C)[C@H](C)Cc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1454";"LEVAMISOLE";"4";"204.30";"0";"2.15";"LEVAMISOLE";"c1ccc([C@H]2CN3CCSC3=N2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL450895";"NYSTATIN";"4";"926.11";"3";"0.94";"NYSTATIN";"C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL33224";"";"0";"589.65";"1";"4.02";"5h";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(C(O)c3ccc(F)cc3)n2)cc1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"9.50";"0.18";"1.58";"3.72";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL84117";"";"0";"579.72";"1";"4.10";"10a";"CCCCCCN1C(=O)CN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"9.83";"0.19";"1.60";"4.32";"False";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL417613";"";"0";"442.54";"0";"2.77";"20";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"15.19";"0.30";"3.95";"6.23";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL3764088";"";"0";"418.50";"0";"2.28";"18";"O=C(Cn1ncccc1=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3767773";"Displacement of [125]I-cyanopindolol from human recombinant beta2 adrenergic receptor after 1 hr by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763146";"1";"Scientific Literature";"J. Med. Chem.";"2016";"None";""
"CHEMBL338790";"";"0";"212.21";"0";"1.31";"4-AMINO-1,8-NAPHTHALIMIDE";"Nc1ccc2c3c(cccc13)C(=O)NC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201216";"DAPIPRAZOLE";"4";"325.46";"0";"2.29";"DAPIPRAZOLE";"Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL22386";"L-764646";"0";"563.72";"1";"4.28";"2a";"CCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"8.73";"0.17";"0.64";"4.16";"True";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL350931";"";"0";"607.68";"1";"4.47";"1l";"O=C1N(Cc2ccc(F)c(F)c2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"8.98";"0.17";"0.99";"4.75";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL1946768";"";"0";"516.49";"2";"5.31";"10";"O=c1[nH]c2c(O)ccc(CCNCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1";"IC50";"'='";"0.631";"nM";"9.20";"";"";"UO_0000065";"17.81";"0.37";"3.89";"11.92";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945041";"";"0";"484.02";"0";"4.10";"33";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4Cl)c3)c2s1";"IC50";"'='";"1.995";"nM";"8.70";"";"";"UO_0000065";"17.97";"0.36";"4.60";"8.93";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL714";"ALBUTEROL";"4";"239.31";"0";"1.31";"Albuterol";"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1";"IC50";"'='";"1995.26";"nM";"5.70";"";"";"UO_0000065";"23.82";"0.46";"4.39";"7.84";"False";"CHEMBL1943767";"Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938358";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1940808";"";"0";"474.60";"1";"1.83";"5f";"OCc1cc(C(O)CNCC2CCCC(CNCC(O)c3ccc(O)c(CO)c3)C2)ccc1O";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.54";"0.20";"3.17";"3.44";"False";"CHEMBL1943767";"Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938358";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL513389";"ICI-118551";"0";"277.41";"0";"2.61";"ICI 118551";"Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2";"IC50";"'='";"0.74";"nM";"9.13";"";"";"UO_0000065";"32.91";"0.62";"6.52";"22.01";"False";"CHEMBL3779529";"Displacement of [3H](-)CGP12177 from human recombinant Beta-2 adrenergic receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3774372";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2016";"CHEMBL3308072";""
"CHEMBL188921";"BUFLOMEDIL";"0";"307.39";"0";"2.77";"BUFLOMEDIL";"COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL407030";"";"0";"1281.13";"None";"None";"GAMMA-CYCLODEXTRIN";"OC[C@H]1OC2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)OC(OC9[C@@H](CO)OC(C1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL306043";"GOLD SODIUM THIOMALATE";"4";"346.11";"None";"None";"GOLD SODIUM THIOMALATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL177";"AMIKACIN";"4";"585.61";"3";"-8.42";"AMIKACIN";"NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL499815";"ATRACTYLOSIDE";"0";"803.00";"2";"1.67";"ATRACTYLOSIDE";"C=C1[C@@H]2CCC3[C@]4(C)C[C@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@H](C(=O)O)[C@H]4CC[C@]3(C2)[C@@H]1O.[K+].[K+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL35";"FUROSEMIDE";"4";"330.75";"0";"1.89";"FUROSEMIDE";"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL79363";"";"0";"605.80";"2";"5.37";"6b";"CCCCCCCCn1c(C)cn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"8.51";"0.16";"-0.22";"4.36";"False";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL30327";"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN";"0";"321.97";"1";"6.20";"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN";"Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1319362";"HOMATROPINE HYDROBROMIDE";"4";"356.26";"0";"1.89";"HOMATROPINE HYDROBROMIDE";"Br.CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL12856";"INAMRINONE";"4";"187.20";"0";"1.02";"AMRINONE";"Nc1cc(-c2ccncc2)c[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL65513";"";"0";"590.66";"1";"4.20";"12d";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(F)c(F)c3)n2)cc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"10.16";"0.20";"1.80";"4.92";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL4530266";"";"0";"593.73";"2";"1.61";"5a";"CC(C)NC[C@H](O)COc1ccccc1-n1cc(CNCc2cn(-c3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1";"IC50";"'='";"169.82";"nM";"6.77";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4462252";"";"0";"649.84";"2";"2.12";"5c";"CC(C)NC[C@H](O)COc1ccccc1CCn1cc(CNCc2cn(CCc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1";"IC50";"'='";"4.677";"nM";"8.33";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4514723";"";"0";"677.90";"2";"2.90";"5d";"CC(C)NC[C@H](O)COc1ccccc1CCCn1cc(CNCc2cn(CCCc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1";"IC50";"'='";"2.884";"nM";"8.54";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4574652";"";"0";"530.71";"2";"2.25";"3a";"CC(C)NC[C@H](O)COc1ccccc1CCNC(=O)NCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"2.188";"nM";"8.66";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL55541";"";"0";"467.66";"1";"6.15";"8f";"O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1nc(CCCC2CCCC2)cs1";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"12.93";"0.26";"-0.10";"9.70";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL3128178";"";"0";"434.57";"0";"3.60";"5";"O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)[C@@H]1CCc2scnc21";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3767773";"Displacement of [125]I-cyanopindolol from human recombinant beta2 adrenergic receptor after 1 hr by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763146";"1";"Scientific Literature";"J. Med. Chem.";"2016";"None";""
"CHEMBL28405";"";"0";"591.64";"1";"4.67";"9b";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc(F)c(F)c3)no2)cc1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"9.47";"0.18";"0.93";"4.30";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL3763998";"";"0";"433.51";"0";"2.23";"23";"C[C@@H](C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)n1ncccc1=O";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3767773";"Displacement of [125]I-cyanopindolol from human recombinant beta2 adrenergic receptor after 1 hr by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763146";"1";"Scientific Literature";"J. Med. Chem.";"2016";"None";""
"CHEMBL64760";"";"0";"484.62";"0";"3.16";"29";"CC(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1";"IC50";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"12.93";"0.25";"3.11";"4.95";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL57486";"";"0";"539.70";"1";"4.45";"5m, (L-757793)";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"10.23";"0.20";"1.07";"4.17";"True";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL32411";"";"0";"607.64";"1";"4.66";"6a";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(F)c(F)c3)n2)cc1";"IC50";"'='";"1430.0";"nM";"5.84";"";"";"UO_0000065";"9.62";"0.19";"1.18";"4.19";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL275291";"";"0";"542.66";"2";"3.29";"26";"CC(C)NC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"11.34";"0.22";"2.86";"4.13";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL198949";"";"0";"429.92";"0";"4.18";"A1B1";"CC(=O)Nc1cc(Cl)ccc1/C=C/C(=O)N1CCN(Cc2ccc(F)cc2)C[C@H]1C";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL869394";"Inhibition of human adrenergic beta-2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141202";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2005";"None";""
"CHEMBL54821";"";"0";"469.68";"1";"6.54";"8c";"CCCCCCCCc1csc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"12.53";"0.25";"-0.65";"9.45";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL442172";"";"0";"552.43";"1";"3.66";"5";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccc(I)cc1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"13.22";"0.32";"3.64";"8.33";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL285520";"";"0";"622.67";"2";"6.01";"6g";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(Cc3ccc(C(F)(F)F)cc3)n2)cc1";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"10.45";"0.20";"0.50";"5.55";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL3128183";"";"0";"474.63";"0";"4.48";"24";"O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)[C@@H]1CCc2sc(C3CC3)nc21";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128201";"";"0";"449.58";"0";"3.19";"17";"Nc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128186";"";"0";"391.48";"0";"2.31";"27";"O=C(Cn1cccn1)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128197";"";"0";"476.65";"0";"4.57";"13a";"Nc1nc2c(s1)CCCC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL287880";"";"0";"590.65";"2";"5.27";"5l";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(Cc3ccc(F)c(F)c3)o2)cc1";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"9.02";"0.17";"0.06";"4.54";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL1210154";"";"0";"336.42";"1";"5.39";"10i";"C/C(=N\OC(=O)Nc1ccccc1)c1cccc(-c2cccs2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1212467";"Displacement of [3H](-)CGP 12177 from human recombinant beta2 receptor expressed in CHO cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208724";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL13521";"";"0";"572.68";"2";"2.92";"25";"COCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"10.48";"0.20";"3.08";"3.79";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL66964";"";"0";"457.55";"0";"2.46";"17";"COc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1";"IC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"13.73";"0.27";"3.82";"5.72";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL54749";"";"0";"453.61";"1";"6.07";"13c";"CCCCCCCCc1cnc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)o1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"14.87";"0.29";"0.67";"8.94";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL33755";"";"0";"589.76";"2";"5.70";"18";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(CCCC3CCCCC3)n2)cc1";"IC50";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"10.48";"0.20";"0.48";"4.75";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL287561";"";"0";"573.65";"1";"4.53";"5j";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3cccc(F)c3)n2)cc1";"IC50";"'='";"695.0";"nM";"6.16";"";"";"UO_0000065";"10.73";"0.21";"1.63";"4.73";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL22318";"";"0";"593.75";"1";"3.85";"9b";"CCCCCCCCn1nnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"10.52";"0.20";"2.39";"4.34";"False";"CHEMBL876752";"Inhibitory activity against cloned human Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132038";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL308860";"";"0";"644.79";"3";"6.53";"10";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1";"IC50";"'='";"990.0";"nM";"6.00";"";"";"UO_0000065";"9.31";"0.18";"-0.53";"4.03";"False";"CHEMBL647877";"Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132774";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL125246";"";"0";"488.38";"0";"4.85";"7b";"O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cc(Cl)cc(Cl)c1";"IC50";"'='";"5600.0";"nM";"5.25";"";"";"UO_0000065";"10.75";"0.22";"0.40";"4.67";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL12498";"";"0";"436.57";"0";"2.90";"25";"CCCCCS(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"15.12";"0.30";"3.70";"6.12";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL350590";"";"0";"591.78";"1";"4.96";"1r";"O=C1N(CCC2CCCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"10.14";"0.20";"1.04";"5.22";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL294172";"";"0";"590.81";"2";"6.38";"5c";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(CCCC3CCCC3)cs2)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"9.35";"0.18";"-0.86";"5.30";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL124597";"";"0";"734.81";"2";"7.99";"11";"N#CN/C(=N\c1ccc2c(c1)CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc2cc(CCNC[C@H](O)c3cccnc3)ccc2c1";"IC50";"'='";"7100.0";"nM";"5.15";"";"";"UO_0000065";"7.01";"0.13";"-2.84";"3.94";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL431678";"";"0";"684.75";"2";"6.83";"4b";"N#CN/C(=N\c1ccc2c(c1)CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"9.85";"0.19";"-0.09";"5.16";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL13003";"";"0";"484.62";"0";"3.34";"30";"O=S(=O)(CCCc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1";"IC50";"";"";"nM";"";"";"Not Determined";"";"";"";"";"";"False";"CHEMBL647104";"Agonist activity against cloned human beta-2 adrenergic receptor as percent activation of adenyl cyclase activity at a concentration of 1000 nM";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL13278";"";"0";"492.60";"0";"3.92";"37";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc2ccccc2c1";"IC50";"'='";"630.0";"nM";"6.20";"";"";"UO_0000065";"12.59";"0.24";"2.28";"5.75";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL12450";"";"0";"476.98";"0";"3.42";"33";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Cl)cc1";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"13.74";"0.28";"3.13";"6.07";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL338664";"";"0";"628.91";"2";"8.03";"2";"CCCCCCCCc1csc(N2CCc3cc(N/C(S)=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)ccc32)n1";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"10.47";"0.20";"-1.44";"7.69";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL294849";"";"0";"607.80";"1";"4.72";"5d";"CC(=O)NCCCCCc1csc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"7.89";"0.16";"0.08";"3.60";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL293994";"";"0";"592.69";"2";"5.82";"5q";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"9.73";"0.19";"-0.05";"5.54";"True";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL64697";"";"0";"523.40";"1";"3.35";"5j";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(I)cc1";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"9.85";"0.24";"1.80";"5.64";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL267545";"";"0";"521.43";"1";"3.53";"39";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Br)cc1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"12.94";"0.29";"3.21";"6.25";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL4087670";"";"0";"524.62";"1";"2.90";"19d";"O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1CCN(Cc2ncn(CC(F)F)n2)CC1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4004025";"Activity at human beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL1194";"PRILOCAINE";"4";"220.32";"0";"2.32";"PRILOCAINE";"CCCNC(C)C(=O)Nc1ccccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL428";"TROVAFLOXACIN";"4";"416.36";"0";"1.89";"TROVAFLOXACIN";"N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL406";"INDAPAMIDE";"4";"365.84";"0";"2.08";"INDAPAMIDE";"CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL787";"MONTELUKAST";"4";"586.20";"2";"8.95";"MONTELUKAST";"CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1";"IC50";"'='";"3488.0";"nM";"5.46";"";"";"UO_0000065";"9.31";"0.18";"-3.49";"7.75";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL320138";"";"0";"558.70";"1";"4.71";"5u";"O=C(CCCc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"10.20";"0.19";"0.99";"4.73";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL6466";"COUMARIN";"4";"146.14";"0";"1.79";"COUMARIN";"O=c1ccc2ccccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1456";"MYCOPHENOLATE MOFETIL";"4";"433.50";"0";"2.52";"MYCOPHENOLATE MOFETIL";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1521";"ZALEPLON";"4";"305.34";"0";"2.64";"ZALEPLON";"CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4459989";"";"0";"600.80";"2";"2.35";"4c";"CC(C)NC[C@H](O)COc1ccccc1CCC(=O)NCCCNC(=O)CCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"8.318";"nM";"8.08";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4556017";"";"0";"614.83";"2";"2.74";"(R,R)-4d";"CC(C)NC[C@@H](O)COc1ccccc1CCCC(=O)NCCNC(=O)CCCc1ccccc1OC[C@H](O)CNC(C)C";"IC50";"'='";"213.8";"nM";"6.67";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4578042";"";"0";"407.56";"0";"1.78";"4d-III";"CCCC(=O)NCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"64.57";"nM";"7.19";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4441975";"";"0";"584.89";"2";"6.85";"1d";"CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"25.7";"nM";"7.59";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4474813";"";"0";"558.72";"2";"1.18";"4a";"CC(C)NC[C@H](O)COc1ccccc1CC(=O)NCCNC(=O)Cc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"213.8";"nM";"6.67";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL679";"EPINEPHRINE";"4";"183.21";"0";"0.35";"EPINEPHRINE";"CNC[C@H](O)c1ccc(O)c(O)c1";"IC50";"'='";"284.0";"nM";"6.55";"";"";"UO_0000065";"35.73";"0.69";"6.20";"9.00";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200600";"FLUOROMETHOLONE";"4";"376.47";"0";"2.92";"FLUOROMETHOLONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL608";"PROBUCOL";"4";"516.86";"2";"9.91";"PROBUCOL";"CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL12718";"";"0";"456.56";"0";"3.07";"34";"Cc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"14.83";"0.29";"3.70";"6.27";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL1365675";"AMITRAZ";"0";"293.41";"0";"4.87";"AMITRAZ";"Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL666";"FOSCARNET";"4";"126.00";"0";"-0.16";"FOSCARNET";"O=C(O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL27577";"SALICYLAMIDE";"0";"137.14";"0";"0.49";"SALICYLAMIDE";"NC(=O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3736433";"";"0";"260.15";"None";"None";"2";"CB1C=Cc2cccc(OCC(O)CN(C)C)c2N1";"IC50";"'='";"501.19";"nM";"6.30";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3738004";"Antagonist activity at human beta2 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3734721";"1";"Scientific Literature";"J. Med. Chem.";"2015";"CHEMBL3307512";""
"CHEMBL1200585";"OXYMETHOLONE";"4";"332.48";"0";"4.40";"OXYMETHOLONE";"C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL395110";"MEPAZINE";"4";"310.47";"0";"4.63";"MEPAZINE";"CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200748";"CARBIDOPA";"4";"244.25";"0";"-0.05";"S(-)-CARBIDOPA";"C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL104222";"";"0";"498.61";"0";"3.71";"5p";"CCCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.03";"0.20";"1.29";"3.86";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL106746";"";"0";"469.57";"0";"2.50";"5k";"CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"10.85";"0.21";"2.60";"3.85";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL289249";"";"0";"587.63";"1";"4.17";"5p";"O=C(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"8.21";"0.16";"0.65";"3.27";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL4459696";"";"0";"355.50";"0";"2.26";"6.1f";"COC(=O)CSCCCc1ccccc1OCC(O)CNC(C)C";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"20.09";"0.41";"4.88";"10.54";"False";"CHEMBL4312088";"Antagonist activity at human recombinant beta2 adrenoreceptor expressed in CHOK1 cells incubated for 30 mins by HTRF";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4311931";"1";"Scientific Literature";"MedChemComm";"2019";"None";""
"CHEMBL3763594";"";"0";"418.50";"0";"2.28";"20";"O=C(Cn1cccnc1=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3767773";"Displacement of [125]I-cyanopindolol from human recombinant beta2 adrenergic receptor after 1 hr by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763146";"1";"Scientific Literature";"J. Med. Chem.";"2016";"None";""
"CHEMBL3765335";"";"0";"432.52";"0";"2.84";"22";"C[C@@H](C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)n1ncccc1=O";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3767773";"Displacement of [125]I-cyanopindolol from human recombinant beta2 adrenergic receptor after 1 hr by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763146";"1";"Scientific Literature";"J. Med. Chem.";"2016";"None";""
"CHEMBL12876";"";"0";"303.36";"0";"1.67";"15";"Oc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"22.49";"0.42";"5.15";"8.33";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL13459";"";"0";"570.71";"2";"4.08";"21";"CCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"11.31";"0.22";"2.38";"4.33";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL419787";"";"0";"511.58";"2";"5.34";"7e";"O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(Oc2ccccc2)c1";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"13.01";"0.24";"1.32";"5.48";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL57486";"";"0";"539.70";"1";"4.45";"1b";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"10.23";"0.20";"1.07";"4.17";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL294753";"";"0";"612.82";"2";"6.84";"5s";"CC(C)(C)c1ccc(-c2csc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"9.30";"0.18";"-1.14";"5.47";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL418308";"";"0";"620.80";"2";"6.62";"5f";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc4ccccc4c3)cs2)cc1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"9.08";"0.18";"-0.98";"5.41";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL1257915";"";"0";"478.59";"0";"4.50";"38";"OC(CNC1CCN(c2ncnc3scc(-c4ccc(F)cc4)c23)CC1)COc1ccccc1";"IC50";"'='";"123.0";"nM";"6.91";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1261259";"Antagonist activity at human recombinant adrenergic beta2 receptor expressed in CHO cells assessed as inhibition of isoproterenol-induced cyclic AMP formation by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1258026";"";"0";"482.63";"0";"4.12";"41";"Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5cccs5)c34)CC2)cc1";"IC50";"'='";"327.0";"nM";"6.49";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1261259";"Antagonist activity at human recombinant adrenergic beta2 receptor expressed in CHO cells assessed as inhibition of isoproterenol-induced cyclic AMP formation by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1258373";"";"0";"414.53";"0";"2.70";"47";"Cc1csc2ncnc(N3CCC(NCC(O)COc4ccc(O)cc4)CC3)c12";"IC50";"'='";"5500.0";"nM";"5.26";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1261259";"Antagonist activity at human recombinant adrenergic beta2 receptor expressed in CHO cells assessed as inhibition of isoproterenol-induced cyclic AMP formation by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL83753";"";"0";"591.78";"2";"5.06";"2b";"CCCCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"10.95";"0.21";"1.42";"5.48";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL286800";"";"0";"549.65";"1";"3.71";"15";"CC(=O)CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"57000.0";"nM";"4.24";"";"";"UO_0000065";"7.72";"0.15";"0.53";"2.88";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL1730";"CEFOTAXIME";"4";"455.47";"1";"-0.62";"Cefotaxime";"CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL806";"FLUTAMIDE";"4";"276.21";"0";"3.21";"FLUTAMIDE";"CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL312546";"";"0";"577.75";"1";"4.59";"6a";"CCCCCCn1c(C)cn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"8.92";"0.17";"0.56";"4.36";"False";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL299175";"TRETOQUINOL";"0";"345.40";"0";"2.55";"3";"COc1cc(CC2NCCc3cc(O)c(O)cc32)cc(OC)c1OC";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL647876";"Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-2 adrenergic receptor (AR) in the presence of [125I]-iodocyanopindolol";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132774";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL288083";"";"0";"563.72";"2";"5.31";"10";"CCCCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"1415.0";"nM";"5.85";"";"";"UO_0000065";"10.38";"0.20";"0.54";"4.49";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL318165";"";"0";"538.71";"2";"5.05";"5t";"CCCCCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"9.28";"0.18";"-0.05";"4.15";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL32891";"";"0";"588.66";"1";"3.99";"5i";"NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"9.68";"0.19";"1.71";"3.65";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL33155";"";"0";"646.70";"1";"4.38";"5q";"COC(=O)NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"8.15";"0.16";"0.89";"3.12";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL34441";"";"0";"648.77";"1";"3.76";"5n";"CS(=O)(=O)Nc1ccc(Cc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"8.51";"0.17";"1.76";"3.13";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL314893";"";"0";"564.71";"1";"3.68";"8a";"CCCCCCn1ncn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O";"IC50";"'='";"8500.0";"nM";"5.07";"";"";"UO_0000065";"8.98";"0.17";"1.39";"3.87";"False";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL304991";"";"0";"638.67";"1";"4.82";"12f";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(OC(F)(F)F)cc3)n2)cc1";"IC50";"'='";"860.0";"nM";"6.07";"";"";"UO_0000065";"9.50";"0.18";"1.25";"4.62";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL104076";"";"0";"560.68";"1";"4.54";"5r";"O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1)OCCc1ccccc1";"IC50";"'='";"820.0";"nM";"6.09";"";"";"UO_0000065";"10.86";"0.21";"1.55";"4.69";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL276480";"";"0";"408.52";"0";"2.12";"24";"CCCS(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"15.42";"0.31";"4.18";"5.84";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL12939";"";"0";"585.72";"1";"4.89";"17";"CCCCCCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"11.88";"0.23";"2.07";"4.76";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL4557995";"";"0";"564.72";"1";"2.65";"2b";"CC(C)NC[C@H](O)COc1ccccc1OCCOCCOCCOc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"74.13";"nM";"7.13";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4564189";"";"0";"586.82";"2";"3.81";"3c";"CC(C)NC[C@H](O)COc1ccccc1CCCCNC(=O)NCCCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"1.585";"nM";"8.80";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4465278";"";"0";"614.87";"2";"4.59";"3d";"CC(C)NC[C@H](O)COc1ccccc1CCCCCNC(=O)NCCCCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"1.738";"nM";"8.76";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL13467";"";"0";"612.79";"3";"5.25";"24";"CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"11.05";"0.22";"1.52";"4.54";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL252273";"";"0";"394.43";"0";"3.16";"4";"Cc1cc2[nH]c(C(=O)NCCC(=O)O)c(CCc3ccccc3)c2cc1C(=O)O";"IC50";"'='";"820000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"False";"CHEMBL944925";"Binding affinity to GST tagged human beta 2 adrenergic receptor PDZ1 domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141464";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2008";"None";""
"CHEMBL65042";"";"0";"496.42";"0";"3.76";"16";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(Cl)c(Cl)c1";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"12.98";"0.28";"2.68";"6.41";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL433252";"";"0";"461.63";"1";"6.09";"10f";"O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1cccc(CCCC2CCCC2)n1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"13.75";"0.26";"0.26";"10.19";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL296380";"";"0";"462.66";"1";"7.08";"11c";"CCCCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)c1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"12.59";"0.24";"-1.26";"11.79";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL53517";"";"0";"463.60";"0";"4.92";"6e";"CN(C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21)C(C)(C)Cc1ccccc1";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"10.99";"0.21";"0.18";"7.31";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL67534";"";"0";"476.99";"0";"2.69";"24";"Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc2)cn1";"IC50";"'='";"990.0";"nM";"6.00";"";"";"UO_0000065";"12.59";"0.26";"3.31";"4.74";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL37512";"";"0";"478.57";"0";"3.71";"6a";"Cc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)co1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"9.45";"0.18";"0.81";"3.85";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL285481";"";"0";"549.70";"1";"4.92";"9";"CCCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"10.92";"0.21";"1.08";"4.61";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL291992";"";"0";"564.78";"2";"5.99";"5b";"CCCCCCc1csc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1";"IC50";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"10.99";"0.22";"0.22";"5.96";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL291516";"";"0";"595.75";"2";"6.02";"5j";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3c[nH]c4ccccc34)cs2)cc1";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"7.22";"0.14";"-1.72";"3.58";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL61429";"";"0";"634.83";"2";"6.54";"8f";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(Cc2nc(Cc3ccc4ccccc4c3)cs2)cc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"8.98";"0.17";"-0.84";"5.47";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL53679";"";"0";"443.64";"1";"6.59";"14c";"CCCCCCCCc1csc(Nc2ccc(S(=O)(=O)Nc3ccccc3)cc2)n1";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"14.58";"0.29";"-0.12";"9.10";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL68021";"";"0";"455.58";"0";"3.02";"18";"CCc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"15.42";"0.30";"4.01";"6.99";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL292407";"";"0";"443.61";"1";"5.26";"6c";"CCCCCCCCN(C)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"13.53";"0.26";"0.74";"8.61";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL67993";"";"0";"442.54";"0";"2.04";"20";"Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccccc3)cc2)cn1";"IC50";"'='";"630.0";"nM";"6.20";"";"";"UO_0000065";"14.01";"0.27";"4.16";"4.90";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL285458";"";"0";"577.75";"2";"5.70";"11";"CCCCCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"9.70";"0.19";"-0.10";"4.30";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL420";"GUANABENZ";"4";"231.09";"0";"1.81";"GUANABENZ";"N=C(N)N/N=C/c1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL364713";"NOSCAPINE";"4";"413.43";"0";"2.88";"NOSCAPINE";"COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL290053";"";"0";"608.64";"2";"6.09";"6c";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(-c3ccc(C(F)(F)F)cc3)n2)cc1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"9.62";"0.19";"-0.24";"4.99";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL290106";"BITHIONOL";"4";"356.06";"1";"5.86";"BITHIONOL";"Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL402794";"BIS(2-ETHYLHEXYL)PHTHALATE";"0";"390.56";"1";"6.43";"BIS(2-ETHYLHEXYL)PHTHALATE";"CCCC[C@H](CC)COC(=O)c1ccccc1C(=O)OC[C@H](CC)CCCC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL426123";"";"0";"258.23";"0";"0.09";"(-)-THALIDOMIDE";"O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL101168";"";"0";"134.14";"0";"0.15";"1-AMINOBENZOTRIAZOLE";"Nn1nnc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1430";"PENICILLAMINE";"4";"149.22";"0";"0.11";"PENICILLAMINE";"CC(C)(S)[C@@H](N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL316561";"PROGLUMIDE";"4";"334.42";"0";"2.30";"PROGLUMIDE";"CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL27";"PROPRANOLOL";"4";"259.35";"0";"2.58";"PROPRANOLOL";"CC(C)NCC(O)COc1cccc2ccccc12";"IC50";"'='";"1.116";"nM";"8.95";"";"";"UO_0000065";"34.52";"0.64";"6.37";"21.58";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL178";"DAUNORUBICIN";"4";"527.53";"2";"1.03";"DAUNORUBICIN";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3128184";"";"0";"527.67";"2";"6.01";"25";"O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)[C@@H]1CCc2sc(-c3ccc(F)cc3)nc21";"IC50";"'='";"2513.0";"nM";"5.60";"";"";"UO_0000065";"10.61";"0.20";"-0.41";"7.54";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL273428";"";"0";"499.59";"0";"2.72";"7";"CC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"11.41";"0.22";"2.98";"4.16";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL291467";"";"0";"463.65";"1";"6.48";"10c";"CCCCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"15.53";"0.30";"0.72";"11.56";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL53842";"";"0";"401.53";"0";"4.14";"5b";"CCCCCCNC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21";"IC50";"'='";"36000.0";"nM";"4.44";"";"";"UO_0000065";"11.07";"0.22";"0.30";"5.66";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL629";"AMITRIPTYLINE";"4";"277.41";"0";"4.17";"amitriptyline";"CN(C)CCC=C1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3311308";"";"0";"305.40";"0";"3.42";"8, GSK137647A";"COc1ccc(S(=O)(=O)Nc2c(C)cc(C)cc2C)cc1";"IC50";"'>'";"31622.78";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3362286";"Antagonist activity at human beta 2 adrenergic receptor by TR FRET/summary (Abse5) assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351646";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2014";"None";""
"CHEMBL79915";"";"0";"606.75";"1";"3.00";"1i";"O=C(CCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O)N1CCCC1";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"6.59";"0.13";"1.00";"2.96";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL1082";"AMOXICILLIN";"4";"365.41";"0";"0.02";"AMOXICILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL374478";"RIFAMPIN";"4";"822.95";"3";"4.34";"RIF";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4591417";"";"0";"446.56";"1";"5.32";"31";"Cc1cc(Nc2nccc(-c3sc(C4CCNCC4)nc3-c3ccc(F)cc3)n2)ccn1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4416183";"Antagonist activity at human beta2 adrenoceptor";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414601";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL166188";"";"0";"599.76";"1";"4.62";"1j";"O=C1N(CCCc2ccccc2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"9.50";"0.18";"1.08";"4.96";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL434284";"";"0";"567.71";"1";"3.42";"1h";"COCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"7.58";"0.15";"0.88";"3.47";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL1503";"OMEPRAZOLE";"4";"345.42";"0";"2.90";"OMEPRAZOLE";"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1262";"OXICONAZOLE";"4";"429.13";"1";"6.12";"OXICONAZOLE";"Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL287947";"";"0";"574.75";"2";"5.92";"5g";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(CCCC3CCCC3)o2)cc1";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"11.30";"0.22";"0.57";"5.53";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL180672";"";"0";"408.93";"0";"4.72";"3";"CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1cccc(Cl)c1C#N";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"20.46";"0.39";"3.65";"12.82";"False";"CHEMBL1052906";"Inhibition of beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154613";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL285001";"";"0";"591.64";"1";"4.67";"5e";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(F)c(F)c3)n2)cc1";"IC50";"'='";"980.0";"nM";"6.01";"";"";"UO_0000065";"10.16";"0.20";"1.34";"4.61";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL3746068";"";"0";"422.55";"0";"3.05";"24a";"Nc1nc(CNC(=O)c2ccc(C[C@@H]3CC[C@H]([C@H](O)c4ccccc4)N3)cc2)cs1";"IC50";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"12.51";"0.24";"2.23";"5.27";"False";"CHEMBL3750559";"Displacement of [125I]CYP from human beta-2 adrenergic receptor expressed in CHO cell membrane after 1 hr by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745665";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2016";"CHEMBL3308072";""
"CHEMBL3745890";"";"0";"458.57";"0";"2.09";"24j";"Cn1nnc([C@@H]2[C@H]3CN(C(=O)c4ccc(C[C@@H]5CC[C@H]([C@H](O)c6ccccc6)N5)cc4)C[C@H]32)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3750559";"Displacement of [125I]CYP from human beta-2 adrenergic receptor expressed in CHO cell membrane after 1 hr by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745665";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2016";"CHEMBL3308072";""
"CHEMBL3747356";"";"0";"444.54";"0";"2.95";"24h";"O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1C[C@H]2[C@@H](C1)[C@@H]2c1nnco1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3750559";"Displacement of [125I]CYP from human beta-2 adrenergic receptor expressed in CHO cell membrane after 1 hr by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745665";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2016";"CHEMBL3308072";""
"CHEMBL3764774";"";"0";"468.56";"0";"3.43";"17";"O=C(Cn1cnc2ccccc2c1=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"12.07";"0.22";"2.23";"5.88";"False";"CHEMBL3767773";"Displacement of [125]I-cyanopindolol from human recombinant beta2 adrenergic receptor after 1 hr by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763146";"1";"Scientific Literature";"J. Med. Chem.";"2016";"None";""
"CHEMBL193";"NIFEDIPINE";"4";"346.34";"0";"2.18";"NIFEDIPINE";"COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4458797";"";"0";"471.66";"0";"1.20";"6.1b";"CC(C)NCC(O)COc1ccccc1CCCSCC(=O)NCCOCCOCCN";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"16.37";"0.33";"6.52";"6.71";"False";"CHEMBL4312088";"Antagonist activity at human recombinant beta2 adrenoreceptor expressed in CHOK1 cells incubated for 30 mins by HTRF";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4311931";"1";"Scientific Literature";"MedChemComm";"2019";"None";""
"CHEMBL348501";"";"0";"516.06";"1";"3.82";"43";"Cc1ccc(S(=O)(=O)NC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1";"IC50";"'='";"5011.87";"nM";"5.30";"";"";"UO_0000065";"10.27";"0.21";"1.48";"4.93";"False";"CHEMBL652427";"Receptor binding assay(Beta-2 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135599";"1";"Scientific Literature";"J. Med. Chem.";"2002";"CHEMBL3308860";""
"CHEMBL154419";"";"0";"362.86";"0";"3.09";"3a";"C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1";"IC50";"'='";"794.33";"nM";"6.10";"";"";"UO_0000065";"16.81";"0.33";"3.01";"7.48";"False";"CHEMBL652427";"Receptor binding assay(Beta-2 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135599";"1";"Scientific Literature";"J. Med. Chem.";"2002";"CHEMBL3308860";""
"CHEMBL106";"FLUCONAZOLE";"4";"306.28";"0";"0.74";"FLC";"OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL104377";"";"0";"363.48";"0";"2.10";"5b";"CC(C)S(=O)(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"11.83";"0.23";"2.20";"4.71";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL1542";"AZATHIOPRINE";"4";"277.27";"0";"1.15";"AZATHIOPRINE";"Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4285281";"";"0";"297.35";"0";"2.60";"2; AK-2-202";"COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"29.78";"0.55";"6.25";"17.46";"False";"CHEMBL4258826";"Displacement of [3H]-CGP-12177 from human beta2-adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257493";"1";"Scientific Literature";"MedChemComm";"2018";"None";""
"CHEMBL63138";"";"0";"576.63";"1";"4.27";"7c";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(F)c(F)c3)n2)cc1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"10.21";"0.20";"1.62";"4.82";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL36609";"";"0";"606.65";"2";"5.26";"6i";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(COc3ccc(F)c(F)c3)n2)cc1";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"8.99";"0.17";"0.20";"4.31";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL63760";"";"0";"608.65";"2";"5.01";"7e";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(C(F)(F)F)cc3)n2)cc1";"IC50";"'='";"21000.0";"nM";"4.68";"";"";"UO_0000065";"7.69";"0.15";"-0.33";"3.83";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL229476";"";"0";"303.36";"0";"2.06";"BDBM50213106";"C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1";"IC50";"'='";"6.09";"nM";"8.21";"";"365701";"UO_0000065";"27.08";"0.51";"6.16";"8.84";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL1940809";"";"0";"468.55";"1";"1.73";"5g";"OCc1cc(C(O)CNCc2ccc(CNCC(O)c3ccc(O)c(CO)c3)cc2)ccc1O";"IC50";"'='";"50118.72";"nM";"4.30";"";"";"UO_0000065";"9.18";"0.17";"2.57";"2.96";"False";"CHEMBL1943767";"Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938358";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL4450606";"";"0";"586.77";"2";"1.96";"4b";"CC(C)NC[C@H](O)COc1ccccc1CCC(=O)NCCNC(=O)CCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"75.86";"nM";"7.12";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL1395661";"";"0";"249.35";"0";"2.15";"(R)-ALP";"C=CCc1ccccc1OC[C@H](O)CNC(C)C";"IC50";"'='";"75.86";"nM";"7.12";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4593049";"";"0";"457.62";"0";"3.30";"3b-I";"COc1ccccc1CCCNC(=O)NCCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"13.8";"nM";"7.86";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4594173";"";"0";"614.83";"2";"2.74";"4d";"CC(C)NC[C@H](O)COc1ccccc1CCCC(=O)NCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"1.549";"nM";"8.81";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4530266";"";"0";"593.73";"2";"1.61";"5a";"CC(C)NC[C@H](O)COc1ccccc1-n1cc(CNCc2cn(-c3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1";"IC50";"'='";"12.02";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4532142";"";"0";"513.68";"1";"3.01";"4d-I";"COc1ccccc1CCCC(=O)NCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"3.89";"nM";"8.41";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL1160734";"";"0";"249.35";"0";"2.15";"(S)-ALP";"C=CCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"0.7244";"nM";"9.14";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL291306";"";"0";"612.80";"2";"6.75";"5h";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cc4ccccc4s3)cs2)cc1";"IC50";"'='";"93000.0";"nM";"4.03";"";"";"UO_0000065";"6.58";"0.13";"-2.72";"3.87";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL54750";"";"0";"460.64";"1";"6.69";"11f";"O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1cccc(CCCC2CCCC2)c1";"IC50";"'='";"7500.0";"nM";"5.12";"";"";"UO_0000065";"11.13";"0.21";"-1.57";"10.37";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL312074";"";"0";"644.79";"3";"6.53";"11";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL647876";"Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-2 adrenergic receptor (AR) in the presence of [125I]-iodocyanopindolol";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132774";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL163531";"";"0";"592.77";"1";"4.46";"8b";"CCCCCCCCn1ncn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"9.61";"0.19";"1.24";"4.35";"False";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL274782";"";"0";"345.44";"0";"2.75";"2";"COc1ccc(CC[C@H](C)NC[C@H](O)COc2ccc(O)cc2)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"22.29";"0.42";"4.95";"10.85";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL1684578";"";"0";"623.72";"2";"7.16";"3";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2ccccc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1";"IC50";"'='";"780.0";"nM";"6.11";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1687005";"Agonist activity at human beta2 adrenergic receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681775";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2011";"None";""
"CHEMBL58798";"";"0";"574.70";"2";"5.68";"5p";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)cc3)cs2)cc1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"9.96";"0.20";"0.04";"5.49";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL307647";"";"0";"527.17";"1";"3.37";"4";"COc1c(I)cc(CC2NCCc3nc(N)sc32)cc1I";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"13.76";"0.47";"3.88";"12.05";"False";"CHEMBL647877";"Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132774";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL4450606";"";"0";"586.77";"2";"1.96";"4b";"CC(C)NC[C@H](O)COc1ccccc1CCC(=O)NCCNC(=O)CCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"3.311";"nM";"8.48";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4442559";"";"0";"621.79";"2";"1.73";"5b";"CC(C)NC[C@H](O)COc1ccccc1Cn1cc(CNCc2cn(Cc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1";"IC50";"'='";"6.31";"nM";"8.20";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL57908";"";"0";"596.73";"2";"6.28";"5i";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cc4ccccc4o3)cs2)cc1";"IC50";"'='";"49000.0";"nM";"4.31";"";"";"UO_0000065";"7.22";"0.14";"-1.97";"3.67";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL433248";"";"0";"557.70";"1";"4.93";"5n";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccccn3)cs2)cc1";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"9.68";"0.19";"0.47";"4.61";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL277613";"";"0";"638.67";"1";"4.93";"15b";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(COc3ccc(C(F)(F)F)cc3)n2)cc1";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"9.61";"0.19";"1.21";"4.68";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL13453";"";"0";"527.64";"1";"3.50";"9";"CCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"12.58";"0.25";"3.14";"4.85";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL503468";"";"0";"770.97";"2";"10.44";"8";"O=C(Nc1ccc2[nH]cc(C3CCN(CCCCCCCN4CCC(c5c[nH]c6ccc(NC(=O)c7ccc(F)cc7)cc56)CC4)CC3)c2c1)c1ccc(F)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL965246";"Binding affinity to human adrenergic beta2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150432";"1";"Scientific Literature";"J. Med. Chem.";"2008";"None";""
"CHEMBL349651";"";"0";"589.76";"1";"4.67";"2e";"O=c1n(CCCC2CCCC2)ccn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"760.0";"nM";"6.12";"";"";"UO_0000065";"10.38";"0.20";"1.45";"5.17";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL275511";"";"0";"542.66";"2";"3.30";"20";"CCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"11.55";"0.23";"2.97";"4.21";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL12679";"";"0";"331.41";"0";"2.36";"13";"COc1ccc(C[C@H](C)NC[C@H](O)COc2ccc(O)cc2)cc1";"IC50";"";"";"nM";"";"";"Not Determined";"";"";"";"";"";"False";"CHEMBL647880";"Compound was tested for binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand; Not determined";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL1078749";"";"0";"465.60";"0";"4.98";"59";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(CCc2ccccc2)c1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"13.74";"0.25";"1.42";"8.62";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1204009";"";"0";"511.06";"0";"4.56";"11";"CCOC(=O)CCc1ccc(OC[C@H](O)CNC(C)(C)Cc2ccc3ccccc3c2)c(C#N)c1.Cl";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"16.55";"0.31";"3.29";"8.58";"False";"CHEMBL1052906";"Inhibition of beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154613";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL1258024";"";"0";"490.63";"0";"4.37";"12";"COc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1261259";"Antagonist activity at human recombinant adrenergic beta2 receptor expressed in CHO cells assessed as inhibition of isoproterenol-induced cyclic AMP formation by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL75604";"";"0";"628.79";"3";"6.70";"9";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL647876";"Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-2 adrenergic receptor (AR) in the presence of [125I]-iodocyanopindolol";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132774";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL1255834";"BW-723C86";"0";"286.40";"0";"3.70";"BW-723C86";"CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL517712";"ATROPINE";"4";"289.37";"0";"1.93";"ATROPINE";"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL126055";"";"0";"526.38";"1";"3.72";"3a";"N#CN/C(=N\c1ccc(I)cc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"12.86";"0.30";"3.05";"6.43";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL124863";"";"0";"492.58";"0";"4.91";"3f";"N#CN/C(=N\c1cccc(Oc2ccccc2)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"15.02";"0.27";"2.49";"6.46";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL144870";"";"0";"598.77";"2";"4.86";"23";"CCCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"11.19";"0.22";"1.84";"4.50";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL1095699";"AZASERINE";"0";"173.13";"0";"-1.76";"AZASERINE";"[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL428880";"CROMOLYN";"4";"468.37";"0";"2.11";"CROMOLYN";"O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL338794";"";"0";"624.71";"2";"6.56";"2f";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cccc(C(F)(F)F)c3)cs2)cc1";"IC50";"'='";"980.0";"nM";"6.01";"";"";"UO_0000065";"9.62";"0.19";"-0.55";"5.77";"False";"CHEMBL647872";"Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-2 adrenergic receptor in the presence of [125I]- iodocyanopindolol.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133690";"1";"Scientific Literature";"J. Med. Chem.";"2000";"CHEMBL3308072";""
"CHEMBL13238";"";"0";"408.52";"0";"2.11";"26";"CC(C)S(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"17.71";"0.35";"5.13";"6.71";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL1201220";"DIATRIZOIC ACID";"4";"613.92";"1";"3.12";"DIATRIZOIC ACID";"CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4103112";"";"0";"525.60";"1";"2.29";"19h";"O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1CCN(Cc2nnn(CC(F)F)n2)CC1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4004025";"Activity at human beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL844";"BRIMONIDINE";"4";"292.14";"0";"1.76";"BRIMONIDINE";"Brc1c(NC2=NCCN2)ccc2nccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL2220427";"ERYTHROMYCIN PROPIONATE";"4";"790.00";"2";"2.75";"ERYTHROMYCIN PROPIONATE";"CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL468";"THALIDOMIDE";"4";"258.23";"0";"0.09";"THALIDOMIDE";"O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL388590";"BENZBROMARONE";"4";"424.09";"1";"5.46";"BENZBROMARONE";"CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL429023";"ROTENONE";"0";"394.42";"0";"3.70";"ROTENONE";"C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL10";"SB-203580";"0";"377.44";"0";"4.68";"SB-203580";"C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1544";"LIOTHYRONINE";"4";"650.98";"1";"3.95";"3,3',5-TRIIODO-L-THYRONINE";"N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL372795";"STREPTOMYCIN";"4";"581.58";"3";"-8.16";"STREPTOMYCIN";"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL277100";"TEMAFLOXACIN";"4";"417.39";"0";"2.90";"TEMAFLOXACIN";"CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL29292";"UBENIMEX";"2";"308.38";"0";"0.53";"UBENIMEX";"CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL388570";"";"0";"303.36";"0";"2.06";"BDBM50213098";"C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1";"IC50";"'='";"0.14";"nM";"9.85";"";"365700";"UO_0000065";"32.48";"0.61";"7.79";"10.60";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL1800936";"";"0";"317.39";"0";"2.45";"BDBM50348426";"CC[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1";"IC50";"'='";"1.44";"nM";"8.84";"";"365712";"UO_0000065";"27.86";"0.53";"6.39";"9.51";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL67404";"";"0";"608.65";"1";"4.34";"12g";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3c(F)cc(F)cc3F)n2)cc1";"IC50";"'='";"8800.0";"nM";"5.06";"";"";"UO_0000065";"8.31";"0.16";"0.72";"4.14";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL4574652";"";"0";"530.71";"2";"2.25";"3a";"CC(C)NC[C@H](O)COc1ccccc1CCNC(=O)NCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"16.22";"nM";"7.79";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4446394";"";"0";"558.76";"2";"3.03";"3b";"CC(C)NC[C@H](O)COc1ccccc1CCCNC(=O)NCCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"7.586";"nM";"8.12";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL163579";"";"0";"592.77";"1";"4.46";"7b";"CCCCCCCCn1cnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"10.35";"0.20";"1.68";"4.68";"False";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL1366";"AURANOFIN";"4";"678.49";"None";"None";"AURANOFIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL838";"BENAZEPRIL";"4";"424.50";"0";"2.57";"BENAZEPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1235242";"";"0";"183.18";"0";"0.78";"4-FLUORO-L-PHENYLALANINE";"N[C@@H](Cc1ccc(F)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL632";"BETAMETHASONE";"4";"392.47";"0";"1.90";"BETAMETHASONE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL63357";"";"0";"588.66";"1";"4.14";"7d";"COc1ccc(-c2cnn(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1F";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"9.52";"0.18";"1.46";"4.27";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL286859";"";"0";"573.65";"1";"4.53";"5k";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(F)cc3)n2)cc1";"IC50";"'='";"1660.0";"nM";"5.78";"";"";"UO_0000065";"10.08";"0.19";"1.25";"4.44";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL14";"CARBACHOL";"4";"182.65";"0";"-0.21";"CARBACHOL";"C[N+](C)(C)CCOC(N)=O.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL113";"CAFFEINE";"4";"194.19";"0";"-1.03";"CAFFEINE";"Cn1c(=O)c2c(ncn2C)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL79806";"";"0";"564.71";"1";"3.68";"7a";"CCCCCCn1cnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O";"IC50";"'='";"4500.0";"nM";"5.35";"";"";"UO_0000065";"9.47";"0.18";"1.67";"4.08";"False";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL3746280";"";"0";"476.62";"0";"4.03";"24d";"CC1(C)CC2(CCN(C(=O)c3ccc(C[C@@H]4CC[C@H]([C@H](O)c5ccccc5)N4)cc3)CC2)C(=O)O1";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"10.40";"0.19";"0.93";"6.29";"False";"CHEMBL3750559";"Displacement of [125I]CYP from human beta-2 adrenergic receptor expressed in CHO cell membrane after 1 hr by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745665";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2016";"CHEMBL3308072";""
"CHEMBL3746885";"";"0";"448.56";"0";"2.96";"24g";"CCOC(=O)[C@H]1[C@H]2CN(C(=O)c3ccc(C[C@@H]4CC[C@H]([C@H](O)c5ccccc5)N4)cc3)C[C@H]21";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3750559";"Displacement of [125I]CYP from human beta-2 adrenergic receptor expressed in CHO cell membrane after 1 hr by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745665";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2016";"CHEMBL3308072";""
"CHEMBL13102";"";"0";"344.41";"0";"1.92";"17";"CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"23.11";"0.43";"6.04";"8.76";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL332010";"";"0";"443.51";"0";"2.22";"3e";"N#CN/C(=N\c1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(C(N)=O)c1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"14.43";"0.26";"4.18";"4.31";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL4587648";"";"0";"426.55";"0";"0.77";"6.2b";"C=CCc1ccccc1OCC(O)CNCCOCCOCCOCCOCCN";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.41";"0.32";"6.23";"6.70";"False";"CHEMBL4312088";"Antagonist activity at human recombinant beta2 adrenoreceptor expressed in CHOK1 cells incubated for 30 mins by HTRF";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4311931";"1";"Scientific Literature";"MedChemComm";"2019";"None";""
"CHEMBL799";"CILOSTAZOL";"4";"369.47";"0";"3.46";"CILOSTAZOL";"O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL12131";"CLOSANTEL";"0";"663.08";"2";"7.12";"CLOSANTEL";"Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL12";"DIAZEPAM";"4";"284.75";"0";"3.15";"DIAZEPAM";"CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL614";"PYRAZINAMIDE";"4";"123.11";"0";"-0.42";"PYRAZINAMIDE";"NC(=O)c1cnccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL91";"MICONAZOLE";"4";"416.14";"1";"6.45";"MICONAZOLE";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201117";"METHOCARBAMOL";"4";"241.24";"0";"0.53";"METHOCARBAMOL";"COc1ccccc1OCC(O)COC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL569";"PROCAINE";"4";"236.31";"0";"1.77";"PROCAINE";"CCN(CC)CCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909049";"";"0";"309.41";"0";"3.79";"1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"COc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL25";"ASPIRIN";"4";"180.16";"0";"1.31";"ASPIRIN";"CC(=O)Oc1ccccc1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL294199";"CAPSAICIN";"4";"305.42";"0";"3.79";"CAPSAICIN";"COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL13378";"(R,S)-AMPA";"0";"186.17";"0";"-0.36";"(RS)-AMPA";"Cc1onc(O)c1CC(N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL820";"BUSULFAN";"4";"246.31";"0";"-0.28";"BUSULFAN";"CS(=O)(=O)OCCCCOS(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1110";"ALOSETRON";"4";"294.36";"0";"2.41";"ALOSETRON";"Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL41543";"";"0";"238.29";"0";"3.00";"10,11-DIHYDRO-CARBAMAZEPINE";"NC(=O)N1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200993";"GALLAMINE TRIETHIODIDE";"4";"891.54";"2";"5.45";"GALLAMINE TRIETHIODIDE";"CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1297";"FENOPROFEN";"4";"242.27";"0";"3.67";"FENOPROFEN";"CC(C(=O)O)c1cccc(Oc2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL696";"ETHOSUXIMIDE";"4";"141.17";"0";"0.45";"ETHOSUXIMIDE";"CCC1(C)CC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL515914";"AZARIBINE";"4";"371.30";"1";"-1.74";"AZARIBINE";"CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1282";"IMIQUIMOD";"4";"240.31";"0";"2.82";"IMIQUIMOD";"CC(C)Cn1cnc2c(N)nc3ccccc3c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1460";"DIDANOSINE";"4";"236.23";"0";"-0.21";"DIDANOSINE";"O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL765";"GUANETHIDINE";"4";"198.31";"0";"0.53";"GUANETHIDINE";"NC(N)=NCCN1CCCCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1477";"CERIVASTATIN";"4";"459.56";"0";"4.88";"CERIVASTATIN";"COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL47";"VITAMIN E";"0";"430.72";"1";"8.84";"ALPHA-TOCOPHEROL";"Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1458880";"CADMIUM DICHLORIDE";"0";"183.32";"None";"None";"CADMIUM CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL181";"DIAZOXIDE";"4";"230.68";"0";"1.87";"DIAZOXIDE";"CC1=NS(=O)(=O)c2cc(Cl)ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL461727";"AMYGDALIN";"0";"457.43";"2";"-3.11";"AMYGDALIN(D)";"N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL558551";"";"0";"258.23";"0";"0.09";"(+)-THALIDOMIDE";"O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL253376";"BROMHEXINE";"4";"376.14";"0";"4.56";"BROMHEXINE";"CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL203266";"TRIMETAZIDINE";"4";"266.34";"0";"1.12";"TRIMETAZIDINE";"COc1ccc(CN2CCNCC2)c(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1219";"RABEPRAZOLE";"4";"359.45";"0";"2.99";"RABEPRAZOLE";"COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1168";"RAMIPRIL";"4";"416.52";"0";"2.38";"RAMIPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL15770";"SULINDAC";"4";"356.42";"0";"4.37";"SULINDAC";"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1236282";"THIAMPHENICOL";"1";"356.23";"0";"0.40";"THIAMPHENICOL";"CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL865";"VALDECOXIB";"4";"314.37";"0";"2.96";"VALDECOXIB";"Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL13132";"";"0";"591.69";"1";"4.51";"15";"O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1)OCc1ccccc1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"11.64";"0.22";"2.38";"4.71";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL64935";"";"0";"506.42";"1";"3.22";"15";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(Br)cc1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"13.11";"0.29";"3.42";"6.60";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL1231107";"CYROMAZINE";"0";"166.19";"0";"-0.39";"CYROMAZINE";"Nc1nc(N)nc(NC2CC2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL67251";"";"0";"427.53";"0";"2.45";"10";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccccc1";"IC50";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"14.33";"0.28";"3.67";"6.09";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL433454";"";"0";"371.49";"0";"3.95";"8a";"Cc1csc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1";"IC50";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"16.49";"0.33";"2.17";"9.83";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL301594";"";"0";"435.55";"0";"4.14";"6d";"CN(CCc1ccccc1)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"12.86";"0.25";"1.46";"8.04";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL302795";"TENOXICAM";"4";"337.38";"0";"1.64";"TENOXICAM";"CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL242273";"SAFROLE";"0";"162.19";"0";"2.14";"SAFROLE";"C=CCc1ccc2c(c1)OCO2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL547";"ISOTRETINOIN";"4";"300.44";"1";"5.60";"ISOTRETINOIN";"CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL685";"MEBENDAZOLE";"4";"295.30";"0";"2.97";"MEBENDAZOLE";"COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL762";"OXYMETAZOLINE";"4";"260.38";"0";"2.85";"OXYMETAZOLINE";"Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL129";"ZIDOVUDINE";"4";"267.25";"0";"-0.20";"ZIDOVUDINE";"Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1130";"DOXIFLURIDINE";"3";"246.19";"0";"-1.69";"DOXIFLURIDINE";"C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL460291";"LACIDIPINE";"4";"455.55";"0";"4.40";"LACIDIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL86304";"MOCLOBEMIDE";"4";"268.74";"0";"1.40";"MOCLOBEMIDE";"O=C(NCCN1CCOCC1)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL621";"TRAZODONE";"4";"371.87";"0";"2.36";"TRAZODONE";"O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909079";"STANNOUS FLUORIDE";"4";"156.71";"None";"None";"STANNOUS FLUORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL28079";"ZAPRINAST";"0";"271.28";"0";"1.50";"ZAPRINAST";"CCCOc1ccccc1-c1nc2nn[nH]c2c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1753";"CLINDAMYCIN";"4";"424.99";"0";"0.39";"CLINDAMYCIN";"CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL103";"PROGESTERONE";"4";"314.47";"0";"4.72";"PROGESTERONE";"CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1431";"METFORMIN";"4";"129.17";"0";"-1.03";"METFORMIN";"CN(C)C(=N)NC(=N)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1221512";"";"0";"559.80";"1";"1.75";"L-744832";"CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL571";"KETOPROFEN";"4";"254.29";"0";"3.11";"KETOPROFEN";"CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL65461";"";"0";"622.67";"1";"4.94";"12e";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(C(F)(F)F)cc3)n2)cc1";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"8.56";"0.17";"0.39";"4.37";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL22345";"";"0";"565.70";"1";"3.07";"9a";"CCCCCCn1nnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"9.69";"0.19";"2.41";"3.81";"False";"CHEMBL876752";"Inhibitory activity against cloned human Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132038";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL1200633";"IVERMECTIN";"4";"1736.18";"None";"None";"IVERMECTIN";"CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL56337";"EPALRESTAT";"2";"319.41";"0";"2.92";"EPALRESTAT";"CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL13068";"";"0";"527.64";"1";"3.36";"10";"CC(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"12.03";"0.23";"2.99";"4.63";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL43064";"CINNARIZINE";"4";"368.52";"1";"5.11";"CINNARIZINE";"C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL564201";"6-AZAURIDINE";"0";"245.19";"0";"-3.46";"AZAURIDINE";"O=c1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL81";"RALOXIFENE";"4";"473.59";"1";"6.08";"RALOXIFENE";"O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1747";"TOBRAMYCIN";"4";"467.52";"2";"-6.30";"TOBRAMYCIN";"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL248702";"DEXFENFLURAMINE";"4";"231.26";"0";"3.25";"DEXFENFLURAMINE";"CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL193482";"ESTRIOL";"4";"288.39";"0";"2.58";"ESTRIOL";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1454946";"FLUBENDAZOLE";"0";"313.29";"0";"3.11";"FLUBENDAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL282468";"CHOLINE CHLORIDE";"4";"139.63";"None";"None";"CHOLINE CHLORIDE";"C[N+](C)(C)CCO.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1539";"SULFADOXINE";"4";"310.34";"0";"0.88";"SULFADOXINE";"COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1076211";"TOLPERISONE";"3";"245.37";"0";"3.30";"TOLPERISONE";"Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL127";"MEROPENEM";"4";"383.47";"0";"-0.31";"MEROPENEM";"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1535";"HYDROXYCHLOROQUINE";"4";"335.88";"0";"3.78";"HYDROXYCHLOROQUINE";"CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL446";"SULFAMETHAZINE";"4";"278.34";"0";"1.48";"SULFAMETHAZINE";"Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL221886";"SISOMICIN";"3";"447.53";"2";"-3.85";"SISOMICIN";"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL689";"MANNITOL";"4";"182.17";"1";"-3.59";"MANNITOL";"OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL686";"MEFENAMIC ACID";"4";"241.29";"0";"3.75";"MEFENAMIC ACID";"Cc1cccc(Nc2ccccc2C(=O)O)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201356";"METHYLERGONOVINE";"4";"339.44";"0";"1.92";"METHYLERGONOVINE";"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1536";"ERGOCALCIFEROL";"4";"396.66";"1";"7.64";"ERGOCALCIFEROL";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL287562";"";"0";"621.72";"2";"5.53";"6e";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc4ccccc4c3)n2)cc1";"IC50";"'='";"90000.0";"nM";"4.05";"";"";"UO_0000065";"6.51";"0.12";"-1.48";"2.90";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL63323";"NIFLUMIC ACID";"0";"282.22";"0";"3.54";"NIFLUMIC ACID";"O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1480987";"CYCLANDELATE";"4";"276.38";"0";"3.48";"CYCLANDELATE";"CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL45";"MELATONIN";"4";"232.28";"0";"1.86";"MELATONIN";"COc1ccc2[nH]cc(CCNC(C)=O)c2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL918";"PHENACEMIDE";"4";"178.19";"0";"0.42";"PHENACEMIDE";"NC(=O)NC(=O)Cc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909063";"LEAD(IV) ACETATE";"0";"443.38";"None";"None";"LEAD(IV) ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL897";"PROBENECID";"4";"285.36";"0";"2.20";"PROBENECID";"CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL698";"TETRACAINE";"4";"264.37";"0";"2.62";"TETRACAINE";"CCCCNc1ccc(C(=O)OCCN(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1082723";"CIPARGAMIN";"2";"390.25";"0";"4.34";"NITD609";"C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1247727";"Binding affinity to human recombinant adrenergic beta2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240532";"1";"Scientific Literature";"Science";"2010";"None";""
"CHEMBL1169";"AMINOSALICYLIC ACID";"4";"153.14";"0";"0.67";"AMINOSALICYLIC ACID";"Nc1ccc(C(=O)O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL278172";"BENZOCAINE";"4";"165.19";"0";"1.45";"BENZOCAINE";"CCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL12633";"";"0";"317.39";"0";"2.06";"14";"C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)COc1ccc(O)cc1";"IC50";"'='";"84.0";"nM";"7.08";"";"";"UO_0000065";"22.29";"0.42";"5.02";"8.63";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL894";"BUPROPION";"4";"239.75";"0";"3.30";"BUPROPION";"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL720";"BENZYL ALCOHOL";"4";"108.14";"0";"1.18";"BENZYL ALCOHOL";"OCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201207";"BETAMETHASONE PHOSPHORIC ACID";"4";"472.45";"0";"2.01";"BETAMETHASONE PHOSPHATE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL33515";"";"0";"639.66";"2";"5.29";"5m";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3cccc(OC(F)(F)F)c3)n2)cc1";"IC50";"'='";"5500.0";"nM";"5.26";"";"";"UO_0000065";"8.22";"0.16";"-0.03";"3.77";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL305558";"";"0";"558.64";"1";"4.13";"7b";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(F)cc3)n2)cc1";"IC50";"'='";"9300.0";"nM";"5.03";"";"";"UO_0000065";"9.01";"0.17";"0.90";"4.12";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL66936";"";"0";"607.78";"1";"4.88";"9b";"CCCCCCCCN1CC(=O)N(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"8.72";"0.17";"0.42";"4.02";"False";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL111201";"";"0";"624.71";"2";"6.56";"2e";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"9.03";"0.18";"-0.92";"5.41";"True";"CHEMBL647872";"Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-2 adrenergic receptor in the presence of [125I]- iodocyanopindolol.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133690";"1";"Scientific Literature";"J. Med. Chem.";"2000";"CHEMBL3308072";""
"CHEMBL1055";"CHLORTHALIDONE";"4";"338.77";"0";"0.92";"CHLORTHALIDONE";"NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL76403";"";"0";"618.76";"3";"6.02";"18";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(OCC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL647877";"Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132774";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL1371937";"PANTHENOL";"3";"205.25";"0";"-1.14";"PANTHENOL";"CC(C)(CO)C(O)C(=O)NCCCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL476";"DACARBAZINE";"4";"182.19";"0";"0.07";"DACARBAZINE";"CN(C)/N=N/c1[nH]cnc1C(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL13209";"NITRAZEPAM";"4";"281.27";"0";"2.38";"NITRAZEPAM";"O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200528";"CHROMIC CHLORIDE";"4";"158.36";"None";"None";"CHROMIUM(III) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL557555";"CIPROFIBRATE";"4";"289.16";"0";"3.59";"CIPROFIBRATE";"CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL94";"PHYSOSTIGMINE";"4";"275.35";"0";"1.77";"PHYSOSTIGMINE";"CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL75435";"DEXKETOPROFEN";"4";"254.29";"0";"3.11";"DEXKETOPROFEN";"C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1466";"DICUMAROL";"4";"336.30";"0";"2.90";"DICUMAROL";"O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1490";"TRIHEXYPHENIDYL";"4";"301.47";"0";"4.33";"TRIHEXYPHENIDYL";"OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL447";"SECOBARBITAL";"4";"238.29";"0";"1.35";"SECOBARBITAL";"C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1614641";"FLUNOXAPROFEN";"0";"285.27";"0";"3.82";"FLUNOXAPROFEN";"C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL293492";"CINNAMALDEHYDE";"0";"132.16";"0";"1.90";"CINNAMALDEHYDE";"O=C/C=C/c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL404811";"DIGITONIN";"0";"1229.32";"None";"None";"DIGITONIN";"C[C@H]1[C@H]2[C@@H](O[C@]13CC[C@@H](C)CO3)[C@@H](O)[C@H]1[C@@H]3CC[C@H]4C[C@@H](O[C@@H]5O[C@H](CO)[C@H](O[C@@H]6O[C@H](CO)C(O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)C[C@]4(C)[C@H]3CC[C@@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL15511";"ENROFLOXACIN";"0";"359.40";"0";"2.32";"ENROFLOXACIN";"CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201195";"CEFMETAZOLE";"4";"471.55";"1";"-0.73";"CEFMETAZOLE";"CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1108";"DROPERIDOL";"4";"379.44";"0";"3.68";"DROPERIDOL";"O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1177";"PEMOLINE";"4";"176.18";"0";"0.60";"PEMOLINE";"NC1=NC(=O)C(c2ccccc2)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1373";"MODAFINIL";"4";"273.36";"0";"2.01";"MODAFINIL";"NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL757";"NANDROLONE";"3";"274.40";"0";"3.49";"NANDROLONE";"C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL573";"NIACIN";"4";"123.11";"0";"0.78";"NIACIN";"O=C(O)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL895";"NALBUPHINE";"4";"357.45";"0";"1.71";"NALBUPHINE";"Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1089386";"";"0";"415.50";"0";"2.94";"11";"O=C(Cn1cc2ccccc2n1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1090746";"";"0";"458.59";"0";"4.25";"18";"O=C(Cc1csc(-c2ccccc2)n1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"12.58";"0.24";"1.52";"6.62";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1086411";"";"0";"380.45";"0";"1.56";"22";"Cc1nnc(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)[nH]1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1078695";"";"0";"465.60";"0";"4.98";"60";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(CCc2ccccc2)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.03";"0.27";"2.02";"9.43";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1086149";"";"0";"415.50";"0";"3.00";"8";"O=C(Cc1nc2ccccc2[nH]1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"12.57";"0.23";"2.22";"5.07";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1204416";"";"0";"415.93";"0";"2.34";"38, entB";"CC(C(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)n1cccn1.Cl";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1091478";"";"0";"393.49";"0";"2.52";"39";"CC(C)(C(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)n1cccn1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1089053";"";"0";"410.54";"0";"3.20";"43";"Cc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c(C)s1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL68301";"";"0";"606.65";"1";"4.19";"15a";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(COc3ccc(F)c(F)c3)n2)cc1";"IC50";"'='";"690.0";"nM";"6.16";"";"";"UO_0000065";"10.16";"0.20";"1.97";"4.69";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL79675";"";"0";"591.66";"1";"4.33";"1m";"O=C1N(CCCC(F)(F)F)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"6500.0";"nM";"5.19";"";"";"UO_0000065";"8.77";"0.17";"0.86";"4.52";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL351967";"";"0";"577.75";"1";"4.57";"1p";"O=C1N(CCC2CCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"9.18";"0.18";"0.73";"4.61";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL22386";"L-764646";"0";"563.72";"1";"4.28";"5a";"CCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"8.73";"0.17";"0.64";"4.16";"False";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL32996";"";"0";"590.71";"1";"3.35";"19";"O=C(CCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1)N1CCCC1";"IC50";"'='";"51000.0";"nM";"4.29";"";"";"UO_0000065";"7.27";"0.14";"0.94";"2.85";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL55852";"";"0";"436.58";"1";"5.09";"9b";"CCCCCCc1ccnc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1";"IC50";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"14.22";"0.27";"1.12";"8.26";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL56308";"";"0";"434.61";"1";"6.30";"11b";"CCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)c1";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"14.58";"0.28";"0.04";"12.83";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL33168";"";"0";"479.56";"0";"3.11";"5";"Cc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.43";"0.20";"1.89";"3.84";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL960";"LEFLUNOMIDE";"4";"270.21";"0";"3.25";"LEFLUNOMIDE";"Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL33";"LEVOFLOXACIN";"4";"361.37";"0";"1.54";"LEVOFLOXACIN";"C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL291593";"";"0";"606.86";"2";"6.70";"8a";"CCCCCCCCc1csc(Cc2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"9.89";"0.20";"-0.70";"5.76";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL33292";"";"0";"639.66";"2";"5.29";"5f";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(OC(F)(F)F)cc3)n2)cc1";"IC50";"'='";"7600.0";"nM";"5.12";"";"";"UO_0000065";"8.00";"0.16";"-0.17";"3.67";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL286438";"";"0";"632.75";"2";"5.45";"5b";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(-c4ccccn4)cc3)n2)cc1";"IC50";"'='";"4500.0";"nM";"5.35";"";"";"UO_0000065";"8.45";"0.16";"-0.10";"3.74";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL286398";"PROPYLENE GLYCOL";"3";"76.09";"0";"-0.64";"PROPYLENE GLYCOL";"CC(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL285240";"";"0";"573.65";"1";"4.53";"9a";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc(F)cc3)no2)cc1";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"9.41";"0.18";"0.87";"4.14";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL293577";"";"0";"607.76";"2";"6.09";"5k";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cnc4ccccc4c3)cs2)cc1";"IC50";"'='";"47000.0";"nM";"4.33";"";"";"UO_0000065";"7.12";"0.14";"-1.76";"3.70";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL164401";"";"0";"495.61";"0";"2.62";"1a";"CN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"11.50";"0.22";"3.08";"4.96";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL64932";"";"0";"445.52";"0";"2.59";"13";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(F)cc1";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"13.57";"0.27";"3.46";"6.01";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL304090";"";"0";"470.60";"0";"2.60";"28";"CCc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"14.79";"0.29";"4.36";"5.50";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL38254";"";"0";"560.72";"2";"5.53";"5f";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(CCC3CCCC3)o2)cc1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"10.25";"0.20";"0.21";"4.90";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL570593";"";"0";"446.55";"0";"4.08";"12";"CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1ccc(CCC(=O)O)cc1C#N";"IC50";"'>'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1052906";"Inhibition of beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154613";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL67672";"";"0";"460.53";"0";"2.18";"23";"Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(F)cc3)cc2)cn1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"13.03";"0.26";"3.82";"4.74";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL304878";"";"0";"570.42";"1";"3.80";"7";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(F)cc2)cc1)c1ccc(I)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"12.27";"0.30";"3.20";"7.99";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL56594";"";"0";"415.56";"0";"4.48";"6b";"CCCCCCN(C)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21";"IC50";"'='";"6500.0";"nM";"5.19";"";"";"UO_0000065";"12.48";"0.24";"0.71";"7.44";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL1089052";"";"0";"411.53";"0";"2.63";"42";"CNc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cs1";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"11.65";"0.23";"2.17";"4.84";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1089734";"";"0";"437.54";"0";"4.87";"46";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2ccccc2)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"16.51";"0.30";"2.35";"9.73";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL111201";"";"0";"624.71";"2";"6.56";"1";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"9.03";"0.18";"-0.92";"5.41";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1084136";"";"0";"396.52";"0";"2.89";"19";"Cc1csc(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1084137";"";"0";"458.59";"0";"4.25";"20";"O=C(Cc1nc(-c2ccccc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"12.58";"0.24";"1.52";"6.62";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1077238";"";"0";"443.51";"0";"2.30";"24";"O=C(Cn1cnc2ccccc2c1=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1085928";"";"0";"431.50";"0";"3.57";"29";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)OCc1nc2ccccc2[nH]1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1083216";"";"0";"517.63";"2";"5.12";"36";"O=C(Cn1nc(-c2ccccc2)cc1-c1ccccc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"10.52";"0.19";"0.32";"5.91";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1083832";"";"0";"443.59";"1";"5.25";"51";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1C1CCCCC1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"12.45";"0.23";"0.27";"7.44";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1078465";"";"0";"465.60";"0";"4.98";"54";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1CCc1ccccc1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"12.39";"0.23";"0.79";"7.77";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL285713";"";"0";"548.71";"2";"5.53";"5c";"CCCCCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"10.79";"0.21";"0.39";"5.05";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL66859";"";"0";"511.43";"1";"3.34";"26";"Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(Cl)c(Cl)c3)cc2)cn1";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"12.55";"0.27";"3.08";"5.07";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL68334";"";"0";"478.57";"0";"3.00";"11";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1cnc2ccccc2c1";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"13.18";"0.25";"3.31";"5.56";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL68408";"";"0";"584.74";"2";"3.74";"22";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"10.59";"0.21";"2.45";"3.69";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL1084145";"";"0";"477.59";"0";"2.97";"26";"Cc1sc2ncn(CC(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)c(=O)c2c1C";"IC50";"'='";"7800.0";"nM";"5.11";"";"";"UO_0000065";"10.70";"0.21";"2.14";"4.68";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1078394";"";"0";"427.50";"0";"4.46";"52";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1ccco1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL54885";"";"0";"331.40";"0";"2.19";"5a";"CNC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21";"IC50";"'='";"7300.0";"nM";"5.14";"";"";"UO_0000065";"15.50";"0.31";"2.95";"6.54";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL294008";"";"0";"414.57";"1";"5.13";"4c";"CCCCCCCCC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"14.47";"0.28";"0.87";"9.03";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL33438";"";"0";"549.65";"1";"3.71";"13";"CCC(=O)CCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"8.95";"0.17";"1.21";"3.34";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL38704";"";"0";"576.62";"2";"5.35";"5k";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(-c3ccc(F)c(F)c3)o2)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"9.58";"0.18";"0.17";"4.71";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL42710";"EUGENOL";"0";"164.20";"0";"2.13";"EUGENOL";"C=CCc1ccc(O)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909050";"";"0";"293.41";"0";"4.09";"1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"Cc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL50588";"EMETINE";"0";"480.65";"0";"4.94";"EMETINE";"CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL456";"ETHACRYNIC ACID";"4";"303.14";"0";"3.61";"ETHACRYNIC ACID";"C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL19224";"PAPAVERINE";"4";"339.39";"0";"3.86";"PAPAVERINE";"COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1566";"ACARBOSE";"4";"645.61";"3";"-8.56";"ACARBOSE";"C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL117405";"";"0";"248.33";"0";"1.91";"(S)-(-)-PINDOLOL";"CC(C)NC[C@H](O)COc1cccc2[nH]ccc12";"IC50";"'='";"1.571";"nM";"8.80";"";"";"UO_0000065";"35.45";"0.67";"6.89";"15.37";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL184";"ACYCLOVIR";"4";"225.21";"0";"-0.92";"ACYCLOVIR";"Nc1nc(O)c2ncn(COCCO)c2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201469";"GRAMICIDIN";"4";"None";"None";"None";"GRAMICIDIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL976";"PRAZIQUANTEL";"4";"312.41";"0";"2.53";"PRAZIQUANTEL";"O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1071";"OXAPROZIN";"4";"293.32";"0";"4.03";"OXAPROZIN";"O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL715";"OLANZAPINE";"4";"312.44";"0";"3.44";"OLANZAPINE";"Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL254219";"DIGITOXIN";"4";"764.95";"2";"3.25";"DIGITOXIN";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL936";"DIPHENIDOL";"4";"309.45";"0";"4.19";"DIPHENIDOL";"OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1487";"ATORVASTATIN";"4";"558.65";"2";"6.31";"ATORVASTATIN";"CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL31184";"BENZO[DEF]CHRYSENE";"0";"252.32";"1";"5.74";"BENZO[A]PYRENE";"c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL521589";"BAMBUTEROL";"3";"367.45";"0";"2.23";"BAMBUTEROL";"CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL286139";"";"0";"521.64";"1";"4.14";"7";"CCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"6500.0";"nM";"5.19";"";"";"UO_0000065";"9.94";"0.19";"1.05";"3.98";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL1946767";"";"0";"477.63";"0";"4.01";"9";"COc1ccccc1CCNCc1ccc(CCNCCc2ccc(O)c3[nH]c(=O)sc23)cc1";"IC50";"'='";"199.53";"nM";"6.70";"";"";"UO_0000065";"14.03";"0.27";"2.69";"7.76";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1947151";"";"0";"523.70";"2";"6.19";"13";"C[C@@H](NCc1ccccc1-c1ccc(CCNCCc2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1";"IC50";"'='";"0.7943";"nM";"9.10";"";"";"UO_0000065";"17.38";"0.33";"2.91";"11.80";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1944690";"";"0";"498.05";"0";"4.15";"17";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4Cl)c3)c2s1";"IC50";"'='";"0.631";"nM";"9.20";"";"";"UO_0000065";"18.47";"0.37";"5.05";"9.45";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945035";"";"0";"481.59";"0";"3.63";"27";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccccc3CNCCc3ccccc3F)c2s1";"IC50";"'='";"12.59";"nM";"7.90";"";"";"UO_0000065";"16.40";"0.32";"4.27";"8.11";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL267044";"LEVOSULPIRIDE";"2";"341.43";"0";"0.56";"LEVOSULPIRIDE";"CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL870";"ALENDRONIC ACID";"4";"249.10";"1";"-1.27";"ALENDRONIC ACID";"NCCCC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL40583";"3-METHYLCHOLANTHRENE";"0";"268.36";"1";"5.55";"3-METHYLCHOLANTHRENE";"Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1481";"GLIMEPIRIDE";"4";"490.63";"0";"3.07";"GLIMEPIRIDE";"CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1741";"CLARITHROMYCIN";"4";"747.96";"2";"2.44";"CLARITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL127451";"";"0";"462.51";"0";"2.65";"7d";"NC(=O)c1cccc(N/C(=C/[N+](=O)[O-])Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"12.80";"0.24";"3.27";"3.81";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL338748";"";"0";"469.55";"0";"4.70";"7g";"O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc2ccccc12";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"13.70";"0.25";"1.73";"5.72";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL13389";"";"0";"515.59";"1";"2.94";"13";"COC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"12.35";"0.24";"3.43";"4.35";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL13079";"";"0";"456.56";"0";"2.91";"28";"O=S(=O)(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"16.82";"0.33";"4.77";"7.12";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL1257913";"";"0";"476.60";"0";"4.06";"9";"Oc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1261259";"Antagonist activity at human recombinant adrenergic beta2 receptor expressed in CHO cells assessed as inhibition of isoproterenol-induced cyclic AMP formation by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1258371";"";"0";"490.63";"0";"3.85";"17";"OCc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1";"IC50";"'='";"245.0";"nM";"6.61";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1261259";"Antagonist activity at human recombinant adrenergic beta2 receptor expressed in CHO cells assessed as inhibition of isoproterenol-induced cyclic AMP formation by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1237";"LISINOPRIL";"4";"405.50";"0";"1.24";"LISINOPRIL";"NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1349";"VALACYCLOVIR";"4";"324.34";"0";"-0.80";"VALACYCLOVIR";"CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL38";"TRETINOIN";"4";"300.44";"1";"5.60";"TRETINOIN";"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1630579";"MYRTECAINE";"0";"265.44";"0";"3.73";"MYRTECAINE";"CCN(CC)CCOCCC1=CCC2CC1C2(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1513";"IRBESARTAN";"4";"428.54";"0";"4.78";"IRBESARTAN";"CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL12943";"";"0";"513.62";"1";"3.11";"8";"CCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"12.96";"0.25";"3.55";"4.86";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL274144";"";"0";"598.77";"1";"4.81";"28";"CCCCCCN(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"720.0";"nM";"6.14";"";"";"UO_0000065";"10.26";"0.20";"1.33";"4.38";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL486278";"";"0";"385.46";"0";"2.22";"2";"COc1ccc(CC(C)(C)NC[C@H](O)COc2cccc3[nH]c(=O)[nH]c23)cc1";"IC50";"'='";"1.3";"nM";"8.89";"Potential transcription error";"";"UO_0000065";"";"";"";"";"True";"CHEMBL952690";"Binding affinity to beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137011";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL504479";"";"0";"354.45";"0";"2.92";"rac-12";"COc1ccc(CC(C)(C)NCC(O)COc2ccccc2C#N)cc1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"21.66";"0.40";"4.76";"10.30";"False";"CHEMBL952690";"Binding affinity to beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137011";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL523475";"";"0";"388.89";"0";"3.57";"rac-13";"COc1ccc(CC(C)(C)NCC(O)COc2cccc(Cl)c2C#N)cc1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"19.64";"0.39";"4.07";"10.25";"False";"CHEMBL952690";"Binding affinity to beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137011";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL506247";"TANNIC ACID";"4";"1701.21";"None";"None";"TANNIC ACID";"O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL127656";"";"0";"636.87";"2";"7.17";"6a";"CCCCCCCCc1csc(N2CCc3c(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)cccc32)n1";"IC50";"'='";"930.0";"nM";"6.03";"";"";"UO_0000065";"9.47";"0.18";"-1.14";"4.96";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL141343";"";"0";"520.72";"1";"4.21";"U-78517F";"Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1256017";"ARCAINE SULFATE";"0";"270.31";"1";"-1.27";"ARCAINE SULFATE";"N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL36994";"ANIRACETAM";"0";"219.24";"0";"1.46";"ANIRACETAM";"COc1ccc(C(=O)N2CCCC2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL196";"ASCORBIC ACID";"4";"176.12";"0";"-1.41";"ASCORBIC ACID";"O=C1O[C@H]([C@@H](O)CO)C(O)=C1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909051";"";"0";"347.38";"0";"4.80";"4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE";"O=C(c1ccccc1C(F)(F)F)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL285242";"";"0";"577.71";"1";"4.30";"20";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(CCOC3CCCC3)n2)cc1";"IC50";"'='";"2667.0";"nM";"5.57";"";"";"UO_0000065";"9.65";"0.19";"1.27";"4.00";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL945";"AMILORIDE";"4";"229.63";"0";"-1.08";"AMILORIDE";"N=C(N)NC(=O)c1nc(Cl)c(N)nc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL67886";"";"0";"582.46";"1";"3.67";"6";"COc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(I)cc3)cc2)cc1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"11.72";"0.28";"3.15";"7.04";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL36101";"";"0";"546.69";"2";"5.14";"5e";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(CC3CCCC3)o2)cc1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"10.25";"0.20";"0.46";"4.77";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL115769";"";"0";"334.35";"0";"3.97";"RWJ-68354";"COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1489254";"TRIACETIN";"2";"218.21";"0";"0.04";"TRIACETIN";"CC(=O)OCC(COC(C)=O)OC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL744";"RILUZOLE";"4";"234.20";"0";"2.78";"RILUZOLE";"Nc1nc2ccc(OC(F)(F)F)cc2s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL850";"SPARFLOXACIN";"4";"392.41";"0";"2.08";"SPARFLOXACIN";"C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200629";"VECURONIUM BROMIDE";"4";"637.74";"2";"5.97";"VECURONIUM BROMIDE";"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL42";"CLOZAPINE";"4";"326.83";"0";"3.72";"CLOZAPINE";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1089";"PHENELZINE";"4";"136.20";"0";"0.69";"PHENELZINE";"NNCCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1729";"CISAPRIDE";"4";"465.95";"0";"3.36";"CISAPRIDE";"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1198";"PRAMOXINE";"4";"293.41";"0";"2.97";"PRAMOXINE";"CCCCOc1ccc(OCCCN2CCOCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1572";"NETILMICIN";"4";"475.59";"2";"-3.20";"NETILMICIN";"CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL334255";"CETYLPYRIDINIUM BROMIDE";"0";"384.45";"1";"6.46";"CETYLPYRIDINIUM BROMIDE";"CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1554";"DACTINOMYCIN";"4";"1255.44";"None";"None";"DACTINOMYCIN";"Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL284782";"";"0";"363.84";"0";"3.06";"1, BRL-37344";"C[C@H](Cc1ccc(OCC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"15.18";"0.30";"2.46";"7.01";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL923";"RISEDRONIC ACID";"4";"283.11";"0";"-0.37";"RISEDRONIC ACID";"O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL499";"TIMOLOL";"4";"316.43";"0";"0.50";"TIMOLOL";"CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1";"IC50";"'='";"0.292";"nM";"9.54";"";"";"UO_0000065";"30.13";"0.62";"9.03";"11.96";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL991";"STAVUDINE";"4";"224.22";"0";"-0.71";"STAVUDINE";"Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1109";"SULFAPHENAZOLE";"4";"314.37";"0";"2.26";"SULFAPHENAZOLE";"Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL438";"SULFAMERAZINE";"4";"264.31";"0";"1.17";"SULFAMERAZINE";"Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL184618";"FRAMYCETIN";"3";"614.65";"3";"-8.90";"NEOMYCIN";"NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL87285";"ANDROSTERONE";"0";"290.45";"0";"3.96";"ANDROSTERONE";"C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]1CCC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL983";"SUCCINYLCHOLINE CHLORIDE";"4";"361.31";"0";"0.27";"SUXAMETHONIUM CHLORIDE";"C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL104061";"";"0";"497.62";"0";"3.28";"5l";"CCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"10.24";"0.20";"1.82";"3.85";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL1433";"DOXYCYCLINE ANHYDROUS";"4";"444.44";"1";"-0.35";"DOXYCYCLINE";"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1687";"TUBOCURARINE CHLORIDE";"0";"645.20";"2";"6.70";"D-TUBOCURARINE CHLORIDE";"COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL6273";"FLEROXACIN";"0";"369.34";"0";"1.70";"FLEROXACIN";"CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL30008";"FLUNARIZINE";"4";"404.50";"1";"5.39";"FLUNARIZINE";"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL558";"MEXILETINE";"4";"179.26";"0";"2.03";"MEXILETINE";"Cc1cccc(C)c1OCC(C)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL534";"KETOTIFEN";"4";"309.43";"0";"4.01";"KETOTIFEN";"CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL41";"FLUOXETINE";"4";"309.33";"0";"4.44";"FLUOXETINE";"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201012";"FLURANDRENOLIDE";"4";"436.52";"0";"2.50";"FLURANDRENOLIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1806874";"";"0";"467.70";"1";"6.84";"(-)-15";"CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)CCCCC2CCSS2)c1-3";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1811749";"Antagonist activity at adrenergic beta2 receptor expressed in HEK293 cells co-transfected with Galpha16 assessed as inhibition of adrenaline-induced intracellular calcium after 3 to 5 mins by Fluo-4/AM assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1806354";"1";"Scientific Literature";"J. Med. Chem.";"2011";"CHEMBL3307715";""
"CHEMBL39804";"";"0";"562.74";"2";"5.77";"5h";"CC(C)(C)CCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"10.66";"0.20";"0.23";"5.11";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL286437";"";"0";"605.72";"2";"5.54";"5d";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc4ccccc4c3)n2)cc1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"9.61";"0.18";"0.28";"4.47";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL633";"AMIODARONE";"4";"645.32";"2";"6.94";"AMIODARONE";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL123745";"";"0";"636.87";"2";"7.17";"4a";"CCCCCCCCc1csc(N2CCc3cc(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)ccc32)n1";"IC50";"";"";"nM";"";"";"Not Determined";"";"";"";"";"";"False";"CHEMBL647112";"Binding affinity towards human Beta-2 adrenergic receptor; ND= not determined";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"None";""
"CHEMBL120238";"";"0";"684.75";"2";"6.83";"6b";"N#CN/C(=N\c1cccc2c1CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL1598608";"AZASETRON";"0";"349.82";"0";"1.52";"AZASETRON";"CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL195437";"4-OCTYLPHENOL";"0";"206.33";"0";"4.30";"4-OCTYLPHENOL";"CCCCCCCCc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL15245";"YOHIMBINE";"4";"354.45";"0";"2.65";"YOHIMBINE";"COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL6966";"VERAPAMIL";"4";"454.61";"1";"5.09";"VERAPAMIL";"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1191";"SULFAMETHIZOLE";"4";"270.34";"0";"1.23";"SULFAMETHIZOLE";"Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL403";"SULBACTAM";"4";"233.25";"0";"-0.79";"SULBACTAM";"CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL37335";"";"0";"588.66";"2";"5.12";"6h";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(COc3ccc(F)cc3)n2)cc1";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"8.57";"0.16";"-0.07";"3.99";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL38562";"";"0";"558.63";"2";"5.21";"5j";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(-c3ccc(F)cc3)o2)cc1";"IC50";"'='";"21000.0";"nM";"4.68";"";"";"UO_0000065";"8.37";"0.16";"-0.53";"3.99";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL107";"COLCHICINE";"4";"399.44";"0";"2.87";"COLCHICINE";"COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1255837";"DIHYDROERGOCRISTINE MESYLATE";"0";"707.85";"1";"2.72";"DIHYDROERGOCRISTINE MESYLATE";"CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1766";"DESOXIMETASONE";"4";"376.47";"0";"2.78";"DESOXIMETASONE";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1084706";"";"0";"549.63";"1";"4.93";"38";"O=C1c2cccc3cc(O)cc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1117707";"Antagonist activity at human adrenergic beta2 receptor expressed in CHOK1 cells assessed as inhibition of cAMP accumulation by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155476";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3307512";""
"CHEMBL1684580";"";"0";"649.76";"2";"7.69";"32, diastereomeric mixture";"O=S(=O)(Nc1ccc(CC2CC[C@@H]([C@@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1";"IC50";"'='";"3530.0";"nM";"5.45";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1687005";"Agonist activity at human beta2 adrenergic receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681775";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2011";"None";""
"CHEMBL1684584";"";"0";"649.76";"2";"7.69";"36, trans";"O=S(=O)(Nc1ccc(C[C@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1";"IC50";"'='";"297.0";"nM";"6.53";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1687005";"Agonist activity at human beta2 adrenergic receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681775";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2011";"None";""
"CHEMBL312364";"";"0";"608.76";"1";"3.75";"11b";"CCCCCCCCn1c(=O)[nH]n(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"9.07";"0.18";"1.77";"3.65";"False";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL39269";"";"0";"540.65";"2";"5.07";"5i";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(-c3ccccc3)o2)cc1";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"10.09";"0.19";"0.39";"4.65";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL515";"CHLORAMBUCIL";"4";"304.22";"0";"3.38";"CHLORAMBUCIL";"O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL56367";"NIMESULIDE";"4";"308.31";"0";"2.76";"NIMESULIDE";"CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL600325";"PROSCILLARIDIN";"4";"530.66";"1";"3.01";"PROSCILLARIDIN";"C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL205596";"CHOLIC ACID";"4";"408.58";"0";"3.45";"CHOLIC ACID";"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL635";"PREDNISONE";"4";"358.43";"0";"1.77";"PREDNISONE";"C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL347582";"";"0";"516.06";"1";"3.82";"44";"Cc1ccc(S(=O)(=O)NC(=O)Cc2cccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)c2)cc1";"IC50";"'='";"15848.93";"nM";"4.80";"";"";"UO_0000065";"9.30";"0.19";"0.98";"4.46";"False";"CHEMBL652427";"Receptor binding assay(Beta-2 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1135599";"1";"Scientific Literature";"J. Med. Chem.";"2002";"CHEMBL3308860";""
"CHEMBL7002";"CIGLITAZONE";"0";"333.45";"0";"3.93";"CIGLITAZONE";"CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL856";"PRIMIDONE";"4";"218.26";"0";"0.54";"PRIMIDONE";"CCC1(c2ccccc2)C(=O)NCNC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL504";"DIMETHYL SULFOXIDE";"4";"78.14";"0";"-0.01";"DIMETHYL SULFOXIDE";"C[S+](C)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200656";"NATAMYCIN";"4";"665.73";"3";"0.12";"PIMARICIN";"C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1140";"NIACINAMIDE";"4";"122.13";"0";"0.18";"NIACINAMIDE";"NC(=O)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200406";"DIMENHYDRINATE";"4";"469.97";"None";"None";"DIMENHYDRINATE";"CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL891";"CLOXACILLIN";"4";"435.89";"0";"2.55";"CLOXACILLIN";"Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL44884";"ETHAMBUTOL";"4";"204.31";"0";"-0.29";"ETHAMBUTOL";"CC[C@@H](CO)NCCN[C@@H](CC)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL742";"KETAMINE";"4";"237.73";"0";"2.90";"KETAMINE";"CNC1(c2ccccc2Cl)CCCCC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL12994";"";"0";"331.41";"0";"2.45";"12";"C[C@@H](CCc1ccc(O)cc1)NC[C@H](O)COc1ccc(O)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"24.14";"0.46";"5.55";"9.76";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL485259";"EUCALYPTOL";"3";"154.25";"0";"2.74";"EUCALYPTOL";"CC12CCC(CC1)C(C)(C)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL513";"CARMUSTINE";"4";"214.05";"0";"1.16";"CARMUSTINE";"O=NN(CCCl)C(=O)NCCCl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL2105807";"MADURAMICIN";"0";"934.17";"2";"4.32";"MADURAMICIN";"CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC.N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL514";"LOMUSTINE";"4";"233.70";"0";"2.25";"LOMUSTINE";"O=NN(CCCl)C(=O)NC1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL201946";"";"0";"284.36";"0";"2.81";"13d";"O=C(OC[C@@H]1CCN2CCC[C@@H]12)c1c[nH]c2ccccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL858809";"Binding affinity to adrenergic beta-2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149398";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL2218907";"ZILPATEROL";"0";"261.32";"0";"1.13";"(rac)-1, Zilpaterol";"CC(C)NC1CCn2c(=O)[nH]c3cccc(c32)C1O";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"22.80";"0.43";"4.83";"8.51";"False";"CHEMBL1010734";"Displacement of [3H]CGP1217 from human recombinant adrenergic beta2 receptor transfected in insect Sf9 cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152790";"1";"Scientific Literature";"J. Med. Chem.";"2009";"CHEMBL3308860";""
"CHEMBL56768";"";"0";"426.54";"0";"4.69";"7b";"CCCCCCc1nc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)no1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"17.08";"0.33";"2.59";"8.25";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL107681";"";"0";"448.55";"0";"3.30";"5f";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cnc2ccccc2c1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"13.38";"0.26";"2.70";"5.76";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL1388";"MONOBENZONE";"4";"200.24";"0";"2.97";"MONOBENZONE";"Oc1ccc(OCc2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201139";"MEGESTROL ACETATE";"4";"384.52";"0";"4.58";"MEGESTROL ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL900";"ORPHENADRINE";"4";"269.39";"0";"3.66";"ORPHENADRINE";"Cc1ccccc1C(OCCN(C)C)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1684585";"";"0";"422.55";"0";"3.30";"4";"Nc1nc(CC(=O)Nc2ccc(C[C@@H]3CC[C@H]([C@H](O)c4ccccc4)N3)cc2)cs1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3767773";"Displacement of [125]I-cyanopindolol from human recombinant beta2 adrenergic receptor after 1 hr by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763146";"1";"Scientific Literature";"J. Med. Chem.";"2016";"None";""
"CHEMBL104180";"";"0";"397.50";"0";"2.75";"5d";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"12.82";"0.25";"2.35";"5.58";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL487508";"";"0";"398.33";"0";"4.35";"33";"COc1ccc(CC(C)(C)NC[C@H](O)COc2cccc(Cl)c2Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.59";"0.47";"4.65";"17.74";"False";"CHEMBL952690";"Binding affinity to beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137011";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL57";"NEVIRAPINE";"4";"266.30";"0";"2.65";"NEVIRAPINE";"Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL252556";"IDEBENONE";"4";"338.44";"0";"3.46";"IDEBENONE";"COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL460499";"CARMOFUR";"0";"257.26";"0";"0.81";"CARMOFUR";"CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL726";"FLUPHENAZINE";"4";"437.53";"0";"4.31";"FLUPHENAZINE";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL660";"AMANTADINE";"4";"151.25";"0";"1.91";"AMANTADINE";"NC12CC3CC(CC(C3)C1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL22317";"L-766892";"0";"591.78";"1";"4.96";"1o";"O=C1N(CCCC2CCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"760.0";"nM";"6.12";"";"";"UO_0000065";"10.34";"0.20";"1.16";"5.33";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL1940683";"";"0";"448.56";"1";"1.59";"5b";"OCc1cc(C(O)CNCCCCCCNCC(O)c2ccc(O)c(CO)c2)ccc1O";"IC50";"'='";"7943.28";"nM";"5.10";"";"";"UO_0000065";"11.37";"0.22";"3.51";"3.51";"False";"CHEMBL1943767";"Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938358";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1940684";"";"0";"434.53";"1";"1.05";"5c";"CC(C)(CNCC(O)c1ccc(O)c(CO)c1)CNCC(O)c1ccc(O)c(CO)c1";"IC50";"'='";"251188.64";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1943767";"Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938358";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1940811";"";"0";"496.60";"1";"1.81";"5i";"OCc1cc(C(O)CNCCc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)ccc1O";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"8.05";"0.15";"2.19";"2.75";"False";"CHEMBL1943767";"Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938358";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1940813";"";"0";"454.52";"1";"2.05";"5k";"OCc1cc(C(O)CNCc2ccc(NCC(O)c3ccc(O)c(CO)c3)cc2)ccc1O";"IC50";"'='";"1995.26";"nM";"5.70";"";"";"UO_0000065";"12.54";"0.24";"3.65";"3.92";"False";"CHEMBL1943767";"Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938358";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1085929";"";"0";"443.55";"0";"3.41";"30";"Cn1c(CCC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)nc2ccccc21";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1091816";"";"0";"411.53";"0";"2.73";"41";"CC(C(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1csc(N)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1085441";"";"0";"428.50";"0";"2.78";"48";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1946769";"";"0";"487.67";"1";"5.05";"11";"O=c1[nH]c2c(O)ccc(CCNCCc3cccc(CN4CCC(c5ccccc5)CC4)c3)c2s1";"IC50";"'='";"31.62";"nM";"7.50";"";"";"UO_0000065";"15.38";"0.29";"2.45";"10.97";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945031";"";"0";"516.67";"2";"4.28";"23";"Cc1cccc2c(CCNCc3cccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)c3)c[nH]c12";"IC50";"'='";"0.631";"nM";"9.20";"";"";"UO_0000065";"17.81";"0.34";"4.92";"8.13";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945036";"";"0";"477.63";"0";"4.05";"28";"CC(CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1";"IC50";"'='";"0.1995";"nM";"9.70";"";"";"UO_0000065";"20.31";"0.39";"5.65";"9.96";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945292";"";"0";"417.53";"0";"1.90";"40";"COCCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"18.20";"0.36";"5.70";"7.13";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945293";"";"0";"417.53";"0";"1.90";"41";"COCCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1";"IC50";"'='";"316.23";"nM";"6.50";"";"";"UO_0000065";"15.57";"0.31";"4.60";"6.10";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945300";"";"0";"420.55";"0";"3.08";"48";"OCc1cc([C@@H](O)CNCCc2ccc(CNCCc3ccccc3)cc2)ccc1O";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"14.74";"0.27";"3.12";"7.32";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1085897";"";"0";"389.50";"0";"3.82";"6";"Cc1ccc(C)c(C(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL60281";"";"0";"592.83";"2";"6.77";"5a";"CCCCCCCCc1csc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"9.32";"0.18";"-1.25";"5.30";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL4564495";"";"0";"427.59";"0";"3.29";"3b-II";"CC(C)NC[C@H](O)COc1ccccc1CCCNC(=O)NCCCc1ccccc1";"IC50";"'='";"14.13";"nM";"7.85";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4468271";"";"0";"351.49";"0";"2.07";"3b-III";"CCCNC(=O)NCCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"85.11";"nM";"7.07";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4515576";"";"0";"483.65";"0";"3.00";"4d-II";"CC(C)NC[C@H](O)COc1ccccc1CCCC(=O)NCCNC(=O)CCCc1ccccc1";"IC50";"'='";"5.888";"nM";"8.23";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4527821";"";"0";"528.78";"2";"5.29";"1b";"CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"5.248";"nM";"8.28";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4564189";"";"0";"586.82";"2";"3.81";"3c";"CC(C)NC[C@H](O)COc1ccccc1CCCCNC(=O)NCCCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"1.778";"nM";"8.75";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL84190";"";"0";"593.79";"2";"5.35";"4b";"CCCCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"10.81";"0.21";"1.07";"5.59";"False";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL351467";"";"0";"580.71";"1";"2.97";"11a";"CCCCCCn1c(=O)[nH]n(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"8.61";"0.17";"2.03";"3.31";"False";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL1084667";"";"0";"415.50";"0";"3.00";"9";"O=C(Cc1n[nH]c2ccccc12)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1093086";"";"0";"366.43";"0";"1.18";"14";"O=C(Cn1cncn1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1093387";"";"0";"381.44";"0";"0.76";"15";"Nc1ncn(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL415039";"";"0";"623.66";"2";"5.41";"5l";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(C(F)(F)F)cc3)n2)cc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"9.14";"0.18";"0.29";"4.38";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL1684581";"";"0";"649.76";"2";"7.69";"33, diastereomeric mixture";"O=S(=O)(Nc1ccc(CC2CC[C@@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1";"IC50";"'='";"3530.0";"nM";"5.45";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1687005";"Agonist activity at human beta2 adrenergic receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681775";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2011";"None";""
"CHEMBL1086077";"";"0";"446.52";"0";"4.79";"46";"O=C(c1ccc(F)cc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1117707";"Antagonist activity at human adrenergic beta2 receptor expressed in CHOK1 cells assessed as inhibition of cAMP accumulation by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155476";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3307512";""
"CHEMBL13";"METOPROLOL";"4";"267.37";"0";"1.61";"METOPROLOL";"COCCc1ccc(OCC(O)CNC(C)C)cc1";"IC50";"'='";"2573.0";"nM";"5.59";"";"";"UO_0000065";"20.91";"0.40";"3.98";"11.02";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL650";"METHYLPREDNISOLONE";"4";"374.48";"0";"1.80";"METHYLPREDNISOLONE";"C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1732";"DIHYDROERGOTAMINE";"4";"583.69";"1";"2.08";"DIHYDROERGOTAMINE";"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200623";"ETHYLESTRENOL";"4";"288.48";"1";"5.09";"ETHYLESTRENOL";"CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1073";"GLIPIZIDE";"4";"445.55";"0";"2.08";"GLIPIZIDE";"Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL357995";"BOPINDOLOL";"0";"380.49";"0";"4.47";"BOPINDOLOL";"Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"20.23";"0.38";"3.23";"12.15";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL584";"NELFINAVIR";"4";"567.80";"1";"4.75";"NELFINAVIR";"Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL495778";"PENICILLIC ACID";"0";"170.16";"0";"0.34";"PENICILLIC ACID";"C=C(C)C1(O)OC(=O)C=C1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1237174";"HYDRAZINE";"0";"32.05";"0";"-1.18";"HYDRAZINE";"NN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL275742";"DEXPROPRANOLOL";"0";"259.35";"0";"2.58";"R-(+)-PROPRANOLOL";"CC(C)NC[C@@H](O)COc1cccc2ccccc12";"IC50";"'='";"76.0";"nM";"7.12";"";"";"UO_0000065";"27.45";"0.51";"4.54";"17.16";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL723";"CARVEDILOL";"4";"406.48";"0";"3.74";"CARVEDILOL";"COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12";"IC50";"'='";"0.241";"nM";"9.62";"";"";"UO_0000065";"23.66";"0.44";"5.88";"12.70";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL389390";"";"0";"303.36";"0";"2.06";"BDBM50213114";"C[C@@H](Cc1ccc(O)cc1)NC[C@@H](O)c1cc(O)cc(O)c1";"IC50";"'='";"184.2";"nM";"6.74";"";"365703";"UO_0000065";"22.20";"0.42";"4.67";"7.25";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL427526";"(R)-IBUPROPHEN";"1";"206.28";"0";"3.07";"R(-)-IBUPROFEN";"CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL611";"TERAZOSIN";"4";"387.44";"0";"1.06";"TERAZOSIN";"COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1537";"AZLOCILLIN";"4";"461.50";"0";"0.09";"AZLOCILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1476898";"CADMIUM ACETATE";"0";"230.50";"None";"None";"CADMIUM ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL291338";"3,3',4',5-TETRACHLOROSALICYLANILIDE";"4";"351.02";"1";"5.26";"3,3',4',5-TETRACHLOROSALICYLANILIDE";"O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1077";"BROMFENAC";"4";"334.17";"0";"2.89";"BROMFENAC";"Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1231530";"BETAMIPRON";"0";"193.20";"0";"0.89";"BETAMIPRON";"O=C(O)CCNC(=O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL472";"GLYBURIDE";"4";"494.01";"0";"3.64";"GLYBURIDE";"COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1499";"";"0";"360.45";"0";"1.99";"CORTISONE";"C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL862";"GUANFACINE";"4";"246.10";"0";"1.55";"GUANFACINE";"N=C(N)NC(=O)Cc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL595449";"";"0";"350.47";"0";"4.00";"5b";"CN(C)Cc1nc(-c2ccc(C(C)(C)C)cc2)n(-c2cccc(O)c2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1050441";"Inhibition of beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152515";"1";"Scientific Literature";"Bioorg. Med. Chem.";"2009";"None";""
"CHEMBL572163";"";"0";"421.54";"0";"4.21";"9";"CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc1ccc(CCC(=O)O)cc1";"IC50";"'>'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1052906";"Inhibition of beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154613";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL83668";"TOLNAFTATE";"4";"307.42";"0";"4.95";"TOLNAFTATE";"Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL320228";"";"0";"431.95";"0";"3.40";"5h";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(Cl)cc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.58";"0.24";"1.60";"5.48";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL318802";"";"0";"447.56";"0";"3.90";"5e";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc2ccccc2c1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"13.41";"0.26";"2.10";"6.57";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL498847";"SECNIDAZOLE";"4";"185.18";"0";"0.48";"DNDI2266591";"Cc1ncc([N+](=O)[O-])n1CC(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL192";"SILDENAFIL";"4";"474.59";"0";"1.61";"SILDENAFIL";"CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3084803";"ASTROMICIN";"0";"405.50";"1";"-3.59";"ASTROMICIN";"CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL165790";"IPRIFLAVONE";"0";"280.32";"0";"4.25";"IPRIFLAVONE";"CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL139835";"CYPROTERONE ACETATE";"4";"416.95";"0";"4.61";"CYPROTERONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL64936";"";"0";"461.97";"0";"3.11";"14";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(Cl)cc1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"13.78";"0.28";"3.26";"6.33";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL40898";"";"0";"576.62";"2";"5.35";"6d";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(-c3ccc(F)c(F)c3)n2)cc1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"9.81";"0.19";"0.31";"4.82";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL281200";"";"0";"572.75";"2";"6.16";"2";"NCCCCCOC[C@H]1O[C@@H](OCCc2c[nH]c3ccccc23)[C@H](OCc2ccccc2)C[C@@H]1OCc1ccccc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"9.64";"0.18";"-0.64";"6.28";"False";"CHEMBL647109";"Binding affinity towards cloned human Beta-2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129787";"1";"Scientific Literature";"J. Med. Chem.";"1996";"None";""
"CHEMBL288418";"";"0";"478.57";"0";"3.71";"5a";"Cc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"11.54";"0.22";"1.81";"4.71";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL12188";"";"0";"380.47";"0";"1.34";"19";"CS(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"17.50";"0.35";"5.32";"6.17";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL106487";"";"0";"496.63";"0";"3.88";"5s";"CCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"10.16";"0.20";"1.17";"4.19";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL127422";"";"0";"450.55";"0";"4.27";"3g";"N#CN/C(=N\c1ccc2ccccc2c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"16.20";"0.29";"3.03";"6.93";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL289316";"";"0";"608.64";"2";"5.41";"5m";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(Cc3cc(F)c(F)c(F)c3)o2)cc1";"IC50";"'='";"940.0";"nM";"6.03";"";"";"UO_0000065";"9.90";"0.19";"0.62";"5.14";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL338618";"";"0";"469.38";"0";"4.42";"3c";"N#CN/C(=N\c1cc(Cl)cc(Cl)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"14.60";"0.29";"2.43";"6.51";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL84190";"";"0";"593.79";"2";"5.35";"1f";"CCCCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"10.81";"0.21";"1.07";"5.59";"True";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL291246";"";"0";"601.75";"2";"5.11";"5c";"CSc1ccc(Cc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1";"IC50";"'='";"9500.0";"nM";"5.02";"";"";"UO_0000065";"8.35";"0.16";"-0.09";"3.86";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL298594";"";"0";"441.62";"1";"5.76";"8b";"CCCCCCc1csc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"14.25";"0.29";"0.53";"10.10";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL349689";"";"0";"589.64";"1";"4.04";"2d";"O=c1n(CCCC(F)(F)F)ccn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"8.48";"0.17";"0.96";"4.23";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL691";"ETHINYL ESTRADIOL";"4";"296.41";"0";"3.61";"ETHINYLESTRADIOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL154";"NAPROXEN";"4";"230.26";"0";"3.04";"NAPROXEN";"COc1ccc2cc([C@H](C)C(=O)O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1257916";"";"0";"494.59";"0";"4.20";"39";"Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccc(F)cc5)c34)CC2)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1261259";"Antagonist activity at human recombinant adrenergic beta2 receptor expressed in CHO cells assessed as inhibition of isoproterenol-induced cyclic AMP formation by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1726";"NISOLDIPINE";"4";"388.42";"0";"3.20";"NISOLDIPINE";"COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL299719";"";"0";"435.59";"1";"5.70";"10b";"CCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"15.73";"0.30";"1.15";"11.00";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL293818";"";"0";"553.73";"1";"4.47";"1c";"CCCCCCNC(=O)N(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"9.03";"0.18";"0.53";"4.04";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL295502";"";"0";"452.58";"1";"5.08";"7f";"O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1noc(CCCC2CCCC2)n1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"16.30";"0.31";"2.30";"8.35";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL1909069";"";"0";"None";"None";"None";"MC 288769";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL139";"DICLOFENAC";"4";"296.15";"0";"4.36";"DICLOFENAC";"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL628";"PENTOXIFYLLINE";"4";"278.31";"0";"0.19";"PENTOXIFYLLINE";"CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL40";"PHENOBARBITAL";"4";"232.24";"0";"0.70";"PHENOBARBITAL";"CCC1(c2ccccc2)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL531";"PERGOLIDE";"4";"314.50";"0";"4.27";"PERGOLIDE";"CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL404520";"CHLORTETRACYCLINE";"4";"478.89";"1";"0.44";"CHLORTETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL2106399";"KITASAMYCIN";"0";"785.97";"2";"2.44";"KITASAMYCIN";"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL189";"MILRINONE";"4";"211.22";"0";"1.62";"MILRINONE";"Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL267648";"PEFLOXACIN";"4";"333.36";"0";"1.61";"PEFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL219916";"DOMPERIDONE";"4";"425.92";"0";"3.35";"DOMPERIDONE";"O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL112";"ACETAMINOPHEN";"4";"151.16";"0";"1.35";"ACETAMINOPHEN";"CC(=O)Nc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL19215";"METERGOLINE";"4";"403.53";"0";"4.06";"METERGOLINE";"CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL307145";"PYROGALLOL";"4";"126.11";"0";"0.80";"PYROGALLOL";"Oc1cccc(O)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL416";"METHOXSALEN";"4";"216.19";"0";"2.55";"METHOXSALEN";"COc1c2occc2cc2ccc(=O)oc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL338216";"";"0";"610.68";"2";"5.96";"2d";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cc(F)c(F)c(F)c3)cs2)cc1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"8.68";"0.17";"-0.66";"5.09";"False";"CHEMBL647872";"Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-2 adrenergic receptor in the presence of [125I]- iodocyanopindolol.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133690";"1";"Scientific Literature";"J. Med. Chem.";"2000";"CHEMBL3308072";""
"CHEMBL44618";"CHLOROFORM";"4";"119.38";"0";"1.99";"CHLOROFORM";"ClC(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL338976";"";"0";"592.69";"2";"5.82";"2c";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)cc3F)cs2)cc1";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"9.42";"0.19";"-0.23";"5.36";"False";"CHEMBL647872";"Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-2 adrenergic receptor in the presence of [125I]- iodocyanopindolol.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133690";"1";"Scientific Literature";"J. Med. Chem.";"2000";"CHEMBL3308072";""
"CHEMBL48449";"CANTHARIDIN";"4";"196.20";"0";"0.64";"CANTHARIDIN";"C[C@]12C(=O)OC(=O)[C@@]1(C)[C@@H]1CC[C@H]2O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL295416";"PIRINIXIC ACID";"0";"323.81";"0";"3.67";"PIRINIXIC ACID";"Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL2221249";"COLISTIN";"4";"2296.97";"None";"None";"COLISTIN";"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL417";"EPIRUBICIN";"4";"543.53";"3";"0.00";"EPIRUBICIN";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1370";"BUDESONIDE";"4";"430.54";"0";"2.72";"BUDESONIDE";"CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL433257";"HARRINGTONINE";"0";"531.60";"1";"2.19";"HARRINGTONINE";"COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1092502";"";"0";"415.50";"0";"2.94";"10";"O=C(Cn1ncc2ccccc21)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"11.61";"0.21";"1.88";"5.24";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1084138";"";"0";"442.52";"0";"2.91";"21";"O=C(Cc1nnc(-c2ccccc2)[nH]1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1085693";"";"0";"401.47";"0";"3.08";"27";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1nc2ccccc2[nH]1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"14.84";"0.27";"2.88";"5.79";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1077273";"";"0";"401.47";"0";"2.85";"31";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc2ccnn12";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"15.50";"0.28";"3.37";"6.80";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1088076";"";"0";"517.63";"2";"5.12";"32";"O=C(Cn1ncc(-c2ccccc2)c1-c1ccccc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1090416";"";"0";"393.49";"0";"2.40";"35";"Cc1cc(C)n(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1089396";"";"0";"437.54";"0";"4.87";"45";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(-c2ccccc2)c1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"14.62";"0.26";"1.53";"8.62";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1083831";"";"0";"494.62";"1";"5.48";"50";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1nc2ccccc2s1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1078696";"";"0";"444.58";"0";"4.11";"61";"Cc1ccc(N2CCCC2)c(C(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c1";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"10.85";"0.20";"0.71";"6.23";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL53359";"";"0";"464.64";"1";"5.87";"9c";"CCCCCCCCc1ccnc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1";"IC50";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"13.51";"0.26";"0.41";"8.35";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL83698";"";"0";"607.78";"1";"4.88";"10b";"CCCCCCCCN1C(=O)CN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"10.58";"0.20";"1.55";"4.87";"False";"CHEMBL647106";"Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132063";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL56767";"";"0";"457.67";"1";"6.61";"15c";"CCCCCCCCc1csc(N(C)c2ccc(S(=O)(=O)Nc3ccccc3)cc2)n1";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"13.89";"0.28";"-0.25";"10.20";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL1650";"CORTISONE ACETATE";"4";"402.49";"0";"2.56";"CORTISONE ACETATE";"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL954";"ENCLOMIPHENE";"3";"405.97";"1";"6.56";"CLOMIPHENE";"CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL456807";"PHENYLHYDRAZINE";"0";"108.14";"0";"0.97";"PHENYLHYDRAZINE";"NNc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL34431";"CILOSTAMIDE";"0";"342.44";"0";"3.89";"CILOSTAMIDE";"CN(C(=O)CCCOc1ccc2nc(O)ccc2c1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL451";"CHLORDIAZEPOXIDE";"4";"299.76";"0";"2.95";"CHLORDIAZEPOXIDE";"CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL70927";"DEFERIPRONE";"4";"139.15";"0";"0.40";"DEFERIPRONE";"Cc1c(O)c(=O)ccn1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1902627";"CLORPRENALINE";"0";"213.71";"0";"2.37";"CLORPRENALINE";"CC(C)NCC(O)c1ccccc1Cl";"IC50";"'='";"1993.0";"nM";"5.70";"";"";"UO_0000065";"26.67";"0.56";"3.33";"17.67";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL16073";"PHENACETIN";"4";"179.22";"0";"2.04";"PHENACETIN";"CCOc1ccc(NC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL553025";"VINORELBINE";"4";"778.95";"2";"4.75";"VINORELBINE";"CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL86";"METOCLOPRAMIDE";"4";"299.80";"0";"2.00";"METOCLOPRAMIDE";"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL878";"METOLAZONE";"4";"365.84";"0";"2.71";"METOLAZONE";"Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL880";"FAMCICLOVIR";"4";"321.34";"0";"0.54";"FAMCICLOVIR";"CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1566249";"AMPIROXICAM";"0";"447.47";"0";"2.56";"AMPIROXICAM";"CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL2252949";"(-)-CAMPHOR";"0";"152.24";"0";"2.40";"L-CAMPHOR";"CC1(C)[C@H]2CC[C@]1(C)C(=O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL562";"GRISEOFULVIN";"4";"352.77";"0";"2.81";"Griseofulvin";"COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL407";"FLUMAZENIL";"4";"303.29";"0";"1.77";"FLUMAZENIL";"CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL710";"FINASTERIDE";"4";"372.55";"0";"3.81";"FINASTERIDE";"CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909056";"COBALT(II) ACETYLACETONATE";"0";"257.15";"None";"None";"COBALT(II) ACETYLACETONATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL487894";"DIPYRONE SODIUM";"0";"333.35";"0";"0.77";"DIPYRONE";"Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1117";"IDARUBICIN";"4";"497.50";"0";"1.02";"IDARUBICIN";"CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL185";"FLUOROURACIL";"4";"130.08";"0";"-0.80";"FLUOROURACIL";"O=c1[nH]cc(F)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1515";"METHIMAZOLE";"4";"114.17";"0";"1.08";"METHIMAZOLE";"Cn1cc[nH]c1=S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL74085";"";"0";"552.70";"3";"5.03";"5";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"12.12";"0.23";"1.67";"4.79";"False";"CHEMBL647877";"Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132774";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL294492";"";"0";"557.70";"1";"4.93";"5m";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cccnc3)cs2)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"9.90";"0.19";"0.59";"4.72";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL1902981";"EPERISONE";"3";"259.39";"0";"3.55";"EPERISONE";"CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL32749";"FERULATE";"0";"194.19";"0";"1.50";"FERULIC ACID";"COc1cc(/C=C/C(=O)O)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909057";"COPPER(II) OXIDE";"0";"79.55";"None";"None";"COPPER(II) OXIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL545";"ALCOHOL";"4";"46.07";"0";"0.00";"ETHANOL";"CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL808";"ECONAZOLE";"4";"381.69";"1";"5.80";"ECONAZOLE";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1493";"FLAVOXATE";"4";"391.47";"0";"4.41";"FLAVOXATE";"Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL349505";"";"0";"605.67";"1";"4.03";"2c";"O=c1n(Cc2ccc(F)c(F)c2)ccn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"8.07";"0.16";"0.86";"4.13";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL165177";"";"0";"605.80";"2";"5.35";"1q";"O=C1N(CCCC2CCCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"9.90";"0.19";"0.65";"5.22";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL162043";"";"0";"634.20";"2";"5.28";"1k";"O=C1N(CCCc2ccc(Cl)cc2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"8.99";"0.18";"0.42";"4.96";"False";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL421871";"";"0";"421.49";"0";"4.22";"22";"COc1cc(-c2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc(OC)c1OC";"IC50";"'='";"760.0";"nM";"6.12";"";"";"UO_0000065";"14.52";"0.27";"1.90";"7.63";"False";"CHEMBL647877";"Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132774";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL491251";"";"0";"398.33";"0";"4.35";"rac-11";"COc1ccc(CC(C)(C)NCC(O)COc2cccc(Cl)c2Cl)cc1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"19.27";"0.40";"3.33";"15.14";"False";"CHEMBL952690";"Binding affinity to beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137011";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL487507";"";"0";"398.33";"0";"4.35";"32";"COc1ccc(CC(C)(C)NC[C@@H](O)COc2cccc(Cl)c2Cl)cc1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"16.38";"0.34";"2.17";"12.86";"False";"CHEMBL952690";"Binding affinity to beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137011";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL4279531";"";"0";"297.35";"0";"2.60";"1";"COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@H]3NCC2";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"22.46";"0.41";"4.08";"13.17";"False";"CHEMBL4258826";"Displacement of [3H]-CGP-12177 from human beta2-adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257493";"1";"Scientific Literature";"MedChemComm";"2018";"None";""
"CHEMBL305891";"";"0";"628.79";"3";"6.70";"8";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1";"IC50";"'='";"32000.0";"nM";"4.50";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL646906";"Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-2 adrenergic receptor (AR) in the presence of [125I]-iodocyanopindolol";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132774";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL67998";"";"0";"602.76";"3";"6.18";"17";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(CC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"10.82";"0.21";"0.34";"4.67";"False";"CHEMBL647877";"Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132774";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL74860";"";"0";"628.79";"3";"6.70";"7";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)cc2)cc1";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"6.36";"0.12";"-2.70";"2.86";"False";"CHEMBL647877";"Inhibitory activity against CHO cells expressing human Beta-2 adrenergic receptor with [125I]-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132774";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL331744";"";"0";"640.71";"2";"6.44";"2h";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(OC(F)(F)F)cc3)cs2)cc1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"9.24";"0.18";"-0.52";"5.22";"False";"CHEMBL647872";"Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-2 adrenergic receptor in the presence of [125I]- iodocyanopindolol.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133690";"1";"Scientific Literature";"J. Med. Chem.";"2000";"CHEMBL3308072";""
"CHEMBL34406";"";"0";"601.69";"1";"4.39";"6d";"COc1ccc(OCc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"8.81";"0.17";"0.91";"3.56";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL1258257";"";"0";"478.59";"0";"4.50";"14";"OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccccc1F";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1261259";"Antagonist activity at human recombinant adrenergic beta2 receptor expressed in CHO cells assessed as inhibition of isoproterenol-induced cyclic AMP formation by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL289248";"";"0";"666.76";"1";"3.58";"5r";"CS(=O)(=O)NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"8.40";"0.17";"2.02";"3.18";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL34328";"";"0";"551.67";"1";"3.50";"14";"CCC(O)CCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"24000.0";"nM";"4.62";"";"";"UO_0000065";"8.37";"0.16";"1.12";"3.07";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL58407";"";"0";"606.77";"2";"6.69";"5g";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc4ccccc4c3)cs2)cc1";"IC50";"'='";"6300.0";"nM";"5.20";"";"";"UO_0000065";"8.57";"0.17";"-1.49";"4.99";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL58241";"";"0";"640.87";"2";"7.66";"5r";"CCCCCCc1ccc(-c2csc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1";"IC50";"'='";"90000.0";"nM";"4.05";"";"";"UO_0000065";"6.31";"0.12";"-3.61";"3.88";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL102194";"";"0";"590.79";"1";"4.30";"26";"CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL650883";"Compound was tested for the antagonistic activity against Beta-2 adrenergic receptor";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134913";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2002";"None";""
"CHEMBL59270";"";"0";"584.77";"2";"5.66";"5e";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(CCc3ccccc3)cs2)cc1";"IC50";"'='";"910.0";"nM";"6.04";"";"";"UO_0000065";"10.33";"0.20";"0.38";"5.80";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL285704";"";"0";"628.71";"1";"4.34";"6g";"CC(=O)Nc1ccc(OCc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1";"IC50";"'='";"9500.0";"nM";"5.02";"";"";"UO_0000065";"7.99";"0.15";"0.68";"2.98";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL934";"METYRAPONE";"4";"226.28";"0";"2.64";"METYRAPONE";"CC(C)(C(=O)c1cccnc1)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL567";"PERPHENAZINE";"4";"403.98";"0";"3.94";"PERPHENAZINE";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL268291";"DIMETHYLFORMAMIDE";"0";"73.10";"0";"-0.30";"N,N-DIMETHYLFORMAMIDE";"CN(C)C=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3559671";"POLYVINYL ALCOHOL";"4";"None";"None";"None";"POLYVINYL ALCOHOL";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL475534";"NITRENDIPINE";"4";"360.37";"0";"2.57";"NITRENDIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1068";"OXCARBAZEPINE";"4";"252.27";"0";"2.64";"OXCARBAZEPINE";"NC(=O)N1c2ccccc2CC(=O)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL125963";"";"0";"592.69";"2";"5.82";"2b";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cccc(F)c3F)cs2)cc1";"IC50";"'='";"760.0";"nM";"6.12";"";"";"UO_0000065";"10.32";"0.20";"0.30";"5.87";"False";"CHEMBL647872";"Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-2 adrenergic receptor in the presence of [125I]- iodocyanopindolol.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133690";"1";"Scientific Literature";"J. Med. Chem.";"2000";"CHEMBL3308072";""
"CHEMBL1321";"PROCARBAZINE";"4";"221.30";"0";"1.05";"PROCARBAZINE";"CNNCc1ccc(C(=O)NC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201151";"MESTRANOL";"4";"310.44";"0";"3.92";"MESTRANOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL286231";"";"0";"587.66";"1";"4.08";"6c";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccccc3O)n2)cc1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"9.53";"0.18";"1.52";"3.51";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL276257";"";"0";"568.43";"1";"3.37";"3";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(I)cc1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"12.18";"0.30";"3.55";"6.41";"True";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL415690";"BETADEX";"3";"1134.99";"None";"None";"BETA CYCLODEXTRIN";"OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL418971";"BISPHENOL A";"0";"228.29";"0";"3.42";"BISPHENOL A";"CC(C)(c1ccc(O)cc1)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3736156";"";"0";"260.15";"None";"None";"3";"CB1C=Cc2c(cccc2OCC(O)CN(C)C)N1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3738004";"Antagonist activity at human beta2 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3734721";"1";"Scientific Literature";"J. Med. Chem.";"2015";"CHEMBL3307512";""
"CHEMBL932";"DIPYRIDAMOLE";"4";"504.64";"2";"-0.02";"DIPYRIDAMOLE";"OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1261";"CITRIC ACID";"4";"192.12";"0";"-1.25";"CITRIC ACID";"O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL510139";"CITRININ";"0";"250.25";"0";"1.72";"CITRININ";"CC1=C2C(=CO[C@H](C)[C@H]2C)C(O)=C(C(=O)O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL311469";"2-ACETYLAMINOFLUORENE";"0";"223.27";"0";"3.22";"2-ACETYLAMINOFLUORENE";"CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL252077";"";"0";"395.46";"0";"4.25";"2";"Cc1cc2[nH]c(C(O)CCCC(=O)O)c(CCc3ccccc3)c2cc1C(=O)O";"IC50";"'='";"777000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"False";"CHEMBL944925";"Binding affinity to GST tagged human beta 2 adrenergic receptor PDZ1 domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141464";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2008";"None";""
"CHEMBL403297";"";"0";"409.48";"0";"4.18";"6";"Cc1cc2c(CO)c(CCCCC(=O)O)n(CCc3ccccc3)c2cc1C(=O)O";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"11.78";"0.22";"0.64";"4.84";"False";"CHEMBL944925";"Binding affinity to GST tagged human beta 2 adrenergic receptor PDZ1 domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141464";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2008";"None";""
"CHEMBL23";"DILTIAZEM";"4";"414.53";"0";"3.37";"DILTIAZEM";"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL926";"DOBUTAMINE";"4";"301.39";"0";"2.96";"DOBUTAMINE";"CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1";"IC50";"'='";"1517.0";"nM";"5.82";"";"";"UO_0000065";"19.31";"0.36";"2.86";"8.00";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL462313";"";"0";"261.32";"0";"1.13";"(-)-1";"CC(C)N[C@@H]1CCn2c(=O)[nH]c3cccc(c32)[C@H]1O";"IC50";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"23.75";"0.45";"5.08";"8.86";"False";"CHEMBL1010734";"Displacement of [3H]CGP1217 from human recombinant adrenergic beta2 receptor transfected in insect Sf9 cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152790";"1";"Scientific Literature";"J. Med. Chem.";"2009";"CHEMBL3308860";""
"CHEMBL418234";"";"0";"572.66";"2";"5.13";"6e";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(Cc3ccc(F)cc3)n2)cc1";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"9.57";"0.18";"0.35";"4.67";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL105968";"";"0";"476.40";"0";"3.51";"5i";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(Br)cc1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"11.13";"0.25";"1.79";"5.80";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL202434";"";"0";"318.81";"0";"2.20";"12h";"O=C(NC[C@@H]1CCN2CCC[C@@H]12)c1cc(Cl)cn2ccnc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL858809";"Binding affinity to adrenergic beta-2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149398";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL803";"CYTARABINE";"4";"243.22";"0";"-2.56";"CYTARABINE";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200431";"GADOPENTETATE DIMEGLUMINE";"4";"742.79";"None";"None";"GADOPENTETATE DIMEGLUMINE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL66789";"";"0";"590.66";"1";"4.20";"12c";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3c(F)cccc3F)n2)cc1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"8.97";"0.17";"1.10";"4.34";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL22375";"";"0";"591.74";"1";"3.46";"9c";"O=c1n(CCCC2CCCC2)nnn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"9.79";"0.19";"2.34";"4.02";"False";"CHEMBL876752";"Inhibitory activity against cloned human Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132038";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL304298";"";"0";"572.67";"1";"4.06";"12b";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(F)cc3)n2)cc1";"IC50";"'='";"780.0";"nM";"6.11";"";"";"UO_0000065";"10.67";"0.20";"2.05";"5.01";"False";"CHEMBL647105";"Binding affinity for clone human Beta-2 adrenergic receptor from CHO cell membranes in the presence of I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133315";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL1258824";"";"0";"518.64";"1";"3.85";"24";"NC(=O)Nc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1";"IC50";"'='";"1280.0";"nM";"5.89";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1261259";"Antagonist activity at human recombinant adrenergic beta2 receptor expressed in CHO cells assessed as inhibition of isoproterenol-induced cyclic AMP formation by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL3128179";"";"0";"447.60";"0";"4.52";"20";"Cc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128200";"";"0";"466.58";"0";"3.93";"16";"Nc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccc(F)cc3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128191";"";"0";"450.61";"0";"4.25";"8a";"CC[C@@H](C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1csc(N)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128198";"";"0";"483.04";"0";"4.44";"14";"Nc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccc(Cl)c3)N2)cc1";"IC50";"'='";"8451.0";"nM";"5.07";"";"";"UO_0000065";"10.50";"0.21";"0.63";"5.06";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL431048";"";"0";"697.78";"2";"2.79";"35";"CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O";"IC50";"'='";"268.0";"nM";"6.57";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL650892";"Compound was tested for the antagonistic activity against Beta-2 adrenergic receptor";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134913";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2002";"None";""
"CHEMBL67015";"";"0";"569.73";"1";"4.16";"12";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"11.17";"0.22";"2.21";"4.49";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL61962";"";"0";"572.71";"2";"5.24";"5t";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(O)cc3)cs2)cc1";"IC50";"'='";"5700.0";"nM";"5.24";"";"";"UO_0000065";"9.16";"0.18";"0.00";"4.21";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL1560";"CAPTOPRIL";"4";"217.29";"0";"0.63";"CAPTOPRIL";"C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1103";"FURAZOLIDONE";"4";"225.16";"0";"0.97";"FURAZOLIDONE";"O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1800962";"";"0";"337.42";"0";"3.51";"BDBM50348429";"C[C@@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1";"IC50";"'='";"72.6";"nM";"7.14";"";"365715";"UO_0000065";"21.16";"0.39";"3.63";"9.82";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL1201346";"BALSALAZIDE";"4";"357.32";"0";"2.71";"BALSALAZIDE";"O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL228996";"";"0";"317.39";"0";"2.36";"BDBM50213120";"COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1";"IC50";"'='";"2.01";"nM";"8.70";"";"365705";"UO_0000065";"27.40";"0.52";"6.34";"10.61";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL1200624";"ETHYNODIOL DIACETATE";"4";"384.52";"0";"4.43";"ETHYNODIOL DIACETATE";"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL108";"CARBAMAZEPINE";"4";"236.27";"0";"3.39";"CARBAMAZEPINE";"NC(=O)N1c2ccccc2C=Cc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1308";"FOMEPIZOLE";"4";"82.11";"0";"0.72";"4-METHYLPYRAZOLE";"Cc1cn[nH]c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL496";"HEXACHLOROPHENE";"4";"406.91";"1";"6.61";"HEXACHLOROPHENE";"Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1586";"BECLOMETHASONE";"2";"408.92";"0";"2.17";"BECLOMETHASONE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL541";"BENZOIC ACID";"4";"122.12";"0";"1.38";"BENZOIC ACID";"O=C(O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1491";"AMLODIPINE";"4";"408.88";"0";"2.27";"AMLODIPINE";"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1467";"ALLOPURINOL";"4";"136.11";"0";"-0.40";"ALLOPURINOL";"O=c1ncnc2[nH][nH]cc1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL508102";"CARBIMAZOLE";"4";"186.24";"0";"1.56";"CARBIMAZOLE";"CCOC(=O)n1ccn(C)c1=S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200845";"HALCINONIDE";"4";"454.97";"0";"3.89";"HALCINONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL52407";"";"0";"454.60";"1";"5.47";"7c";"CCCCCCCCc1nc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)no1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.40";"0.30";"1.53";"7.92";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL65";"CAMPTOTHECIN";"0";"348.36";"0";"2.08";"CAMPTOTHECIN";"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL508112";"BENZOTHIAZYL DISULFIDE";"0";"332.50";"1";"5.71";"BENZOTHIAZYL DISULFIDE";"c1ccc2sc(SSc3nc4ccccc4s3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL301202";"";"0";"345.42";"0";"2.53";"6a";"CN(C)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"14.92";"0.29";"2.62";"7.39";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL104193";"";"0";"559.69";"1";"4.11";"5o";"O=C(NCCc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"11.97";"0.23";"2.59";"5.06";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL513389";"ICI-118551";"0";"277.41";"0";"2.61";"ICI-118551";"Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"32.16";"0.61";"6.31";"21.50";"False";"CHEMBL953125";"Displacement of radiolabeled ICI 118551 from human adrenergic beta2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140203";"1";"Scientific Literature";"J. Med. Chem.";"2008";"None";""
"CHEMBL783";"NATEGLINIDE";"4";"317.43";"0";"3.26";"NATEGLINIDE";"CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL445";"NORTRIPTYLINE";"4";"263.38";"0";"3.83";"NORTRIPTYLINE";"CNCCC=C1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1372";"OXIGLUTATIONE";"4";"612.64";"3";"-3.88";"GLUTATHIONE, OXIDIZED FORM";"N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL95764";"GLYPHOSATE";"0";"169.07";"0";"-1.20";"GLYPHOSATE";"O=C(O)CNCP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL305660";"EBASTINE";"3";"469.67";"1";"7.22";"EBASTINE";"CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL502620";"ACLARUBICIN";"2";"811.88";"2";"3.16";"ACLARUBICIN";"CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL452861";"(-)-PROPANOLOL ";"2";"259.35";"0";"2.58";"S(-)-propranolol";"CC(C)NC[C@H](O)COc1cccc2ccccc12";"IC50";"'='";"0.78";"nM";"9.11";"";"";"UO_0000065";"35.12";"0.65";"6.53";"21.95";"False";"CHEMBL2395283";"Displacement of [3H]CGP12177 from human recombinant beta2 adrenergic receptor expressed in CHO cells after 60 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390918";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2013";"CHEMBL3308072";""
"CHEMBL1390";"";"0";"344.50";"0";"4.08";"MEDROXYPROGESTERONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1214185";"ROXITHROMYCIN";"4";"837.06";"2";"2.21";"ROXITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1762";"TOCAINIDE";"4";"192.26";"0";"1.59";"TOCAINIDE";"Cc1cccc(C)c1NC(=O)C(C)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL959";"RIMANTADINE";"4";"179.31";"0";"2.55";"RIMANTADINE";"CC(N)C12CC3CC(CC(C3)C1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL701";"BACLOFEN";"4";"213.66";"0";"1.86";"BACLOFEN";"NCC(CC(=O)O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL2107797";"NORGESTREL";"4";"312.45";"0";"3.88";"NORGESTREL";"C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1540";"PENCICLOVIR";"4";"253.26";"0";"-0.90";"PENCICLOVIR";"Nc1nc(O)c2ncn(CCC(CO)CO)c2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1230813";"ALFADEX";"1";"972.85";"3";"-13.05";"ALPHA-CYCLODEXTRIN";"OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1684582";"";"0";"649.76";"2";"7.69";"34, diastereomeric mixture";"O=S(=O)(Nc1ccc(CC2CC[C@H]([C@@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1";"IC50";"'='";"2790.0";"nM";"5.55";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1687005";"Agonist activity at human beta2 adrenergic receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681775";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2011";"None";""
"CHEMBL1684585";"";"0";"422.55";"0";"3.30";"39";"Nc1nc(CC(=O)Nc2ccc(C[C@@H]3CC[C@H]([C@H](O)c4ccccc4)N3)cc2)cs1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"True";"CHEMBL1687005";"Agonist activity at human beta2 adrenergic receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1681775";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2011";"None";""
"CHEMBL33725";"";"0";"535.67";"1";"4.53";"8";"CCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"10.31";"0.20";"0.99";"4.24";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL3892218";"";"0";"809.41";"4";"6.28";"BDBM221903";"COc1cc(NC(=O)CCN(C)[C@H]2CC[C@](C)(OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12";"IC50";"'='";"2.2";"nM";"8.66";"";"388363";"UO_0000065";"10.70";"0.21";"2.38";"4.99";"False";"CHEMBL3888303";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 μg/well for beta1 and 5 μg/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 μl, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 μM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886646";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL292947";"";"0";"469.61";"0";"3.58";"19";"CC(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"13.60";"0.26";"2.81";"6.35";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL67461";"";"0";"493.59";"0";"2.58";"21";"Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3cnc4ccccc4c3)cc2)cn1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"11.92";"0.23";"3.31";"4.22";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL1085694";"";"0";"429.52";"0";"3.39";"28";"O=C(CCc1nc2ccccc2[nH]1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1095042";"";"0";"379.46";"0";"2.09";"34";"Cc1ccn(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1093385";"";"0";"379.46";"0";"2.34";"37, entA";"CC(C(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)n1cccn1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1078395";"";"0";"454.57";"0";"4.24";"53";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1CCn1cccc1";"IC50";"'='";"6900.0";"nM";"5.16";"";"";"UO_0000065";"11.35";"0.21";"0.92";"6.52";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1078576";"";"0";"427.51";"0";"3.59";"58";"O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(-c2ncc[nH]2)c1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"14.97";"0.27";"2.81";"6.22";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1089387";"";"0";"416.49";"0";"2.33";"12";"O=C(Cn1nc2ccccc2n1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"11.73";"0.22";"2.56";"4.66";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1089725";"";"0";"416.48";"0";"3.27";"13";"O=C(Cc1nc2ccccc2o1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"14.31";"0.26";"2.69";"5.94";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1090424";"";"0";"396.52";"0";"2.89";"16";"Cc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cs1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1090425";"";"0";"397.50";"0";"2.17";"17";"Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cs1";"IC50";"'='";"8700.0";"nM";"5.06";"";"";"UO_0000065";"12.73";"0.25";"2.89";"4.47";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1084144";"";"0";"443.51";"0";"2.30";"25";"O=C(Cn1c(=O)ncc2ccccc21)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1105983";"Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155428";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL285499";"";"0";"609.63";"1";"4.81";"5a";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3cc(F)c(F)c(F)c3)n2)cc1";"IC50";"'='";"720.0";"nM";"6.14";"";"";"UO_0000065";"10.08";"0.20";"1.33";"4.72";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL286435";"";"0";"589.65";"1";"4.52";"6b";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(F)cc3)n2)cc1";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"10.70";"0.21";"1.79";"4.52";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL288550";"";"0";"589.65";"1";"4.52";"9c";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(COc3ccc(F)cc3)no2)cc1";"IC50";"'='";"7500.0";"nM";"5.12";"";"";"UO_0000065";"8.69";"0.17";"0.60";"3.67";"False";"CHEMBL647110";"Binding affinity to recombinant human beta-2 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL12998";"L-755507";"0";"584.74";"2";"4.47";"2, (L-755507)";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"9.45";"0.18";"1.05";"3.71";"False";"CHEMBL647873";"Beta-2 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131399";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL3890898";"";"0";"769.95";"3";"5.88";"BDBM200744";"CN(CCCc1nc(-c2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)no1)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1";"IC50";"'='";"2.7";"nM";"8.57";"";"356812";"UO_0000065";"11.13";"0.22";"2.69";"4.92";"False";"CHEMBL3887836";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 ug/well for beta1 and 5 ug/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 ul, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 uM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886468";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL3905320";"";"0";"839.43";"3";"5.40";"BDBM200748";"COc1cc(OCC(=O)N(C)CCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12";"IC50";"'='";"5.7";"nM";"8.24";"";"356816";"UO_0000065";"9.82";"0.20";"2.84";"4.74";"False";"CHEMBL3887836";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 ug/well for beta1 and 5 ug/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 ul, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 uM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886468";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL3910208";"";"0";"774.96";"3";"4.49";"BDBM200755";"CC(Cc1ccc(OCC(=O)NCCN[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12";"IC50";"'='";"3.1";"nM";"8.51";"";"356823";"UO_0000065";"10.98";"0.22";"4.02";"4.67";"False";"CHEMBL3887836";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 ug/well for beta1 and 5 ug/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 ul, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 uM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886468";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL319244";"CAFFEIC ACID PHENETHYL ESTER";"0";"284.31";"0";"2.90";"CAFFEIC ACID PHENETHYL ESTER";"O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200396";"BUPIVACAINE HYDROCHLORIDE";"4";"324.90";"0";"3.90";"BUPIVACAINE HYDROCHLORIDE";"CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL26260";"BETA-NAPHTHOFLAVONE";"0";"272.30";"0";"4.61";"BETA-NAPHTHOFLAVONE";"O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL264374";"BEZAFIBRATE";"4";"361.83";"0";"3.55";"BEZAFIBRATE";"CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL221753";"BENZETHONIUM CHLORIDE";"0";"448.09";"1";"6.07";"BENZETHONIUM CHLORIDE";"CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL56752";"";"0";"386.52";"0";"4.35";"4b";"CCCCCCC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"14.74";"0.29";"1.35";"8.57";"False";"CHEMBL647882";"In vitro binding affinity towards cloned human beta-2 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131776";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL1800961";"";"0";"337.42";"0";"3.51";"BDBM50348428";"C[C@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1";"IC50";"'='";"1.91";"nM";"8.72";"";"365714";"UO_0000065";"25.84";"0.48";"5.21";"11.99";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL1800963";"";"0";"367.45";"0";"3.51";"BDBM50348430";"COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)c2ccccc12";"IC50";"'='";"3.98";"nM";"8.40";"";"365716";"UO_0000065";"22.86";"0.42";"4.89";"10.25";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL1800934";"";"0";"367.45";"0";"3.51";"BDBM50348431";"COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)c2ccccc12";"IC50";"'='";"4.37";"nM";"8.36";"";"365717";"UO_0000065";"22.75";"0.42";"4.85";"10.20";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL3923686";"";"0";"758.87";"3";"6.25";"BDBM200750";"CN(CCCn1c(=O)oc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C2(C)c3ccccc3Oc3ccccc32)CC1";"IC50";"'='";"1.5";"nM";"8.82";"";"356818";"UO_0000065";"11.63";"0.22";"2.57";"5.54";"False";"CHEMBL3887836";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 ug/well for beta1 and 5 ug/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 ul, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 uM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886468";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL3911114";"";"0";"772.95";"3";"5.24";"BDBM200754";"CN(CCCn1c(=O)oc2cc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1";"IC50";"'='";"62.0";"nM";"7.21";"";"356822";"UO_0000065";"9.32";"0.18";"1.97";"4.23";"False";"CHEMBL3887836";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 ug/well for beta1 and 5 ug/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 ul, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 uM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886468";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL234926";"ALLYL ALCOHOL";"0";"58.08";"0";"0.16";"ALLYL ALCOHOL";"C=CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL648";"CYCLIZINE";"4";"266.39";"0";"3.02";"CYCLIZINE";"CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL521";"IBUPROFEN";"4";"206.28";"0";"3.07";"IBUPROFEN";"CC(C)Cc1ccc(C(C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL119443";"ERGONOVINE";"4";"325.41";"0";"1.53";"ERGONOVINE";"C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL2220442";"FLUVASTATIN";"4";"411.47";"0";"4.63";"FLUVASTATIN";"CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL597";"PHENTOLAMINE";"4";"281.36";"0";"2.84";"PHENTOLAMINE";"Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909074";"POLYVINYLPYRROLIDONE";"0";"None";"None";"None";"POLYVINYLPYRROLIDONE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1231";"OXYBUTYNIN";"4";"357.49";"0";"3.34";"OXYBUTYNIN";"CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3747546";"";"0";"448.56";"0";"2.96";"24f";"CCOC(=O)[C@@H]1[C@H]2CN(C(=O)c3ccc(C[C@@H]4CC[C@H]([C@H](O)c5ccccc5)N4)cc3)C[C@H]21";"IC50";"'='";"13400.0";"nM";"4.87";"";"";"UO_0000065";"10.86";"0.20";"1.91";"6.18";"False";"CHEMBL3750559";"Displacement of [125I]CYP from human beta-2 adrenergic receptor expressed in CHO cell membrane after 1 hr by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745665";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2016";"CHEMBL3308072";""
"CHEMBL85";"RISPERIDONE";"4";"410.49";"0";"3.59";"RISPERIDONE";"Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3971284";"";"0";"760.94";"3";"4.40";"BDBM200746";"CN(CCNC(=O)COc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"356814";"UO_0000065";"10.18";"0.20";"3.34";"4.47";"False";"CHEMBL3887836";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 ug/well for beta1 and 5 ug/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 ul, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 uM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886468";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL942";"BISACODYL";"4";"361.40";"0";"4.11";"BISACODYL";"CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3934254";"";"0";"695.95";"2";"6.43";"BDBM221898";"CN(CCCCCCCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12)C1CCC(OC(=O)C(O)(c2cccs2)c2cccs2)CC1";"IC50";"'='";"6.4";"nM";"8.19";"";"388358";"UO_0000065";"11.77";"0.23";"1.76";"6.06";"False";"CHEMBL3888303";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 μg/well for beta1 and 5 μg/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 μl, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 μM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886646";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL4634403";"";"0";"370.45";"0";"3.80";"PZL-2";"CC(=O)Nc1ccc(/N=N/c2cccc(OC[C@@H](O)CNC(C)C)c2)cc1";"IC50";"'='";"593.88";"nM";"6.23";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4630500";"Antagonist activity at ADRB2 endogenously expressed in HEK293 cells transfected with cAMP FRET biosensor assessed as inhibition of cimaterol-induced response pre-incubated for 45 mins under dark conditions by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627414";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3307715";""
"CHEMBL4649599";"";"0";"370.45";"0";"3.80";"PZL-3";"CC(=O)Nc1ccc(/N=N/c2ccc(OC[C@@H](O)CNC(C)C)cc2)cc1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4630500";"Antagonist activity at ADRB2 endogenously expressed in HEK293 cells transfected with cAMP FRET biosensor assessed as inhibition of cimaterol-induced response pre-incubated for 45 mins under dark conditions by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627414";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3307715";""
"CHEMBL9514";"NOCODAZOLE";"0";"301.33";"0";"3.03";"NOCODAZOLE";"COC(=O)Nc1nc2ccc(C(=O)c3cccs3)cc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL191";"LOSARTAN";"4";"422.92";"0";"4.27";"LOSARTAN";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL122";"ROFECOXIB";"4";"314.36";"0";"2.56";"ROFECOXIB";"CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909083";"ZIRCONIUM(IV) CHLORIDE";"0";"233.04";"None";"None";"ZIRCONIUM(IV) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL121";"ROSIGLITAZONE";"4";"357.44";"0";"2.49";"ROSIGLITAZONE";"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1790041";"RANITIDINE";"4";"314.41";"0";"1.46";"RANITIDINE";"CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL695";"TRIMETHADIONE";"4";"143.14";"0";"0.37";"TRIMETHADIONE";"CN1C(=O)OC(C)(C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL76904";"TYRPHOSTIN 23";"0";"186.17";"0";"1.53";"TYRPHOSTIN A23";"N#CC(C#N)=Cc1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL822";"TERBINAFINE";"4";"291.44";"0";"4.88";"TERBINAFINE";"CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL2103774";"TIBOLONE";"4";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)C1=C(CC(=O)CC1)C[C@H]3C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL809";"SERTRALINE";"4";"306.24";"1";"5.18";"SERTRALINE";"CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL866";"MYCOPHENOLIC ACID";"4";"320.34";"0";"2.73";"MYCOPHENOLIC ACID";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL67416";"";"0";"472.57";"0";"2.05";"27";"COc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1";"IC50";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"13.14";"0.26";"4.16";"4.57";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL64201";"";"0";"568.44";"1";"2.64";"9";"Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(I)cc3)cc2)cn1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"13.29";"0.32";"4.91";"5.97";"False";"CHEMBL647874";"Evaluated for its agonist activity and the binding affinity against human Beta-2 adrenergic receptor in membranes from chinese hamster ovary cell";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"ovary";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131392";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL439";"SULFADIAZINE";"4";"250.28";"0";"0.86";"SULFADIAZINE";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1064";"SIMVASTATIN";"4";"418.57";"0";"4.59";"SIMVASTATIN";"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL386630";"TESTOSTERONE";"4";"288.43";"0";"3.88";"TESTOSTERONE";"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL118";"CELECOXIB";"4";"381.38";"0";"3.51";"CELECOXIB";"Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL174";"AMPICILLIN";"4";"349.41";"0";"0.32";"Ampicillin";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL134342";"THIOCTIC ACID";"0";"206.33";"0";"2.79";"THIOCTIC ACID";"O=C(O)CCCC[C@@H]1CCSS1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL404";"TAZOBACTAM";"4";"300.30";"0";"-1.52";"TAZOBACTAM";"C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL20";"ACETAZOLAMIDE";"4";"222.25";"0";"-0.86";"ACETAZOLAMIDE";"CC(=O)Nc1nnc(S(N)(=O)=O)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL128";"SUMATRIPTAN";"4";"295.41";"0";"1.32";"SUMATRIPTAN";"CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201631";"INSULIN";"4";"None";"None";"None";"INSULIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200679";"ZINC CHLORIDE";"4";"136.30";"None";"None";"ZINC CHLORIDE";"[Cl-].[Cl-].[Zn+2]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL159";"VINBLASTINE";"4";"810.99";"2";"3.99";"VINBLASTINE";"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1464";"WARFARIN";"4";"308.33";"0";"3.61";"WARFARIN";"CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL227934";"STRYCHNINE";"0";"334.42";"0";"2.09";"STRYCHNINE";"O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3128188";"";"0";"417.51";"0";"2.80";"6";"O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)[C@@H]1CCc2ccnn21";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3767773";"Displacement of [125]I-cyanopindolol from human recombinant beta2 adrenergic receptor after 1 hr by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763146";"1";"Scientific Literature";"J. Med. Chem.";"2016";"None";""
"CHEMBL1200558";"BACITRACIN";"4";"1422.72";"None";"None";"BACITRACIN";"CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL462547";"URETHANE";"4";"89.09";"0";"0.10";"URETHANE";"CCOC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL833";"TICLOPIDINE";"4";"263.79";"0";"3.96";"TICLOPIDINE";"Clc1ccccc1CN1CCc2sccc2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1670";"MITOTANE";"4";"320.05";"1";"5.93";"MITOTANE";"Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL93";"ZILEUTON";"4";"236.30";"0";"2.73";"ZILEUTON";"CC(c1cc2ccccc2s1)N(O)C(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200604";"TROPICAMIDE";"4";"284.36";"0";"2.21";"TROPICAMIDE";"CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4285155";"";"0";"299.37";"0";"2.62";"5";"COc1cc2c(cc1OC)[C@H]([C@H](O)c1ccccc1)NCC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4258826";"Displacement of [3H]-CGP-12177 from human beta2-adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257493";"1";"Scientific Literature";"MedChemComm";"2018";"None";""
"CHEMBL4285281";"";"0";"297.35";"0";"2.60";"2; AK-2-202";"COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2";"IC50";"'='";"6.9";"nM";"8.16";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4258831";"Antagonist activity at human beta2-adrenergic receptor expressed in CHO-K1 cells assessed as decrease in procaterol-induced cAMP accumulation after 20 mins by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257493";"1";"Scientific Literature";"MedChemComm";"2018";"None";""
"CHEMBL1220";"TINIDAZOLE";"4";"247.28";"0";"0.53";"TINIDAZOLE";"CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1946764";"";"0";"524.09";"1";"4.98";"5";"O=c1[nH]c2c(O)ccc(CCNCCc3ccc(CN4CC[C@@H](Oc5ccc(Cl)cc5)C4)cc3)c2s1";"IC50";"'='";"125.89";"nM";"6.90";"";"";"UO_0000065";"13.17";"0.26";"1.92";"8.89";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1947157";"";"0";"532.49";"1";"4.80";"15";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1";"IC50";"'='";"0.1995";"nM";"9.70";"";"";"UO_0000065";"18.22";"0.38";"4.90";"9.96";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1947153";"";"0";"503.67";"1";"4.54";"Table 2, R9C4";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CN4CCC(c5ccccc5)CC4)c3)c2s1";"IC50";"'='";"3.981";"nM";"8.40";"";"";"UO_0000065";"16.68";"0.32";"3.86";"9.48";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1944695";"";"0";"463.60";"0";"3.49";"22";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4)cc3)c2s1";"IC50";"'='";"1.995";"nM";"8.70";"";"";"UO_0000065";"18.77";"0.36";"5.21";"8.93";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL109";"VALPROIC ACID";"4";"144.21";"0";"2.29";"VALPROIC ACID";"CCCC(CCC)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL471";"SOTALOL";"4";"272.37";"0";"1.09";"SOTALOL";"CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1";"IC50";"'='";"433.9";"nM";"6.36";"";"";"UO_0000065";"23.36";"0.48";"5.27";"8.11";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4474813";"";"0";"558.72";"2";"1.18";"4a";"CC(C)NC[C@H](O)COc1ccccc1CC(=O)NCCNC(=O)Cc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"2630.27";"nM";"5.58";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL1945032";"";"0";"516.67";"2";"4.28";"24";"Cc1cccc2c(CCNCc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)cc3)c[nH]c12";"IC50";"'='";"1.995";"nM";"8.70";"";"";"UO_0000065";"16.84";"0.32";"4.42";"7.69";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945296";"";"0";"546.52";"2";"5.19";"44";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1";"IC50";"'='";"6.31";"nM";"8.20";"";"";"UO_0000065";"15.00";"0.31";"3.01";"8.42";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945504";"";"0";"479.60";"0";"3.46";"50";"COc1ccccc1CNCc1ccc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1";"IC50";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"13.76";"0.27";"3.14";"6.19";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL4594173";"";"0";"614.83";"2";"2.74";"4d";"CC(C)NC[C@H](O)COc1ccccc1CCCC(=O)NCCNC(=O)CCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"6.607";"nM";"8.18";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4462252";"";"0";"649.84";"2";"2.12";"5c";"CC(C)NC[C@H](O)COc1ccccc1CCn1cc(CNCc2cn(CCc3ccccc3OC[C@@H](O)CNC(C)C)nn2)nn1";"IC50";"'='";"2.042";"nM";"8.69";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL85728";"4,4'-METHYLENEDIANILINE";"0";"198.27";"0";"2.44";"4,4'-METHYLENEDIANILINE";"Nc1ccc(Cc2ccc(N)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL980";"GUAIFENESIN";"4";"198.22";"0";"0.43";"GUAIFENESIN";"COc1ccccc1OCC(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL768";"ESMOLOL";"4";"295.38";"0";"1.53";"ESMOLOL";"COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL826";"ENOXACIN";"4";"320.32";"0";"0.66";"ENOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1944691";"";"0";"481.59";"0";"3.63";"18";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4F)c3)c2s1";"IC50";"'='";"0.5012";"nM";"9.30";"";"";"UO_0000065";"19.31";"0.37";"5.67";"9.55";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945034";"";"0";"464.59";"0";"2.89";"26";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccn4)cc3)c2s1";"IC50";"'='";"3.162";"nM";"8.50";"";"";"UO_0000065";"18.30";"0.35";"5.61";"7.71";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945299";"";"0";"493.63";"0";"3.50";"47";"COc1ccccc1CNCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1";"IC50";"'='";"1.585";"nM";"8.80";"";"";"UO_0000065";"17.83";"0.34";"5.30";"8.25";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1444";"LETROZOLE";"4";"285.31";"0";"2.66";"LETROZOLE";"N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL75880";"PERHEXILINE";"4";"277.50";"1";"5.30";"PERHEXILINE";"C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL672";"FENOFIBRATE";"4";"360.84";"0";"4.68";"FENOFIBRATE";"CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL340978";"BENOXAPROFEN";"4";"301.73";"0";"4.34";"BENOXAPROFEN";"CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL137";"METRONIDAZOLE";"4";"171.16";"0";"0.09";"METRONIDAZOLE";"Cc1ncc([N+](=O)[O-])n1CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909062";"LEAD (II) ACETATE";"0";"325.29";"None";"None";"LEAD (II) ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909075";"";"0";"None";"None";"None";"QUINOLONE, CHEMI-LINZ ; CYANAMID";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL828";"PHENOTHIAZINE";"0";"199.28";"0";"3.89";"PHENOTHIAZINE";"c1ccc2c(c1)Nc1ccccc1S2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL61";"PODOFILOX";"4";"414.41";"0";"2.41";"PODOPHYLLOTOXIN";"COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL398440";"CHLOROXYLENOL";"4";"156.61";"0";"2.66";"CHLOROXYLENOL";"Cc1cc(O)cc(C)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1113";"AMOXAPINE";"4";"313.79";"0";"3.43";"AMOXAPINE";"Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL64894";"GENTIAN VIOLET";"4";"407.99";"0";"4.46";"GENTIAN VIOLET";"CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL81977";"3-AMINOBENZAMIDE";"0";"136.15";"0";"0.37";"3-AMINOBENZAMIDE";"NC(=O)c1cccc(N)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1463";"FLUCYTOSINE";"4";"129.09";"0";"-0.51";"FLUCYTOSINE";"Nc1[nH]c(=O)ncc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL403296";"";"0";"365.47";"1";"5.18";"1";"CCCCC(O)c1[nH]c2cc(C)c(C(=O)O)cc2c1CCc1ccccc1";"IC50";"'='";"1540000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"False";"CHEMBL944925";"Binding affinity to GST tagged human beta 2 adrenergic receptor PDZ1 domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141464";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2008";"None";""
"CHEMBL250740";"";"0";"379.50";"1";"5.12";"5";"CCCCCc1c(CO)c2cc(C)c(C(=O)O)cc2n1CCc1ccccc1";"IC50";"'='";"280000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"False";"CHEMBL944925";"Binding affinity to GST tagged human beta 2 adrenergic receptor PDZ1 domain";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141464";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2008";"None";""
"CHEMBL14053";"TRICHLOROACETIC ACID";"4";"163.39";"0";"1.44";"TRICHLOROACETIC ACID";"O=C(O)C(Cl)(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL95";"TACRINE";"4";"198.27";"0";"2.70";"TACRINE";"Nc1c2c(nc3ccccc13)CCCC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909054";"CARBOXYMETHYLCELLULOSE";"0";"None";"None";"None";"CARBOXYMETHYLCELLULOSE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1945033";"";"0";"464.59";"0";"2.89";"25";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)c2s1";"IC50";"'='";"2.512";"nM";"8.60";"";"";"UO_0000065";"18.51";"0.36";"5.71";"7.80";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL4649599";"";"0";"370.45";"0";"3.80";"PZL-3";"CC(=O)Nc1ccc(/N=N/c2ccc(OC[C@@H](O)CNC(C)C)cc2)cc1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4630501";"Antagonist activity at ADRB2 endogenously expressed in HEK293 cells transfected with cAMP FRET biosensor assessed as inhibition of cimaterol-induced response pre-incubated for 45 mins under constant violet light conditions by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627414";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3307715";""
"CHEMBL38737";"THIOACETAMIDE";"0";"75.14";"0";"0.91";"THIOACETAMIDE";"CC(=N)S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL877";"TRANEXAMIC ACID";"4";"157.21";"0";"0.84";"TRANEXAMIC ACID";"NC[C@H]1CC[C@H](C(=O)O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL408";"TROGLITAZONE";"4";"441.55";"0";"4.37";"TROGLITAZONE";"Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL114";"SAQUINAVIR";"4";"670.86";"1";"3.09";"SAQUINAVIR";"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909080";"STRONTIUM CHLORIDE HEXAHYDRATE";"0";"266.62";"None";"None";"STRONTIUM CHLORIDE HEXAHYDRATE";"O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1947155";"";"0";"539.70";"2";"5.68";"Table 2, R9C6";"C[C@@H](NCc1ccccc1-c1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1";"IC50";"'='";"1.995";"nM";"8.70";"";"";"UO_0000065";"16.12";"0.30";"3.02";"8.93";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1944694";"";"0";"493.63";"0";"3.50";"21";"COc1ccccc1CCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1";"IC50";"'='";"1.995";"nM";"8.70";"";"";"UO_0000065";"17.62";"0.34";"5.20";"8.16";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945043";"";"0";"450.56";"0";"2.85";"35";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccn4)c3)c2s1";"IC50";"'='";"15.85";"nM";"7.80";"";"";"UO_0000065";"17.31";"0.33";"4.95";"7.07";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL116";"AMPRENAVIR";"4";"505.64";"1";"2.40";"AMPRENAVIR";"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL917";"FLOXURIDINE";"4";"246.19";"0";"-1.68";"5-FLUORO-2'-DEOXYURIDINE";"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL19236";"MOXONIDINE";"4";"241.68";"0";"0.82";"MOXONIDINE";"COc1nc(C)nc(Cl)c1NC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200693";"MANGANESE CHLORIDE";"4";"125.84";"None";"None";"MANGANESE (II) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL486278";"";"0";"385.46";"0";"2.22";"2";"COc1ccc(CC(C)(C)NC[C@H](O)COc2cccc3[nH]c(=O)[nH]c23)cc1";"IC50";"'='";"0.0013";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1052906";"Inhibition of beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154613";"1";"Scientific Literature";"J. Med. Chem.";"2009";"None";""
"CHEMBL158";"AZTREONAM";"4";"435.44";"0";"-1.17";"AZTREONAM";"C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1947154";"";"0";"537.69";"2";"5.34";"Table 2, R9C5";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(-c4cccc(CN5Cc6ccccc6C5)c4)cc3)c2s1";"IC50";"'='";"63.1";"nM";"7.20";"";"";"UO_0000065";"13.39";"0.25";"1.86";"8.13";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL559147";"Y-27632";"0";"247.34";"0";"2.17";"Y-27632";"C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL413";"SIROLIMUS";"4";"914.19";"3";"6.18";"RAPAMYCIN";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL802";"MINOXIDIL";"4";"209.25";"0";"-0.13";"MINOXIDIL";"Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL717";"MEDROXYPROGESTERONE ACETATE";"4";"386.53";"0";"4.66";"MEDROXYPROGESTERONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1440";"TETRACYCLINE";"4";"444.44";"1";"-0.21";"TETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1009";"LEVODOPA";"4";"197.19";"0";"0.05";"LEVODOPA";"N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL566534";"ARTEMETHER";"4";"298.38";"0";"2.84";"ARTEMETHER";"CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL211501";"ANTIMYCIN A";"0";"548.63";"1";"3.48";"ANTIMYCIN A";"CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1123";"DICYCLOMINE";"4";"309.49";"0";"4.40";"DICYCLOMINE";"CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL49080";"CLENBUTEROL";"4";"277.20";"0";"3.00";"(rac)-2";"CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"21.23";"0.47";"2.89";"10.10";"False";"CHEMBL1010734";"Displacement of [3H]CGP1217 from human recombinant adrenergic beta2 receptor transfected in insect Sf9 cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152790";"1";"Scientific Literature";"J. Med. Chem.";"2009";"CHEMBL3308860";""
"CHEMBL998";"LORATADINE";"4";"382.89";"0";"4.89";"4";"CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3";"NICOTINE";"4";"162.24";"0";"1.85";"Nicotine";"CN1CCC[C@H]1c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1908355";"TENIDAP";"0";"320.76";"0";"3.25";"TENIDAP";"NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL384467";"DEXAMETHASONE";"4";"392.47";"0";"1.90";"DEXAMETHASONE";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1167";"SPECTINOMYCIN";"4";"332.35";"0";"-2.93";"SPECTINOMYCIN";"CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1527608";"DOXOFYLLINE";"3";"266.26";"0";"-1.19";"DOXOFYLLINE";"Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL153479";"AMBROXOL";"3";"378.11";"0";"3.19";"AMBROXOL";"Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL127516";"BUTAMBEN";"4";"193.25";"0";"2.23";"BUTAMBEN";"CCCCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL513389";"ICI-118551";"0";"277.41";"0";"2.61";"(rac)-5, ICI-118551";"Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"30.72";"0.58";"5.91";"20.54";"False";"CHEMBL1010734";"Displacement of [3H]CGP1217 from human recombinant adrenergic beta2 receptor transfected in insect Sf9 cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152790";"1";"Scientific Literature";"J. Med. Chem.";"2009";"CHEMBL3308860";""
"CHEMBL1255901";"HUPERZINE A";"2";"242.32";"0";"2.00";"HUPERZINE A";"C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1258023";"";"0";"490.63";"0";"4.37";"11";"COc1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1";"IC50";"'='";"205.0";"nM";"6.69";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1261259";"Antagonist activity at human recombinant adrenergic beta2 receptor expressed in CHO cells assessed as inhibition of isoproterenol-induced cyclic AMP formation by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1257555";"";"0";"506.63";"1";"3.55";"33";"OCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O";"IC50";"'='";"2250.0";"nM";"5.65";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1261259";"Antagonist activity at human recombinant adrenergic beta2 receptor expressed in CHO cells assessed as inhibition of isoproterenol-induced cyclic AMP formation by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1258486";"";"0";"384.51";"0";"2.69";"49";"OC(CNC1CCN(c2ncnc3sccc23)CC1)COc1ccccc1";"IC50";"'='";"862.0";"nM";"6.06";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL1261259";"Antagonist activity at human recombinant adrenergic beta2 receptor expressed in CHO cells assessed as inhibition of isoproterenol-induced cyclic AMP formation by HTRF assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255209";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2010";"CHEMBL3308072";""
"CHEMBL1592";"QUINAPRIL";"4";"438.52";"0";"2.57";"QUINAPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL54126";"NEOSTIGMINE BROMIDE";"4";"303.20";"0";"1.94";"NEOSTIGMINE BROMIDE";"CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201237";"LEVOBUNOLOL";"4";"291.39";"0";"2.33";"LEVOBUNOLOL";"CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O";"IC50";"'='";"0.793";"nM";"9.10";"";"";"UO_0000065";"31.23";"0.59";"6.77";"15.54";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1046";"AMINOCAPROIC ACID";"4";"131.18";"0";"0.59";"AMINOCAPROIC ACID";"NCCCCCC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL412873";"SPARTEINE";"4";"234.39";"0";"2.35";"SPARTEINE";"C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL177756";"FLUORESCEIN";"0";"332.31";"0";"3.97";"FLUORESCEIN";"O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL439794";"";"0";"450.55";"0";"4.27";"3h";"N#CN/C(=N\c1cccc2ccccc12)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"13.86";"0.25";"1.97";"5.93";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL4634403";"";"0";"370.45";"0";"3.80";"PZL-2";"CC(=O)Nc1ccc(/N=N/c2cccc(OC[C@@H](O)CNC(C)C)c2)cc1";"IC50";"'='";"160.64";"nM";"6.79";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4630501";"Antagonist activity at ADRB2 endogenously expressed in HEK293 cells transfected with cAMP FRET biosensor assessed as inhibition of cimaterol-induced response pre-incubated for 45 mins under constant violet light conditions by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627414";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3307715";""
"CHEMBL157548";"DANOFLOXACIN";"0";"357.39";"0";"2.07";"DANOFLOXACIN";"CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201353";"DEXCHLORPHENIRAMINE";"4";"274.80";"0";"3.82";"DEXCHLORPHENIRAMINE";"CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL36715";"PIRACETAM";"4";"142.16";"0";"-0.91";"PIRACETAM";"NC(=O)CN1CCCC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL16";"PHENYTOIN";"4";"252.27";"0";"1.97";"PHENYTOIN";"O=C1N=C(O)NC1(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL27769";"STANOLONE";"2";"290.45";"0";"3.96";"STANOLONE";"C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL469912";"PUROMYCIN";"0";"471.52";"1";"-0.79";"PUROMYCIN";"COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@@H](n3cnc4c(N(C)C)ncnc43)[C@@H]2O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL516";"CYPROHEPTADINE";"4";"287.41";"0";"4.70";"CYPROHEPTADINE";"CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1480";"FELODIPINE";"4";"384.26";"0";"3.96";"FELODIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL49080";"CLENBUTEROL";"4";"277.20";"0";"3.00";"CLENBUTEROL";"CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"26.65";"0.59";"4.39";"12.68";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL773";"GLYCINE";"4";"75.07";"0";"-0.97";"GLYCINE";"NCC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3350037";"";"0";"1019.26";"None";"None";"OCTREOTIDE";"C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL527";"PIROXICAM";"4";"331.35";"0";"1.58";"PIROXICAM";"CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL728";"PROCHLORPERAZINE";"4";"373.95";"0";"4.58";"PROCHLORPERAZINE";"CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL124584";"";"0";"437.48";"0";"3.69";"7c";"O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(F)c1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"12.85";"0.24";"1.93";"5.00";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL275114";"";"0";"612.79";"1";"4.83";"30";"CCCCCCN(C)C(=O)N(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"11.29";"0.22";"2.09";"5.27";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL241694";"ETHISTERONE";"3";"312.45";"0";"3.88";"ETHISTERONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL2367892";"TEICOPLANIN";"0";"1767.46";"None";"None";"TEICOPLANIN";"CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL123745";"";"0";"636.87";"2";"7.17";"4a";"CCCCCCCCc1csc(N2CCc3cc(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)ccc32)n1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"11.46";"0.22";"0.13";"6.01";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL125168";"";"0";"526.38";"1";"3.72";"3b";"N#CN/C(=N\c1cccc(I)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"13.63";"0.32";"3.45";"6.81";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL12769";"";"0";"493.59";"0";"3.31";"38";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1cnc2ccccc2c1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"13.41";"0.26";"3.31";"5.48";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL433042";"";"0";"575.74";"2";"5.31";"17";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(CCCC3CCCC3)n2)cc1";"IC50";"'='";"962.0";"nM";"6.02";"";"";"UO_0000065";"10.45";"0.20";"0.71";"4.62";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL12998";"L-755507";"0";"584.74";"2";"4.47";"22";"CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"11.49";"0.22";"2.25";"4.51";"False";"CHEMBL647878";"In vitro affinity at Beta-2 adrenergic receptor in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131408";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"None";""
"CHEMBL12813";"";"0";"476.98";"0";"3.42";"32";"O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1cccc(Cl)c1";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"13.48";"0.27";"3.01";"5.96";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL127428";"";"0";"545.38";"1";"4.15";"7a";"O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(I)c1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"10.86";"0.25";"1.77";"5.27";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL13034";"";"0";"302.37";"0";"1.55";"16";"Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"20.84";"0.39";"4.75";"7.18";"False";"CHEMBL647879";"Binding affinity against cloned human beta-2 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130810";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1998";"CHEMBL3308072";""
"CHEMBL513389";"ICI-118551";"0";"277.41";"0";"2.61";"ICI 118551";"Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2";"IC50";"'='";"0.49";"nM";"9.31";"";"";"UO_0000065";"33.56";"0.64";"6.70";"22.44";"False";"CHEMBL2395708";"Binding affinity to human adrenergic beta2 receptor by radioligand displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390830";"1";"Scientific Literature";"Eur. J. Med. Chem.";"2013";"None";""
"CHEMBL290131";"";"0";"576.76";"2";"6.31";"5d";"CCCCCCCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"11.39";"0.22";"0.26";"5.60";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL289689";"";"0";"590.65";"2";"5.27";"6f";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(Cc3ccc(F)c(F)c3)n2)cc1";"IC50";"'='";"630.0";"nM";"6.20";"";"";"UO_0000065";"10.50";"0.20";"0.93";"5.28";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL39577";"";"0";"534.68";"2";"5.14";"5b";"CCCCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"10.10";"0.19";"0.26";"4.60";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL1263";"SALMETEROL";"4";"415.57";"0";"4.11";"1";"OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O";"IC50";"'='";"5.012";"nM";"8.30";"";"";"UO_0000065";"19.97";"0.38";"4.19";"10.13";"False";"CHEMBL1943767";"Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938358";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL504760";"CAMPHOR";"4";"152.24";"0";"2.40";"D-CAMPHOR";"CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL280998";"CATECHOL";"0";"110.11";"0";"1.10";"CATECHOL";"Oc1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL578";"ENALAPRIL";"4";"376.45";"0";"1.60";"ENALAPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL457";"GEMFIBROZIL";"4";"250.34";"0";"3.57";"GEMFIBROZIL";"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1062";"HYDROXYPROGESTERONE";"2";"330.47";"0";"3.84";"HYDROXYPROGESTERONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL289469";"GRANISETRON";"4";"312.42";"0";"2.32";"GRANISETRON";"CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL153062";"4-NONYLPHENOL";"0";"220.36";"0";"4.69";"4-NONYLPHENOL";"CCCCCCCCCc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL434063";"";"0";"495.58";"0";"4.94";"GW-1929";"CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL413965";"FELBINAC";"4";"212.25";"0";"2.98";"FELBINAC";"O=C(O)Cc1ccc(-c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201024";"METHSCOPOLAMINE BROMIDE";"0";"398.30";"0";"1.06";"METHSCOPOLAMINE BROMIDE";"C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@H]1O[C@@H]21.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1502";"PANTOPRAZOLE";"4";"383.38";"0";"2.88";"PANTOPRAZOLE";"COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL92401";"IPRONIAZID";"4";"179.22";"0";"0.72";"IPRONIAZID";"CC(C)NNC(=O)c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL841";"LOPERAMIDE";"4";"477.05";"1";"5.09";"LOPERAMIDE";"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1";"IC50";"'='";"3005.0";"nM";"5.52";"";"";"UO_0000065";"11.58";"0.22";"0.43";"12.61";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL71";"CHLORPROMAZINE";"4";"318.87";"0";"4.89";"CHLORPROMAZINE";"CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1619";"CLADRIBINE";"4";"285.69";"0";"-0.30";"CLADRIBINE";"Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL707";"DOXAZOSIN";"4";"451.48";"0";"1.72";"DOXAZOSIN";"COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC";"IC50";"'='";"2748.0";"nM";"5.56";"";"";"UO_0000065";"12.32";"0.23";"3.84";"4.95";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL134";"CLONIDINE";"4";"230.10";"0";"2.17";"CLONIDINE";"Clc1cccc(Cl)c1N=C1NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1518";"PROPYLTHIOURACIL";"4";"170.24";"0";"1.38";"PROPYLTHIOURACIL";"CCCc1cc(=O)[nH]c(=S)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL657";"DIPHENHYDRAMINE";"4";"255.36";"0";"3.35";"DIPHENHYDRAMINE";"CN(C)CCOC(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4649901";"";"0";"1495.48";"None";"None";"BLEOMYCIN A2";"Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL444633";"RIFABUTIN";"4";"847.02";"2";"4.62";"RIFABUTIN";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL423192";"ANISOMYCIN";"0";"265.31";"0";"0.50";"ANISOMYCIN";"COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1425";"MERCAPTOPURINE";"4";"152.18";"0";"0.64";"6-MERCAPTOPURINE";"Sc1ncnc2nc[nH]c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL77675";"";"0";"211.27";"0";"3.15";"1,3-DIPHENYLGUANIDINE";"N=C(Nc1ccccc1)Nc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL9419";"METACETAMOL";"0";"151.16";"0";"1.35";"3-ACETAMIDOPHENOL";"CC(=O)Nc1cccc(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1628227";"DOXEPIN";"4";"279.38";"0";"3.96";"DOXEPIN";"CN(C)CCC=C1c2ccccc2COc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL25719";"GERANIOL";"0";"154.25";"0";"2.67";"GERANIOL";"CC(C)=CCC/C(C)=C/CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL276832";"HYDRALAZINE";"4";"160.18";"0";"0.92";"HYDRALAZINE";"NNc1nncc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL291594";"";"0";"613.76";"2";"5.50";"5u";"CC(=O)Nc1ccc(-c2csc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"9.25";"0.18";"0.18";"4.26";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL443";"SULFAMETHOXAZOLE";"4";"253.28";"0";"1.37";"SULFAMETHOXAZOLE";"Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL24";"ATENOLOL";"4";"266.34";"0";"0.45";"ATENOLOL";"CC(C)NCC(O)COc1ccc(CC(N)=O)cc1";"IC50";"'='";"14634.0";"nM";"4.83";"";"";"UO_0000065";"18.15";"0.35";"4.38";"5.72";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL108545";"METHYL SALICYLATE";"4";"152.15";"0";"1.18";"METHYL SALICYLATE";"COC(=O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL54440";"MEVASTATIN";"0";"390.52";"0";"3.95";"MEVASTATIN";"CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL333417";"";"0";"624.71";"2";"6.56";"2g";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccccc3C(F)(F)F)cs2)cc1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"9.20";"0.18";"-0.82";"5.51";"False";"CHEMBL647872";"Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-2 adrenergic receptor in the presence of [125I]- iodocyanopindolol.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133690";"1";"Scientific Literature";"J. Med. Chem.";"2000";"CHEMBL3308072";""
"CHEMBL292598";"";"0";"607.76";"2";"6.09";"5l";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc4ncccc4c3)cs2)cc1";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"8.39";"0.16";"-0.99";"4.35";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL964";"DISULFIRAM";"4";"296.55";"0";"3.62";"DISULFIRAM";"CCN(CC)C(=S)SSC(=S)N(CC)CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL252557";"GLYCOLIC ACID";"2";"76.05";"0";"-0.94";"GLYCOLIC ACID";"O=C(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL82296";"";"0";"565.74";"1";"4.57";"1d";"CCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"9.97";"0.19";"1.07";"4.91";"True";"CHEMBL647107";"Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132064";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"1999";"CHEMBL3308072";""
"CHEMBL940";"GABAPENTIN";"4";"171.24";"0";"1.37";"GABAPENTIN";"NCC1(CC(=O)O)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL31";"GATIFLOXACIN";"4";"375.40";"0";"1.98";"GATIFLOXACIN";"COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL332132";"";"0";"684.75";"2";"6.83";"5b";"N#CN/C(=N\c1ccc2c(c1)N(c1nc(-c3ccc(OC(F)(F)F)cc3)cs1)CC2)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1";"IC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"8.98";"0.17";"-0.68";"4.70";"False";"CHEMBL647111";"Binding affinity to the human beta-2 adrenergic receptor assayed using [125I]iodocyanopindolol as radioligand in CHO cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134823";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2001";"CHEMBL3308072";""
"CHEMBL4210507";"";"0";"185.23";"0";"1.60";"Entry 23, cpd-1";"NCc1ccc(-c2ncccn2)cc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"26.99";"0.49";"3.40";"9.65";"False";"CHEMBL4381024";"Inhibition of beta2 adrenoreceptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376879";"1";"Scientific Literature";"J Med Chem";"2020";"None";""
"CHEMBL3764950";"";"0";"418.50";"0";"2.28";"19";"O=C(Cn1cnccc1=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3767773";"Displacement of [125]I-cyanopindolol from human recombinant beta2 adrenergic receptor after 1 hr by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763146";"1";"Scientific Literature";"J. Med. Chem.";"2016";"None";""
"CHEMBL3763934";"";"0";"443.55";"0";"3.37";"24";"O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)[C@@H]1CCc2cccc(=O)n21";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3767773";"Displacement of [125]I-cyanopindolol from human recombinant beta2 adrenergic receptor after 1 hr by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763146";"1";"Scientific Literature";"J. Med. Chem.";"2016";"None";""
"CHEMBL2107826";"VIBEGRON";"4";"444.54";"0";"2.77";"7; vibegron; MK-4618";"O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)[C@@H]1CCc2nccc(=O)n21";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3767773";"Displacement of [125]I-cyanopindolol from human recombinant beta2 adrenergic receptor after 1 hr by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763146";"1";"Scientific Literature";"J. Med. Chem.";"2016";"None";""
"CHEMBL418411";"";"0";"551.67";"1";"3.50";"16";"CC(O)CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"44000.0";"nM";"4.36";"";"";"UO_0000065";"7.90";"0.15";"0.86";"2.90";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL4073137";"";"0";"470.62";"0";"3.44";"19a";"O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1CCN(Cc2ccccn2)CC1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4004025";"Activity at human beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4085173";"";"0";"543.59";"1";"2.59";"19i";"O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1CCN(Cc2nnn(CC(F)(F)F)n2)CC1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4004025";"Activity at human beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4440189";"";"0";"640.68";"3";"-0.34";"6.2e";"C=CCc1ccccc1OCC(O)CNCCOCCOCCOCCOCCNC(=O)C1C(C(=O)O)C(C(=O)O)C1C(=O)O";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4312088";"Antagonist activity at human recombinant beta2 adrenoreceptor expressed in CHOK1 cells incubated for 30 mins by HTRF";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4311931";"1";"Scientific Literature";"MedChemComm";"2019";"None";""
"CHEMBL4452249";"";"0";"1312.68";"None";"None";"6.1c";"CC(C)NCC(O)COc1ccccc1CCCSCC(=O)NCCOCCOCCNC(=O)CCCCCC1(C)C(/C=C/C=C/C=C2/N(CCCS(=O)(=O)O)c3ccc(S(=O)(=O)O)cc3C2(C)C)=[N+](CCCS(=O)(=O)[O-])c2ccc(S(=O)(=O)O)cc21";"IC50";"'='";"96.0";"nM";"7.02";"";"";"UO_0000065";"5.35";"None";"None";"None";"False";"CHEMBL4312088";"Antagonist activity at human recombinant beta2 adrenoreceptor expressed in CHOK1 cells incubated for 30 mins by HTRF";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4311931";"1";"Scientific Literature";"MedChemComm";"2019";"None";""
"CHEMBL4454523";"";"0";"685.79";"3";"0.09";"6.1e";"CC(C)NCC(O)COc1ccccc1CCCSCC(=O)NCCOCCOCCNC(=O)C1C(C(=O)O)C(C(=O)O)C1C(=O)O";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"9.36";"0.19";"6.33";"2.79";"False";"CHEMBL4312088";"Antagonist activity at human recombinant beta2 adrenoreceptor expressed in CHOK1 cells incubated for 30 mins by HTRF";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4311931";"1";"Scientific Literature";"MedChemComm";"2019";"None";""
"CHEMBL282575";"ESTRADIOL BENZOATE";"4";"376.50";"1";"5.12";"BETA-ESTRADIOL 3-BENZOATE";"C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4446394";"";"0";"558.76";"2";"3.03";"3b";"CC(C)NC[C@H](O)COc1ccccc1CCCNC(=O)NCCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"1.585";"nM";"8.80";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL430594";"";"0";"588.73";"2";"5.60";"5o";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc(F)cc3)cs2)cc1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"9.52";"0.19";"0.00";"5.38";"False";"CHEMBL647875";"Binding affinity against human Beta-2 adrenergic receptor expressed in CHO cells using [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133294";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL284965";"";"0";"549.70";"1";"4.78";"12";"CC(C)CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"10.92";"0.21";"1.22";"4.61";"False";"CHEMBL647108";"Binding affinity towards Beta-2 adrenergic receptor prepared from CHO cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133131";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"CHEMBL3308072";""
"CHEMBL38861";"";"0";"638.67";"2";"6.00";"6j";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(COc3ccc(C(F)(F)F)cc3)n2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"7.36";"0.14";"-1.30";"3.71";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL3900995";"";"0";"758.92";"3";"5.20";"BDBM200741";"CN(CCCn1c(=O)oc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"356809";"UO_0000065";"9.03";"0.18";"1.65";"4.03";"False";"CHEMBL3887836";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 ug/well for beta1 and 5 ug/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 ul, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 uM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886468";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL288917";"";"0";"560.72";"2";"5.53";"6b";"O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(CCC3CCCC3)n2)cc1";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"9.69";"0.19";"-0.10";"4.63";"False";"CHEMBL647881";"In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133227";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2000";"None";""
"CHEMBL3128192";"";"0";"464.64";"0";"4.64";"9a";"CCC[C@@H](C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1csc(N)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128190";"";"0";"436.58";"0";"3.86";"7b";"C[C@H](C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1csc(N)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL27";"PROPRANOLOL";"4";"259.35";"0";"2.58";"Prop";"CC(C)NCC(O)COc1cccc2ccccc12";"IC50";"'='";"0.55";"nM";"9.26";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4630500";"Antagonist activity at ADRB2 endogenously expressed in HEK293 cells transfected with cAMP FRET biosensor assessed as inhibition of cimaterol-induced response pre-incubated for 45 mins under dark conditions by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627414";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3307715";""
"CHEMBL1752";"DYPHYLLINE";"4";"254.25";"0";"-2.21";"DYPHYLLINE";"Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1760";"TERBUTALINE";"4";"225.29";"0";"1.52";"TERBUTALINE";"CC(C)(C)NCC(O)c1cc(O)cc(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL585";"TRIAMTERENE";"4";"253.27";"0";"0.83";"TRIAMTERENE";"Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1618305";"NALOXONAZINE";"0";"650.78";"1";"3.28";"NALOXONAZINE";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL262777";"VANCOMYCIN";"4";"1449.27";"None";"None";"Vancomycin";"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL659";"GALANTAMINE";"4";"287.36";"0";"1.85";"GALANTAMINE";"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1159650";"CLOBETASOL PROPIONATE";"4";"466.98";"0";"4.10";"CLOBETASOL PROPIONATE";"CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL711";"PHENINDIONE";"4";"222.24";"0";"2.85";"PHENINDIONE";"O=C1c2ccccc2C(=O)C1c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL29";"BENZYLPENICILLIN";"4";"334.40";"0";"0.86";"PENICILLIN G";"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1200545";"DIFLORASONE DIACETATE";"4";"494.53";"0";"2.99";"DIFLORASONE DIACETATE";"CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL376180";"AMINOPTERIN";"2";"440.42";"1";"0.24";"AMINOPTERIN";"Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4066314";"";"0";"542.61";"1";"3.20";"19e";"O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1CCN(Cc2ncn(CC(F)(F)F)n2)CC1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4004025";"Activity at human beta2 adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4002615";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL238071";"VINDESINE";"4";"753.94";"1";"2.73";"VINDESINE";"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL540445";"PARTHENOLIDE";"2";"248.32";"0";"2.76";"PARTHENOLIDE";"C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909076";"";"0";"270.38";"0";"1.21";"S-(N-BENZYLTHIOCARBAMOYL)-L-CYSTEINE";"N[C@H](CSC(=S)NCc1ccccc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1660";"RIFAPENTINE";"4";"877.04";"4";"5.65";"RIFAPENTINE";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL503";"LOVASTATIN";"4";"404.55";"0";"4.20";"LOVASTATIN";"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909067";"";"0";"None";"None";"None";"MC 258714";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL136478";"SODIUM NITROPRUSSIDE";"4";"261.92";"None";"None";"SODIUM NITROPRUSSIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1651906";"STREPTOZOCIN";"4";"265.22";"0";"-2.89";"STREPTOZOTOCIN";"CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL21";"SULFANILAMIDE";"4";"172.21";"0";"-0.08";"SULFANILAMIDE";"Nc1ccc(S(N)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL90555";"VINCRISTINE";"4";"824.97";"2";"3.52";"VINCRISTINE";"CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL182";"GANCICLOVIR";"4";"255.23";"0";"-1.56";"Ganciclovir";"Nc1nc(O)c2ncn(COC(CO)CO)c2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL871";"ETIDRONIC ACID";"4";"206.03";"0";"-0.99";"ETIDRONATE";"CC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL772";"RESERPINE";"4";"608.69";"1";"4.17";"RESERPINE";"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL12948";"SEMUSTINE";"3";"247.73";"0";"2.50";"SEMUSTINE";"CC1CCC(NC(=O)N(CCCl)N=O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL37858";"SARAFLOXACIN";"0";"385.37";"0";"2.38";"SARAFLOXACIN";"O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL498";"CHLORPROPAMIDE";"4";"276.75";"0";"1.74";"CHLORPROPAMIDE";"CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL27";"PROPRANOLOL";"4";"259.35";"0";"2.58";"Prop";"CC(C)NCC(O)COc1cccc2ccccc12";"IC50";"'='";"0.48";"nM";"9.32";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4630501";"Antagonist activity at ADRB2 endogenously expressed in HEK293 cells transfected with cAMP FRET biosensor assessed as inhibition of cimaterol-induced response pre-incubated for 45 mins under constant violet light conditions by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627414";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3307715";""
"CHEMBL3128181";"";"0";"461.63";"0";"4.77";"22";"CCc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128194";"";"0";"448.59";"0";"3.79";"11a";"Nc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128189";"";"0";"436.58";"0";"3.86";"7a";"C[C@@H](C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1csc(N)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL1684585";"";"0";"422.55";"0";"3.30";"4";"Nc1nc(CC(=O)Nc2ccc(C[C@@H]3CC[C@H]([C@H](O)c4ccccc4)N3)cc2)cs1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"True";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL1940682";"";"0";"420.51";"1";"0.81";"5a";"OCc1cc(C(O)CNCCCCNCC(O)c2ccc(O)c(CO)c2)ccc1O";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.89";"0.23";"4.19";"3.44";"False";"CHEMBL1943767";"Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938358";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1940814";"";"0";"376.50";"0";"3.70";"7";"OC(CNCCc1ccc(NCC(O)c2ccccc2)cc1)c1ccccc1";"IC50";"'='";"251.19";"nM";"6.60";"";"";"UO_0000065";"17.53";"0.32";"2.90";"10.23";"False";"CHEMBL1943767";"Displacement of [3H]dihydroalprenolol from beta2-adrenoceptor after 90 mins by liquid scintillation counting";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938358";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL3128188";"";"0";"417.51";"0";"2.80";"29";"O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)[C@@H]1CCc2ccnn21";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"True";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128182";"";"0";"462.62";"0";"4.17";"23";"CCc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128178";"";"0";"434.57";"0";"3.60";"19";"O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)[C@@H]1CCc2scnc21";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"True";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL16068";"BROMOBENZENE";"0";"157.01";"0";"2.45";"BROMOBENZENE";"Brc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3963770";"";"0";"732.90";"2";"4.61";"BDBM200753";"CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4c3OCC(=O)N4)ccc21)[C@H]1CC[C@H](OC(=O)[C@](O)(c2cccs2)C2CCCC2)CC1";"IC50";"'='";"1.4";"nM";"8.85";"";"356821";"UO_0000065";"12.08";"0.23";"4.24";"5.17";"False";"CHEMBL3887836";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 ug/well for beta1 and 5 ug/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 ul, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 uM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886468";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL229614";"";"0";"337.42";"0";"3.51";"BDBM50213110";"C[C@@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1";"IC50";"'='";"1.19";"nM";"8.92";"";"365709";"UO_0000065";"26.45";"0.49";"5.41";"12.27";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL1800960";"";"0";"317.39";"0";"2.45";"BDBM50348427";"CC[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1";"IC50";"'='";"17.88";"nM";"7.75";"";"365713";"UO_0000065";"24.41";"0.46";"5.30";"8.34";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL3962171";"";"0";"795.38";"4";"5.94";"BDBM221904";"COc1cc(NC(=O)CCCN[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12";"IC50";"'='";"2.1";"nM";"8.68";"";"388364";"UO_0000065";"10.91";"0.22";"2.74";"4.76";"False";"CHEMBL3888303";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 μg/well for beta1 and 5 μg/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 μl, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 μM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886646";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL3915601";"";"0";"796.41";"3";"6.72";"BDBM221909";"COc1cc(OCCCCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12";"IC50";"'='";"9.6";"nM";"8.02";"";"388369";"UO_0000065";"10.07";"0.20";"1.30";"5.22";"False";"CHEMBL3888303";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 μg/well for beta1 and 5 μg/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 μl, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 μM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886646";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL3947244";"";"0";"815.37";"4";"5.60";"BDBM221910";"COc1cc(NC(=O)OCCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2c1OCC(=O)N2";"IC50";"'='";"0.38";"nM";"9.42";"";"388370";"UO_0000065";"11.55";"0.23";"3.82";"5.01";"False";"CHEMBL3888303";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 μg/well for beta1 and 5 μg/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 μl, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 μM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886646";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL3906808";"";"0";"797.37";"4";"6.19";"BDBM221912";"COc1cc(NC(=O)OCCN(C)[C@H]2CC[C@H](OC(=O)[C@](O)(c3cccs3)C3CCCC3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12";"IC50";"'='";"1.1";"nM";"8.96";"";"388372";"UO_0000065";"11.24";"0.22";"2.77";"4.90";"False";"CHEMBL3888303";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 μg/well for beta1 and 5 μg/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 μl, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 μM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886646";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL26";"SULPIRIDE";"4";"341.43";"0";"0.56";"SULPIRIDE";"CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL453";"SULFISOXAZOLE";"4";"267.31";"0";"1.67";"SULFISOXAZOLE";"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL532";"ERYTHROMYCIN";"4";"733.94";"2";"1.79";"ERYTHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL60889";"MOSAPRIDE";"3";"421.90";"0";"3.09";"MOSAPRIDE";"CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL62193";"SULFADIMETHOXINE";"4";"310.34";"0";"0.88";"SULFADIMETHOXINE";"COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1873703";"DIELDRIN";"0";"380.91";"0";"4.48";"DIELDRIN";"ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@H]([C@@H]3[C@@]1(Cl)C2(Cl)Cl)[C@H]1O[C@@H]41";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1419";"SIBUTRAMINE";"4";"279.86";"0";"4.74";"SIBUTRAMINE";"CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL442";"ERGOTAMINE";"4";"581.67";"1";"1.99";"ERGOTAMINE";"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"'='";"2761.0";"nM";"5.56";"";"";"UO_0000065";"9.56";"0.18";"3.57";"4.70";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4277196";"";"0";"333.82";"0";"3.28";"4";"COc1cc2c(cc1OC)[C@H]([C@H](O)c1ccccc1Cl)NCC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4258826";"Displacement of [3H]-CGP-12177 from human beta2-adrenergic receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257493";"1";"Scientific Literature";"MedChemComm";"2018";"None";""
"CHEMBL43882";"TRICHLOROETHANE";"0";"133.41";"0";"2.03";"TRICHLOROETHANE";"ClCC(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL485549";"NIFURSOL";"0";"365.21";"0";"1.47";"NIFURSOL";"O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL269732";"TACROLIMUS";"4";"804.03";"2";"4.64";"TACROLIMUS";"C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL642";"ACEBUTOLOL";"4";"336.43";"0";"2.37";"ACEBUTOLOL";"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3286557";"";"0";"304.34";"0";"2.35";"18, PF-4522654";"CNc1nc(C(F)(F)c2ccccc2)nc2c1CCNCC2";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"19.23";"0.36";"3.50";"11.75";"False";"CHEMBL3292430";"Binding affinity to adrenergic beta-2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286089";"1";"Scientific Literature";"J. Med. Chem.";"2014";"None";""
"CHEMBL1276308";"MIFEPRISTONE";"4";"429.60";"1";"5.41";"MIFEPRISTONE";"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL54";"HALOPERIDOL";"4";"375.87";"0";"4.43";"HALOPERIDOL";"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL563";"FLURBIPROFEN";"4";"244.26";"0";"3.68";"FLURBIPROFEN";"CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1381098";"1-NAPHTHYLISOTHIOCYANATE";"0";"185.25";"0";"3.57";"1-NAPHTHYL ISOTHIOCYANATE";"S=C=Nc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL12089";"BERBERINE CHLORIDE";"1";"371.82";"0";"3.10";"BERBERINE CHLORIDE";"COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1567463";"CHOLINE ALFOSCERATE";"3";"257.22";"0";"-1.45";"CHOLINE ALFOSCERATE";"C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL2103747";"ACONITINE";"0";"645.75";"2";"0.65";"ACONITINE";"CCN1C[C@@]2(COC)[C@H]3[C@@H](OC)[C@H]4[C@H]1[C@]3([C@H](OC)C[C@H]2O)[C@@H]1C[C@]2(O)[C@@H](OC)[C@H](O)[C@@]4(OC(C)=O)[C@H]1[C@H]2OC(=O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1909065";"MADURAMICIN";"0";"917.14";"2";"4.32";"LYSERGOL";"CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL313493";"METHANESULFONIC ACID METHYL ESTER";"0";"110.13";"0";"-0.41";"METHYL METHANESULFONATE";"COS(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1070";"NABUMETONE";"4";"228.29";"0";"3.37";"NABUMETONE";"COc1ccc2cc(CCC(C)=O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1160734";"";"0";"249.35";"0";"2.15";"(S)-ALP";"C=CCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"2.291";"nM";"8.64";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL3128180";"";"0";"448.59";"0";"3.91";"21";"Cc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128196";"";"0";"462.62";"0";"4.18";"12a";"Nc1nc2c(s1)CCC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128195";"";"0";"448.59";"0";"3.79";"11b";"Nc1nc2c(s1)CC[C@@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL4434772";"";"0";"556.83";"2";"6.07";"1c";"CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"3.802";"nM";"8.42";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375056";"Antagonist activity at beta2 adrenergic receptor (unknown origin) stably expressed in HEK293 cell membranes assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 30 mins by TR-FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL3128187";"";"0";"405.50";"0";"2.87";"28";"C[C@@H](C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)n1cccn1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128193";"";"0";"464.64";"0";"4.50";"10a";"CC(C)[C@@H](C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1csc(N)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128185";"";"0";"528.65";"2";"5.41";"26";"O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)[C@@H]1CCc2sc(-c3ccc(F)cc3)nc21";"IC50";"'='";"2471.0";"nM";"5.61";"";"";"UO_0000065";"10.61";"0.20";"0.20";"6.43";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL3128177";"";"0";"433.58";"0";"4.21";"18";"O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)[C@@H]1CCc2scnc21";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3129371";"Displacement of [125I]-cyanopindolol from recombinant human beta-2 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124772";"1";"Scientific Literature";"J. Med. Chem.";"2014";"CHEMBL3308072";""
"CHEMBL18797";"SULINDAC SULFIDE";"0";"340.42";"1";"5.35";"SULINDAC SULFIDE";"CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL424";"SALICYLIC ACID";"4";"138.12";"0";"1.09";"SALICYLIC ACID";"O=C(O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL434";"ISOPROTERENOL";"4";"211.26";"0";"1.13";"ISOPRENALINE";"CC(C)NCC(O)c1ccc(O)c(O)c1";"IC50";"'='";"246.0";"nM";"6.61";"";"";"UO_0000065";"31.28";"0.60";"5.48";"9.09";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1400945";"PREGNENOLONE CARBONITRILE ";"0";"341.50";"0";"4.26";"PREGNENOLONE-16ALPHA-CARBONITRILE";"CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1612004";"";"0";"123.15";"0";"1.28";"O-ANISIDINE";"COc1ccccc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL702";"PIPERACILLIN";"4";"517.56";"1";"-0.24";"PIPERACILLIN";"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL480";"LANSOPRAZOLE";"4";"369.37";"0";"3.52";"LANSOPRAZOLE";"Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL429";"LABETALOL";"4";"328.41";"0";"2.14";"labetalol";"CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"23.74";"0.44";"5.66";"8.16";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1201193";"LEVOBUPIVACAINE";"4";"288.44";"0";"3.90";"LEVOBUPIVACAINE";"CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL283196";"ALPHA-NAPHTHOFLAVONE";"0";"272.30";"0";"4.61";"ALPHA-NAPHTHOFLAVONE";"O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL277474";"ANTIPYRINE";"4";"188.23";"0";"1.48";"ANTIPYRINE";"Cc1cc(=O)n(-c2ccccc2)n1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL577294";"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN";"3";"1541.55";"None";"None";"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN";"CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](COCC(C)O)O[C@H](O[C@@H]4[C@@H](COCC(C)O)O[C@H](O[C@@H]5[C@@H](COCC(C)O)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](COCC(C)O)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL157138";"LISURIDE";"4";"338.46";"0";"2.84";"LISURIDE";"CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"21.83";"0.40";"4.55";"14.38";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3902803";"";"0";"717.91";"3";"5.32";"BDBM221899";"CN(CCOc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C1CCC(OC(=O)C(O)(c2cccs2)c2cccs2)CC1";"IC50";"'='";"36.0";"nM";"7.44";"";"388359";"UO_0000065";"10.37";"0.20";"2.12";"5.16";"False";"CHEMBL3888303";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 μg/well for beta1 and 5 μg/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 μl, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 μM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886646";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL3973386";"";"0";"791.34";"4";"6.13";"BDBM221911";"COc1cc(NC(=O)OCCN(C)[C@H]2CC[C@H](OC(=O)[C@](O)(c3ccccc3)C3CCCC3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12";"IC50";"'='";"1.3";"nM";"8.89";"";"388371";"UO_0000065";"11.23";"0.22";"2.76";"4.86";"False";"CHEMBL3888303";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 μg/well for beta1 and 5 μg/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 μl, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 μM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886646";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL411";"DIETHYLSTILBESTROL";"4";"268.36";"0";"4.83";"DIETHYLSTILBESTROL";"CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4633760";"";"0";"370.45";"0";"3.80";"PZL-1";"CC(=O)Nc1ccc(/N=N/c2ccccc2OC[C@@H](O)CNC(C)C)cc1";"IC50";"'='";"1.72";"nM";"8.76";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4630500";"Antagonist activity at ADRB2 endogenously expressed in HEK293 cells transfected with cAMP FRET biosensor assessed as inhibition of cimaterol-induced response pre-incubated for 45 mins under dark conditions by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627414";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3307715";""
"CHEMBL4633760";"";"0";"370.45";"0";"3.80";"PZL-1";"CC(=O)Nc1ccc(/N=N/c2ccccc2OC[C@@H](O)CNC(C)C)cc1";"IC50";"'='";"28.94";"nM";"7.54";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4630501";"Antagonist activity at ADRB2 endogenously expressed in HEK293 cells transfected with cAMP FRET biosensor assessed as inhibition of cimaterol-induced response pre-incubated for 45 mins under constant violet light conditions by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627414";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3307715";""
"CHEMBL1946766";"";"0";"538.72";"2";"5.75";"Table 2, 7";"CCN(Cc1ccncc1)Cc1cccc(-c2ccc(CCNCCc3ccc(O)c4[nH]c(=O)sc34)cc2)c1";"IC50";"'='";"794.33";"nM";"6.10";"";"";"UO_0000065";"11.32";"0.21";"0.35";"7.51";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1944693";"";"0";"493.63";"0";"3.50";"20";"COc1ccccc1CCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1";"IC50";"'='";"0.7943";"nM";"9.10";"";"";"UO_0000065";"18.43";"0.36";"5.60";"8.54";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945038";"";"0";"478.62";"0";"3.28";"30";"O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccn4)c3)c2s1";"IC50";"'='";"0.5012";"nM";"9.30";"";"";"UO_0000065";"19.43";"0.37";"6.02";"8.43";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945289";"";"0";"479.60";"0";"3.46";"37";"COc1ccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)cc1";"IC50";"'='";"5.012";"nM";"8.30";"";"";"UO_0000065";"17.31";"0.33";"4.84";"7.79";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL1945290";"";"0";"493.63";"0";"3.85";"38";"CCOc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"15.40";"0.30";"3.75";"7.13";"False";"CHEMBL1947791";"Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944599";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2012";"None";""
"CHEMBL4466532";"";"0";"526.67";"1";"2.34";"6.2a";"C=CCc1ccccc1OCC(O)CNCCOCCOCCOCCOCCNC(=O)OC(C)(C)C";"IC50";"'='";"6.9";"nM";"8.16";"";"";"UO_0000065";"15.50";"0.30";"5.82";"6.99";"False";"CHEMBL4312088";"Antagonist activity at human recombinant beta2 adrenoreceptor expressed in CHOK1 cells incubated for 30 mins by HTRF";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4311931";"1";"Scientific Literature";"MedChemComm";"2019";"None";""
"CHEMBL1395661";"";"0";"249.35";"0";"2.15";"(R)-ALP";"C=CCc1ccccc1OC[C@H](O)CNC(C)C";"IC50";"'='";"2.344";"nM";"8.63";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL198059";"";"0";"277.41";"0";"2.61";"ICI 118551";"Cc1ccc(OC[C@H](O)[C@H](C)NC(C)C)c2c1CCC2";"IC50";"'='";"0.74";"nM";"9.13";"";"";"UO_0000065";"32.91";"0.62";"6.52";"22.01";"False";"CHEMBL3876342";"Displacement of [3H]CGP 12177 from human recombinant beta2 adrenergic receptor expressed in CHO cells measured after 120 mins by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875185";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"CHEMBL3308072";""
"CHEMBL4473518";"";"0";"500.72";"1";"4.51";"1a";"CC(C)NC[C@H](O)COc1ccccc1CCCCCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"3.236";"nM";"8.49";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4434772";"";"0";"556.83";"2";"6.07";"1c";"CC(C)NC[C@H](O)COc1ccccc1CCCCCCCCCCc1ccccc1OC[C@@H](O)CNC(C)C";"IC50";"'='";"13.8";"nM";"7.86";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4375058";"Antagonist activity at beta2 adrenergic receptor (unknown origin) expressed in HEK293 cell assessed as inhibition of isoproterenol-induced cAMP production preincubated for 15 mins followed by isoproterenol addition and measured after 15 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373696";"1";"Scientific Literature";"J Med Chem";"2019";"CHEMBL3307715";""
"CHEMBL4563408";"";"0";"625.47";"2";"6.58";"38";"O=C(Nc1ccc(OC(F)F)nc1)NC1CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4365008";"Displacement of [3H](-)CGP12177 from recombinant human beta2 adrenergic receptor after 120 mins by scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364254";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL20883";"TEGAFUR";"4";"200.17";"0";"-0.02";"FT, Ftorafur";"O=c1[nH]c(=O)n(C2CCCO2)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1751";"DIGOXIN";"4";"780.95";"3";"2.22";"Digoxin";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL64";"ISONIAZID";"4";"137.14";"0";"-0.31";"INH";"NNC(=O)c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1384";"KANAMYCIN";"4";"484.50";"2";"-7.29";"Kanamycin";"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL488";"AMINOGLUTETHIMIDE";"4";"232.28";"0";"1.35";"AMINOGLUTETHIMIDE";"CCC1(c2ccc(N)cc2)CCC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3906438";"";"0";"834.42";"3";"6.55";"BDBM200747";"COc1cc(-c2noc(CCCN(C)[C@H]3CC[C@H](OC(=O)C(O)(c4cccs4)c4cccs4)CC3)n2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12";"IC50";"'='";"2.2";"nM";"8.66";"";"356815";"UO_0000065";"10.38";"0.21";"2.11";"4.72";"False";"CHEMBL3887836";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 ug/well for beta1 and 5 ug/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 ul, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 uM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886468";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL3926721";"";"0";"734.85";"2";"6.24";"BDBM200751";"CN(CCCn1c(=O)oc2cc(CNC[C@H](O)c3ccc(O)c(NC=O)c3)ccc21)[C@H]1CC[C@H](c2cccc3c2C(C)(C(=O)O)c2ccccc2O3)CC1";"IC50";"'='";"12.0";"nM";"7.92";"";"356819";"UO_0000065";"10.78";"0.20";"1.68";"4.76";"False";"CHEMBL3887836";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 ug/well for beta1 and 5 ug/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 ul, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 uM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886468";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL86754";"IODOQUINOL";"0";"396.95";"0";"3.15";"SID104171357";"Oc1c(I)cc(I)c2cccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4465173";"";"0";"344.25";"0";"4.74";"Entry 23, cpd-2";"Clc1ccc(CNCc2ccc(-c3ncccn3)cc2)cc1Cl";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL4381024";"Inhibition of beta2 adrenoreceptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376879";"1";"Scientific Literature";"J Med Chem";"2020";"None";""
"CHEMBL3960091";"";"0";"728.92";"3";"5.12";"BDBM200752";"CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)[C@](O)(c2cccs2)C2CCCC2)CC1";"IC50";"'='";"13.0";"nM";"7.89";"";"356820";"UO_0000065";"10.82";"0.21";"2.77";"4.76";"False";"CHEMBL3887836";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 ug/well for beta1 and 5 ug/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 ul, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 uM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886468";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL388177";"";"0";"337.42";"0";"3.51";"BDBM50213096";"C[C@H](Cc1cccc2ccccc12)NC[C@@H](O)c1cc(O)cc(O)c1";"IC50";"'='";"14.8";"nM";"7.83";"";"365710";"UO_0000065";"23.20";"0.43";"4.32";"10.77";"False";"CHEMBL3887982";"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37° C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37° C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886528";"37";"BindingDB Database";"";"2016";"CHEMBL3307575";""
"CHEMBL3747244";"";"0";"448.56";"0";"3.25";"24c";"O=C(c1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)N1CCC2(CCOC2=O)CC1";"IC50";"'='";"5600.0";"nM";"5.25";"";"";"UO_0000065";"11.71";"0.22";"2.00";"6.66";"False";"CHEMBL3750559";"Displacement of [125I]CYP from human beta-2 adrenergic receptor expressed in CHO cell membrane after 1 hr by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745665";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2016";"CHEMBL3308072";""
"CHEMBL3747455";"";"0";"472.59";"0";"3.51";"24i";"CCc1nnc([C@@H]2[C@H]3CN(C(=O)c4ccc(C[C@@H]5CC[C@H]([C@H](O)c6ccccc6)N5)cc4)C[C@H]32)o1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3750559";"Displacement of [125I]CYP from human beta-2 adrenergic receptor expressed in CHO cell membrane after 1 hr by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745665";"1";"Scientific Literature";"Bioorg. Med. Chem. Lett.";"2016";"CHEMBL3308072";""
"CHEMBL3764592";"";"0";"417.51";"0";"2.88";"21";"O=C(Cn1ccccc1=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL3767773";"Displacement of [125]I-cyanopindolol from human recombinant beta2 adrenergic receptor after 1 hr by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763146";"1";"Scientific Literature";"J. Med. Chem.";"2016";"None";""
"CHEMBL3978112";"";"0";"795.38";"4";"5.89";"BDBM221900";"COc1cc(NC(=O)CCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12";"IC50";"'='";"8.5";"nM";"8.07";"";"388360";"UO_0000065";"10.15";"0.20";"2.18";"4.65";"False";"CHEMBL3888303";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 μg/well for beta1 and 5 μg/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 μl, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 μM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886646";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL1405";"ESTRONE";"4";"270.37";"0";"3.82";"ESTRONE";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL4475573";"";"0";"593.77";"1";"0.24";"6.1d";"CC(C)NCC(O)COc1ccccc1CCCSCC(=O)NCCOCCOCCNC(=O)CS(=O)(=O)O";"IC50";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"11.90";"0.25";"6.83";"4.10";"False";"CHEMBL4312088";"Antagonist activity at human recombinant beta2 adrenoreceptor expressed in CHOK1 cells incubated for 30 mins by HTRF";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4311931";"1";"Scientific Literature";"MedChemComm";"2019";"None";""
"CHEMBL3892021";"";"0";"740.95";"3";"6.25";"BDBM200743";"CN(CCCn1ccc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1";"IC50";"'='";"220.0";"nM";"6.66";"";"356811";"UO_0000065";"8.99";"0.17";"0.41";"4.75";"False";"CHEMBL3887836";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 ug/well for beta1 and 5 ug/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 ul, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 uM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886468";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL3961014";"";"0";"757.94";"3";"4.94";"BDBM200742";"CN(CCCn1c(=O)[nH]c2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1";"IC50";"'='";"120.0";"nM";"6.92";"";"356810";"UO_0000065";"9.13";"0.18";"1.98";"4.00";"False";"CHEMBL3887836";"Adrenergic Receptor Binding Assay: The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are overexpressed (Perkin Elmer). The membrane suspensions (16 ug/well for beta1 and 5 ug/well for beta2) in assay buffer (75 mM Tris/HCl with 12.5 mM MgCl2 and 2 mM EDTA pH=7.4) were incubated with 0.14 or 0.6 nM of 3H-CGP12177 (Amersham) for beta 1 and beta 2 receptors respectively in a final volume of 250 ul, in GFC Multiscreen 96 well plates (Millipore) previously treated with assay buffer containing 0.3% PEI (Sigma). Non specific binding was measured in the presence of 1 uM propanolol. Incubation was maintained for 60 minutes at room temperature and with gentle shaking. The binding reactions were terminated by filtration and washing with 2.5 volumes of Tris/HCl 50 mM pH=7.4.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886468";"37";"BindingDB Database";"";"2016";"CHEMBL3308860";""
"CHEMBL4542960";"";"0";"571.78";"1";"2.76";"6.1a";"CC(C)NCC(O)COc1ccccc1CCCSCC(=O)NCCOCCOCCNC(=O)OC(C)(C)C";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"13.39";"0.27";"4.90";"6.01";"False";"CHEMBL4312088";"Antagonist activity at human recombinant beta2 adrenoreceptor expressed in CHOK1 cells incubated for 30 mins by HTRF";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4311931";"1";"Scientific Literature";"MedChemComm";"2019";"None";""
"CHEMBL4527905";"";"0";"1267.57";"None";"None";"6.2c";"C=CCc1ccccc1OCC(O)CNCCOCCOCCOCCOCCNC(=O)CCCCCC1(C)C(/C=C/C=C/C=C2/N(CCCS(=O)(=O)O)c3ccc(S(=O)(=O)O)cc3C2(C)C)=[N+](CCCS(=O)(=O)[O-])c2ccc(S(=O)(=O)O)cc21";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"4.97";"None";"None";"None";"False";"CHEMBL4312088";"Antagonist activity at human recombinant beta2 adrenoreceptor expressed in CHOK1 cells incubated for 30 mins by HTRF";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4311931";"1";"Scientific Literature";"MedChemComm";"2019";"None";""
"CHEMBL4545079";"";"0";"548.66";"1";"-0.19";"6.2d";"C=CCc1ccccc1OCC(O)CNCCOCCOCCOCCOCCNC(=O)CS(=O)(=O)O";"IC50";"'='";"83.4";"nM";"7.08";"";"";"UO_0000065";"12.90";"0.26";"7.27";"4.37";"False";"CHEMBL4312088";"Antagonist activity at human recombinant beta2 adrenoreceptor expressed in CHOK1 cells incubated for 30 mins by HTRF";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4311931";"1";"Scientific Literature";"MedChemComm";"2019";"None";""
"CHEMBL603";"ZAFIRLUKAST";"4";"575.69";"2";"5.70";"ZAFIRLUKAST";"COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1483";"ALBENDAZOLE";"4";"265.34";"0";"3.24";"ABZ";"CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL266195";"ALPRENOLOL";"0";"249.35";"0";"2.15";"6";"C=CCc1ccccc1OCC(O)CNC(C)C";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"34.01";"0.64";"6.33";"20.44";"False";"CHEMBL4312088";"Antagonist activity at human recombinant beta2 adrenoreceptor expressed in CHOK1 cells incubated for 30 mins by HTRF";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4311931";"1";"Scientific Literature";"MedChemComm";"2019";"None";""
"CHEMBL141";"LAMIVUDINE";"4";"229.26";"0";"-0.59";"3TC";"Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL179166";"SODIUM ORTHOVANAD";"0";"183.91";"None";"None";"SODIUM ORTHOVANADATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL389621";"HYDROCORTISONE";"4";"362.47";"0";"1.78";"Hydrocortisone";"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1512";"FLUNISOLIDE";"4";"434.50";"0";"2.27";"Flunisolide";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL267345";"AMPHOTERICIN B";"4";"924.09";"3";"0.71";"amphotericin B";"C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL435";"HYDROCHLOROTHIAZIDE";"4";"297.75";"0";"-0.35";"HYDROCHLOROTHIAZIDE";"NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL631";"PROPAFENONE";"4";"341.45";"0";"3.24";"PROPAFENONE";"CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"21.33";"0.40";"4.04";"12.44";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL2";"PRAZOSIN";"4";"383.41";"0";"1.78";"PRAZOSIN";"COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL44";"GENISTEIN";"2";"270.24";"0";"2.58";"GENISTEIN";"O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL101";"PHENYLBUTAZONE";"4";"308.38";"0";"3.79";"PHENYLBUTAZONE";"CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL157101";"KETOCONAZOLE";"4";"531.44";"1";"4.21";"Ketoconazole";"CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL595";"PIOGLITAZONE";"4";"356.45";"0";"3.16";"PIOGLITAZONE";"CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL123292";"CYCLOHEXIMIDE";"0";"281.35";"0";"1.04";"CYCLOHEXIMIDE";"C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL55";"PENTAMIDINE";"4";"340.43";"0";"2.88";"PENTAMIDINE";"N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL49";"BUSPIRONE";"4";"385.51";"0";"2.09";"1";"O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL3039597";"GENTAMICIN";"4";"1390.73";"None";"None";"gentamycin";"CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL437";"SULFATHIAZOLE";"4";"255.32";"0";"1.53";"SID90559";"Nc1ccc(S(=O)(=O)Nc2nccs2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1069";"VALSARTAN";"4";"435.53";"0";"4.16";"Valsartan";"CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1729";"CISAPRIDE";"4";"465.95";"0";"3.36";"1";"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"False";"CHEMBL858809";"Binding affinity to adrenergic beta-2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149398";"1";"Scientific Literature";"J. Med. Chem.";"2006";"None";""
"CHEMBL84158";"TIAPRIDE";"3";"328.43";"0";"1.17";"SID11111853";"CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL428647";"PACLITAXEL";"4";"853.92";"2";"3.74";"Taxol";"CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL490";"PAROXETINE";"4";"329.37";"0";"3.33";"PAROXETINE";"Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL64391";"ITRACONAZOLE";"4";"705.65";"3";"5.58";"ITRACONAZOLE";"CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL53463";"DOXORUBICIN";"4";"543.53";"3";"0.00";"DOXORUBICIN";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1024";"IFOSFAMIDE";"4";"261.09";"0";"1.88";"SID301170";"O=P1(NCCCl)OCCCN1CCCl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1489";"AZACITIDINE";"4";"244.21";"0";"-3.17";"SID56463100";"Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL661";"ALPRAZOLAM";"4";"308.77";"0";"3.58";"Alprazolam";"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL131";"PREDNISOLONE";"4";"360.45";"0";"1.56";"prednisolone";"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL83";"TAMOXIFEN";"4";"371.52";"1";"6.00";"Tomoxifen";"CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL422";"TRIFLUOPERAZINE";"4";"407.51";"0";"4.95";"Trifuoperazine";"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL1403281";"ERGOCRYPTINE";"0";"575.71";"1";"2.43";"ALPHA-ERGOCRYPTINE";"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL6";"INDOMETHACIN";"4";"357.79";"0";"3.93";"INDOMETHACIN";"COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
"CHEMBL9";"NORFLOXACIN";"4";"319.34";"0";"1.27";"NORFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"False";"CHEMBL1909092";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"CHO";"Membrane";"";"";"";"CHEMBL210";"Beta-2 adrenergic receptor";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"CHEMBL3308072";""
